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“To think is to forget differences, generalize, make abstractions.” 







Calcium/Calmodulin-dependent kinase II (CaMKII) is a serine/threonine kinase with a 
wide range of substrates. A number of studies have established that CaMKII is 
fundamentally important for various learning and memory processes. Given this 
importance the activity of CaMKII must be tightly regulated. Two endogenous inhibitor 
proteins of CaMKII, CaMK2N1 and CaMK2N2, have been identified. During contextual 
fear memory formation CaMK2N1 and CaMK2N2 expression increases in brain regions 
that are related to the task. However, the functions of CaMK2Ns are still unknown. Our 
aim was to study the physiological roles of these inhibitors in memory and learning. For 
that purpose we used adeno-associated virus vector to either knockdown the expression 
of CaMK2N1 or overexpress CaMK2N2 in the dorsal hippocampus of mice. Animals were 
trained and tested in contextual fear conditioning paradigm. The knockdown of 
CaMK2N1 expression had no effect on long-term memory formation, but it impaired 
long-term memory maintenance after retrieval. Western blot analyses revealed that 
CaMK2N1 knockdown prevents a decrease in T286 phosphorylation of αCaMKII induced 
by memory testing, as well as a reduction of GluA1 and c-fos levels. This puts forward 
the hypothesis that CaMK2N1 is necessary for inducing a decrease in neuronal activation 
after memory retrieval and that this process is required for memory maintenance. 
Regarding the hippocampal overexpression of CaMK2N2, treatment prior to training 
blocked contextual memory formation. On the other hand, overexpression of the same 
inhibitor after training had no effect on contextual long-term memory maintenance. 
These results support the view persistent CaMKII activity is not the molecular basis of 
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Chapter 1 Introduction 
1.1 Learning and memory 
 Learning and memory are key abilities for the survival of our species and 
throughout the evolution of life on this planet one can follow the emergence of more 
complex learning/memory abilities corresponding to the phylogenetic hierarchy 
(Jensen, 1971). Consequently, these cognitive processes are not unique of our species 
and were adapted and diversified during the evolution of different species. 
Furthermore, it is plausible to assume that different species share learning/memory 
mechanisms. The cognitive process of learning and memory can be divided into three 
different processes: memory formation, memory storage and memory retrieval. 
Memory formation, or learning, as defined by Pavlov (1926) is the association of two 
distinct environmental stimuli resulting in similar behavioural response for both stimuli, 
nowadays called associative learning. However, the learning process is complex. For 
example, memory formation after one training trial and memory formation after 
repeated training trials have different biological substrates (Irvine et al., 2006). It is also 
known that different stimuli require different processing by the brain (Bentz and Schiller, 
2015; McCarthy et al., 1997). Long-term memory formation requires a transient 
consolidation process shortly after training. Typically the cellular mechanism of 
consolidation is completed within 24 hours. Memory consolidation has first been 
proposed by Müller and Pilzecker (1900) based on their observation that, in humans, a 
newly learned information was disrupted by the learning of another information shortly 
after the original learning, but not if it happened a long period after learning of the first 
information. Müller and Pilzecker (1900) suggested that processes underlying new 




was corroborated by the observation that blocking of previously learned information 
could be achieved by pharmacological inhibition of protein synthesis (Agranoff et al., 
1966; Schafe and LeDoux, 2000). After consolidation memory is belived to be stored and 
maintained. Once information is stored it can be retrieved by an environmental stimulus 
which results in behavioural responses in accordance to the previous learned 
information. The retrieval of a memory could result in memory extinction or memory 
reconsolidation (Almeida-Correa and Amaral, 2014; Baldi and Bucherelli, 2015). The first 
evidence of memory reconsolidation process was presented by Misanin et al. (1968), by 
observation of an amnesic effect of electroconvulsive shock 24 hours after fear 
conditioning training dependent on the presentation of the conditioned stimulus. In  
other words, the associative memory between a neutral conditioned stimulus and an 
unconditioned stimulus (shock) was lost after electroconvulsive shock only if the 
memory was retrieved (Misanin et al., 1968). This observation challenged the long 
prevailing theory that memories once consolidated would no longer be labile. Recently, 
memory reconsolidation has been shown to be an important process for the 
maintenance and further strengthening of a memory (Fukushima et al., 2014; Lee, 
2008). Memory extinction, on the other hand, is the learning of new environmental 
conditions that suppresses the previously learned conditioned response (Myers and 
Davis, 2007; Pape and Pare, 2010; Quirk and Mueller, 2008). Memory extinction was 
first described by Pavlov (1926), and it presents behavioural and molecular specificities 
that will be explained in more detail on subchapter “1.5.4 CaMKII and memory 
extinction”. Due to their opposite outcomes, memory reconsolidation and memory 
extinction are considered to be two opposing processes that have different biological 
substrates (Baldi and Bucherelli, 2015; Eisenhardt and Menzel, 2007; Suzuki et al., 2004). 




are actually two different outcomes of the same process and that they share biological 
substrates (Almeida-Correa and Amaral, 2014; Trent et al., 2015). Since most extinction 
protocols require different sessions of re-exposure to the context for extinction to occur, 
Fiorenza et al. (2011) even talks about reconsolidation of the extinction of a memory. 
The molecular bases of the different memory processes explained above will be 
discussed in detail further ahead in this thesis.  
 An important step in the understanding of learning/memory processes was the 
discovery of the electrophysiological phenomenon of long-term potentiation (LTP) (Bliss 
and Collingridge, 1993; Bliss and Lomo, 1973). LTP is a long-lasting increase in synaptic 
transmission that is induced by previous synaptic activity (Bliss and Collingridge, 1993; 
Bliss and Lomo, 1973). LTP is considered to be an important biological substrate for 
learning and memory (Gruart et al., 2015; Maren and Baudry, 1995; Teyler and Discenna, 
1984). In terms of learning, it is known that fear conditioning training induces the 
occurrence of LTP (Rogan et al., 1997), as well as training in other tasks like trace 
eyeblink conditioning (Gruart et al., 2006) and inhibitory avoidance task (Whitlock et al., 
2006). Additionally, genetic and pharmacological manipulations that impaired LTP 
induction also impaired memory formation, as observed by Giese et al. (1998) with a 
knock-in mutation in CaMKII and Gruart et al. (2006) with the blocking of the N-methyl-
D-aspartate receptor (NMDAR). Regarding LTP and memory, Abraham et al. (2002) have 
shown that in the rat brain LTP can last for several months, which means that LTP is a 
feasible biological substrate for memory. Corroborating this hypothesis first Ling et al. 
(2002) have shown that protein kinase Mzeta (PKMz) is necessary for LTP maintenance. 
Later Pastalkova et al. (2006) showed that blocking of PKMz blocks LTP maintenance and 




Indeed it is quite tempting to establish a comparison between LTP and the classical 
Hebbian postulation of a memory mechanism which states that “when neuron A 
repeatedly or persistently fires neuron B, then some metabolic or growth changes are 
induced so neuron A fires neuron B more efficiently” (Hebb, 1949). However, this 
comparison does not hold, since strictly speaking LTP is a synaptic event while Hebb’s 
postulate refers to neuronal firing.  
 Another biological substrate of memory is found in morphological changes at 
synapses. Synapses are the sites where two neurons establish a chemical 
communication and are composed of a presynaptic bouton in contact with a 
postsynaptic dendritic spine, more specifically with the postsynaptic density (PSD), 
which contains receptors, scaffold and signalling proteins (DeFelipe, 2006; Gu and 
Zheng, 2009). Dendritic spines are very plastic structures and their morphology can 
change due to synaptic activity (Yasumatsu et al., 2008). The function of these 
morphological changes are still poorly understood. Hung et al. (2008) observed that 
mice lacking Shank1, an important scaffold protein of the PSD, have more small dendritic 
spines and fewer larger dendritic spines, as well as, enhanced spatial learning but 
decreased memory maintenance. This seems to suggest that larger spines keep the 
memories while smaller spines enable learning. However, in a meta-analysis study by 
Marrone (2007) it was shown that a diversity of morphological changes in hippocampal 
dendritic spines is associated with different learning paradigms. Nevertheless, dendritic 
complexity and spine density were some of the parameters that were increased by 
different learning paradigms (Marrone, 2007). It seems clear as well that large spines 
have larger PSDs, and are more stable over time (Bourne and Harris, 2008). Finally, one 




Alzheimer’s disease patients were it was reported that the loss of synapses has the 
strongest correlation with the patient’s cognitive decline (DeKosky and Scheff, 1990; 
Terry et al., 1991).  
 Regarding studies of biological substrates of learning/memory the hippocampus 
has been one of the most studied areas of the brain. The association between the 
hippocampus and learning/memory has been of great interest since the classical case of 
Henry Gustav Molaison, known widely as HM (Scoville and Milner, 1957). HM was a 
patient with memory disorder caused by a bilateral medial temporal lobectomy which 
surgically removed the anterior two thirds of his hippocampus, parahippocampal 
cortices, entorhinal cortices, piriform cortices, and amygdala in an attempt to cure his 
epilepsy (Scoville and Milner, 1957). Since then, various studies have shown that lesion 
or blocking of hippocampal activity has deleterious effects on learning and memory 
(Bannerman et al., 2004; Greene, 1971; Ricci et al., 2015; Smieskova and Svorad, 1965; 
Wang et al., 2015a; Yoon et al., 2008). As proposed by O'Keefe and Nadel (1978) the 
hippocampus seems to be the neural substrate of a cognitive map of space. In fact, 
various spatial memory tasks for rodents have been shown to be hippocampus 
dependent, for example the radial arm maze (Mitchell et al., 1982), T-maze (Rawlins and 
Olton, 1982), the Morris water maze (MWM) (Morris et al., 1982) and the contextual 
fear conditioning (CFC) (Kim and Fanselow, 1992; Phillips and LeDoux, 1992). The 
prevailing theory was that memories were initially stored in the hippocampus but then 
‘transfered’ to neocortex. This hypothesis was corroborated by impairment of 
contextual fear memory by hippocampal lesioning only if the lesion was done one day 
after training but not if it happened at a more distant time point (Anagnostaras et al., 




observation by Goshen et al. (2011) that quick and selective blocking of the neuronal 
activity at the hippocampal sub-region CA1, by optogenetics, abolishes the recall of 
contextual fear memory even weeks after contextual fear training. Goshen et al. (2011) 
further observed that continuous blocking would trigger an adaptive shift of the memory 
to alternative structures of the brain, which could explain the independence of long-
term contextual fear memories of the hippocampus previously reported by other 
authors (Anagnostaras et al., 1999; Kim and Fanselow, 1992). 
 CFC is a hippocampus-dependent Pavlovian conditioning task in which a neutral 
context [conditioned stimulus (CS)] is associated with an aversive unconditioned 
stimulus (US). After conditioning the CS evokes a learned fear response, the conditional 
response (CR) (Maren, 2008; Pavlov, 1926; Phillips and LeDoux, 1992). The CFC paradigm 
uses a mild foot-shock as US, freezing behaviour as CR and the trained context as CS (box 
size, texture, colour, smell…). Context in which the associative memory was formed has 
been proved to be an efficient stimulus to elicited memory recall as shown by 
presentation of the CR by the animal (Bouton, 1993; Bouton and Swartzentruber, 1986). 
Due to the fact that CFC memory can be formed with one trial only the CFC allows for 
the separated study of memory formation, consolidation and retrieval induced process. 
With respect to retrieval-induced process, CFC has been frequently used to study 
memory extinction by prolonged and repetitive exposition to the context without shock 
(Liu et al., 2015; Wang et al., 2015b). It can also be used to confirm extinction by 
reinstatement with a weak shock (Rescorla and Heth, 1975; Trent et al., 2015) or with a 
shock in a different context (Corcoran et al., 2013). One short re-exposure to the context 
without a shock is used as protocol to study memory reconsolidation (Lee, 2008; Lee et 




paradigm has also been used as a tool for studying post-traumatic stress disorder (PTSD) 
(Eskandarian et al., 2013; Pinna and Rasmusson, 2014; Steiger et al., 2015) and 
generalized anxiety disorder (GAD) (Luyten et al., 2011). CFC memory is a hippocampus-
dependent memory (Phillips and LeDoux, 1992). More specifically the dorsal 
hippocampus plays a key role in CFC memory. Lesion of the dorsal hippocampus causes 
retrograded amnesia of the context if done after CFC training, without affecting tone 
memory (Anagnostaras et al., 2001; Anagnostaras et al., 1999; Kim and Fanselow, 1992). 
On the other hand, the ventral hippocampus seems to have a role in contextual and 
cued fear memory (Anagnostaras et al., 2001; Bhardwaj et al., 2014; Zhu et al., 2014). 
The amygdala has also been shown to be relevant for contextual (Phillips and LeDoux, 
1992) and cued fear memory (Nader et al., 2000; Phillips and LeDoux, 1992). Although 
studies with animal models like the CFC paradigm have helped establish the 
hippocampus, LTP and synaptic plasticity as biological substrates for fear learning and 











1.2 Calcium/Calmodulin-dependent kinase II  
CaMKII is the major post-synaptic density (PSD) protein and accounts for 1-2% of 
total protein in the brain (Cheng et al., 2006; Erondu and Kennedy, 1985; Peng et al., 
2004). CaMKII is a serine/threonine kinase composed of an auto-inhibitory regulatory 
domain, an N-terminal kinase domain and a C-terminal self-association domain (Chao et 
al., 2011; Hell, 2014). During resting state this enzyme is inactive due to blocking of the 
substrate binding site (S-site) and the catalytic domain, both found in the kinase domain, 
by the pseudosubstrate segment in the regulatory domain (Braun and Schulman, 1995a; 
Hell, 2014). The existence of two structurally different inactive states of CaMKII has been 
proposed by Stratton et al. (2013). His hypothesis is based on the differenct diameters 
of CaMKII when observed by electron microscopy (Kolodziej et al., 2000), small angle X-
ray scattering (Rosenberg et al., 2005) or crystallography (Chao et al., 2011). The two 
states would exist in equilibrium with one state being more compact where the kinase 
domain is in high proximity with the self-association domain, whilst the other inactive 
state of the enzyme would be more open with the kinase and regulatory domains further 
apart from the self-association domain (Hell, 2014; Stratton et al., 2013). Only the 
second state would allow the binding of calcium/calmodulin complex (CaM) to the 
enzyme (Hell, 2014; Stratton et al., 2013). Binding with CaM causes a conformation 
change in CaMKII that unblocks the kinase domain from the inhibitory domain activating 
the enzyme (Colbran et al., 1989; Grant et al., 2008; Meyer et al., 1992). However, 
continuous activation of CaMKII by high levels of CaM might actually inhibit CaMKII and 
cause punctate deposition (Grant et al., 2008). A schematic representation of the two 
inactive states of CaMKII and activation by CaM can be seen in Figure 1.2-1. It is 
important to notice that CaMKII activation is regulated by calcium influx in the cell, but 




be facilitated by a 200-ms-long prepulse to +160 mV (Lee et al., 2006). This facilitation 
of calcium influx is abolished by pharmacological blocking of CaMKII kinase activity (Lee 
et al., 2006). Furthermore, Lee et al. (2006) observed that CaMKII coimmunoprecipitated 
with the calcium channel Cav1.2, and that Cav1.2 phosphorylation at serine 1512 and 
serine 1570 by CaMKII is necessary for voltage-induced facilitation of calcium influx. 
Binding of CaMKII to Cav1.2 has been shown to occur in the C and N terminal domains 
of this calcium channel, causing an increase of its expression at the cell surface (Hudmon 
et al., 2005; Simms et al., 2015). Other calcium channels have also been shown to bind 
to CaMKII causing an increase in calcium influx, like for example the calcium channel 
Cav1.3 (Jenkins et al., 2010) and Cav2.1 (Magupalli et al., 2013). CaMKII has a wide range 
of substrates and is involved in many aspects of cellular function, such as the regulation 
of ion channel function, neurotransmitter release, gene transcription, cytoskeleton 
organization and intracellular calcium homeostasis (Erondu and Kennedy, 1985; 
Hudmon and Schulman, 2002; Lisman et al., 2002; Lisman et al., 2012; Lucchesi et al., 
2011; Tobimatsu and Fujisawa, 1989). In mammals 4 different isoforms of this enzyme 
are expressed: α, β, γ and δ isoforms (Gaertner et al., 2004; Tobimatsu and Fujisawa, 
1989). The most abundant isoforms in the brain are α and β CaMKII (Bennett et al., 1983; 
Peng et al., 2004; Tobimatsu and Fujisawa, 1989). These two isoforms differ in their 
kinetic of interaction with CaM, with α isoform requiring approximately 3 times the 
concentration of CaM needed by the β isoform to achieve the same levels of activation 
(De Koninck and Schulman, 1998). βCaMKII, but not αCaMKII, is capable of interaction 
with F-actin (Fink et al., 2003; Okamoto et al., 2009). This unique ability of βCaMKII to 
interact with F-actin has been proposed to be important in the regulation of the size and 
shape of the dendritic spines (Fink et al., 2003) and CaMKII localization in the cell 




the brain. While the α isoform is the predominant isoform in hippocampus and 
neocortex, βCaMKII is most expressed in cerebellum (Cheng et al., 2006; Erondu and 
Kennedy, 1985; Peng et al., 2004). Furthermore, hippocampal levels of αCaMKII tend to 
increase with neuronal activity whilst βCaMKII levels tend to decrease (Thiagarajan et 
al., 2002). Comparison between βCaMKII knockout mice and αCaMKII knockout also 
seems to indicate different functions for these two isoforms. βCaMKII knockout mice 
have impaired LTP in hippocampal neurons, increased long-term depression (LTD) in 
cerebellar neurons, motor impairment, cognitive impairment, decreased anxiety-
related behaviour and a developmental delay in body weight gain (Bachstetter et al., 
2014; Borgesius et al., 2011; van Woerden et al., 2009). On the other hand αCaMKII 
knockout mice have impaired LTP and impaired spatial learning but no change in motor 
skills or body weight gain (Silva et al., 1992a; Silva et al., 1992b). 
Nevertheless, those isoforms are usually associated with both isoforms creating a 
holoenzyme composed of 12 CaMKII subunits organized into two hexameric rings (Hoelz 
et al., 2003; Kolodziej et al., 2000; Rosenberg et al., 2005) (Figure 1.2-1). The 12 subunits 
mainly include α and β CaMKII, creating heteromers, but homomers consisting of only 
αCaMKII have been found (Bronstein et al., 1988b). In fact, rat forebrain CaMKII is 
composed of αCaMKII homomers and αCaMKII and βCaMKII heteromers with a ratio of 
2 α subunits to 1 β (Brocke et al., 1999). The organization of this enzyme in a complex of 
subunits facilitates the occurrence of autophosphorylation. Among the known 
autophosphorylation sites of CaMKII are threonine 305 (T305) and threonine 306 (T306). 
Phosphorylation of these sites is believed to be inhibitory due to blocking of the CaM 
binding site, causing CaMKII to translocate out of the PSD area, and decreasing LTP and 




However, very little is known about these phosphorylation sites. The most studied 
autophosphorylation site of CaMKII is at threonine in position 286 (T286) present in 
αCaMKII. In βCaMKII this threonine is in position 287. Phosphorylation of the T286/287 
sites seems to occur between neighbouring subunits of the same holoenzyme and 
requires binding of CaM to both subunits involved (Hanson et al., 1994; Mukherji and 
Soderling, 1994; Rich and Schulman, 1998) (Figure 1.2-1). On the contrary, T305/306 
autophosphorylation seems to occur within the same subunit and independently of CaM 
(Mukherji and Soderling, 1994). Phosphorylation at T286/287 allows CaMKII to remain 
in an active state even in the absence of CaM, a CaM-independent state of activation 
(Hanson et al., 1994; Irvine et al., 2006; Miller et al., 1988). T286 autophosphorylation 
also enhances CaM binding to the enzyme with an increase of 1000 times in the affinity 
between these two molecules and an increase in release time from less than a second 
to hundreds of seconds (Meyer et al., 1992). This phenomenon has been called CaM 
trapping, and it might play an important role in the increase of CaMKII kinase activity 
after T286 phosphorylation (Hell, 2014; Irvine et al., 2006; Meyer et al., 1992). Indeed 
autophosphorylation of T286/287 allows for longer and stronger translation of calcium 
spike frequency into kinase activity (De Koninck and Schulman, 1998; Fujii et al., 2013). 
T286/287 autophosphorylation also changes CaMKII binding to other molecules. It, for 
example, decreases βCaMKII affinity for F-actin (Shen and Meyer, 1999) and increases 
holoenzyme binding to NMDAR (Bayer et al., 2001). These two binding changes due to 
T286/287 phosphorylation will be discussed in more detail further on this thesis.  
Given the importance of the phosphorylation of T286/287 in CaMKII it is only 
logical to conclude that its dephosphorylation is also an important process for regulation 




dephosphorylation of CaMKII is a key process for controlling CaMKII activity and function 
in long-term changes at the synapses (Kubota and Bower, 2001; Zhabotinsky, 2000). The 
first phosphatases of CaMKII identified were the protein phosphatase PP1, PP2A, PP2B 
and PP2C, that were identified using immunoblotting, chromatography and 
phosphatase inhibitors/activators (Strack et al., 1997). Strack et al. (1997) also reported 
that most of CaMKII dephosphorylation was due to the activity of PP1 and PP2A, with 
PP1 activity more prominent in the PSD and PP2A in the cytosol. PP1 inhibition has been 
shown to be important for the induction of CaMKII-dependent LTP, as shown by 
exogenous and endogenous inhibition of PP1 (Blitzer et al., 1998; Brown et al., 2000). 
Furthermore, PP1 hippocampal mRNA levels were increased in animals with poor 
learning performance in the MWM task (Haege et al., 2010). Hippocampal PP1 and PP2A 
are also necessary for induction of LTD and associated dephosphorylation of 
calcium/cAMP-response element binding protein (CREB) (Mauna et al., 2011). In spite 
of that, the function of PP1 and PP2A in learning and memory cannot be conclusively 
associated with its dephosphorylation of CaMKII, since PP1 and PP2A have also been 
shown to regulate posttranslational modifications of histones with effects on learning 
and memory (Koshibu et al., 2011; Preethi et al., 2014). Another CaMKII phosphatase 
was described by Ishida et al. (1998a) and named CaMKIIPase. Initially thought to be a 
phosphatase specific for CaMKII, CaMKIIPase was later found to also dephosphorylate 
CaMKI and CaMKIV (Ishida et al., 1998b). This serine/threonine phosphatase has its 
activity regulated by Mn2+ levels and its substrate specificity seems to be determined by 
the substrate’s tertiary and secondary structure, more than by its primary structure 
(Ishida et al., 1998a; Ishida et al., 2001). To my knowledge, until the present date no 







Figure 1.2-1 CaMKII holoenzyme  
The figure shows a schematic representation of CaMKII holoenzyme in different states of activation. On the top of 
the figure the different domains of CaMKII subunits and interacting molecules are shown. (A) This panel shows CaMKII 
in its most inactive state, with the regulatory domain connected to the T-site (a hydrophobic region in the kinase 
domain) and S-site of the kinase domain. Both domains are packed in close proximity to the self-association domain 
(Braun and Schulman, 1995a; Hell, 2014). (B) This panel shows the CaMKII in two different states of activation. One is 
an inactive state were the regulatory domain is still blocking the kinase domain, however these domains are found 
further apart from the self-association domain. Only this more open state of inactivation allows CaM to bind to CaMKII 
(Hell, 2014; Stratton et al., 2013). Binding of CaM to CaMKII releases the kinase domain from the regulatory domain 
exposing the S-site, as represented in this panel (Colbran et al., 1989; Grant et al., 2008; Meyer et al., 1992). (C) Once 
activated by CaM, CaMKII will start the autophosphorylation of its subunits at the T286/T287 site. CaM bound to 
CaMKII is necessary for this phosphorylation to occur but not for the maintenance of it. This means that CaMKII 
remains active and phosphorylated at T286/T287 even after CaM is no longer bound to it (Hanson et al., 1994; Irvine 
et al., 2006; Miller et al., 1988). (D) This panel represents the inhibition of CaMKII by the endogenous inhibitors 
CaMK2N1 and CaMK2N2. The inhibitors of CaMKII bind to the enzyme at the regulatory domain and the T-site, 
blocking access of the substrate to the S-site but without directly blocking the T286/T287 site (Chang et al., 2001; Vest 

















1.3 The T286 autophosphorylation theory and LTP 
Due to the ability to switch from a CaM-dependent to a CaM-independent state 
of activation (bistability), CaMKII has been suggested to act as a memory molecule 
preserving “memories” of strong calcium signals (Lisman, 1994). Before the publication 
of his paper in 1994 (Lisman, 1994), Lisman used mathematical models to study if CaMKII 
bistability was a good candidate to store long-term memory (Lisman and Goldring, 
1988a; Lisman and Goldring, 1988b). His models suggested that CaMKII autonomous 
activity could be stable enough to maintain LTP and memories for a lifetime. These 
models were based in the hypothesis that T286 autophosphorylation of neighbouring 
subunits could overcome the dephosphorylation rate of CaMKII, maintaining the 
enzyme activated for a long time. Furthermore, it would also be necessary that degraded 
subunits were replaced by newly synthesized subunits that would subsequently be 
phosphorylated at the T286/287 site by their neighbouring subunits (Irvine et al., 2006; 
Lisman, 1994; Lisman and Goldring, 1988a; Lisman, 1985; Lisman and Goldring, 1988b). 
However, a more recent computational model proposes that this might not be the case. 
Using analysis of the stochastic transition between the ON and OFF states of CaMKII as 
a consequence of T286 phosphorylation, Miller et al. (2005) have reported the 
autophosphorylation to be stable only for a few years.  
However, Miller et al. (2005), Lisman and Goldring (1988a) and Lisman and 
Goldring (1988b) models are unlikely to be corrected. Various authors have suggested 
that LTP induction only results in a transient increase in CaMKII autonomous activity, 
lasting for only a few minutes (Fujii et al., 2013; Lee et al., 2009; Lengyel et al., 2004). 
For example, at the level of single synapses, Fujii et al. (2013) and Lee et al. (2009) used 




energy transfer (FRET)-based sensor to study CaMKII activity and observed that LTP 
induction leads only to transient increase of CaM-independent activity. Lengyel et al. 
(2004) analysed CaMKII CaM-independent kinase activity by quantifying incorporation 
of radioactive phosphorus in CaMKII’s substrate autocamide-2 in the presence of EGTA 
after LTP-inducing electric stimulation and did not detect any changes in autonomous 
CaMKII kinase activity. According to the authors, this might be due to the fact that a 
change in autonomous CaMKII activity was too transient to be detectable, too small to 
be measured or it may not occur. Therefore, the same authors used a chemical 
stimulation to induce LTP and short-term potentiation (STP) and they noticed that both 
protocols produce very similar effects on CaMKII autonomous activity. These 
stimulations led only to a transient increase in CaMKII autonomous activity that lasts up 
to 5 minutes. Interestingly, T286 autophosphorylation, measured by immunoblotting, 
remained elevated for longer. STP would be accompanied by an increase in T286 
autophosphorylation that disappeared after 10 min. LTP induction, on the other hand, 
resulted in increased T286 autophosphorylation even after 60 min (Lengyel et al., 2004). 
Lengyel et al. (2004) observations not only confirm that LTP induction results in transient 
increase in CaMKII kinase activity as it also reveals that CaMKII autonomous kinase 
activity and T286 autophosphorylation are not synonyms. Indeed, Tzortzopoulos and 
Torok (2004) accessed the induction of CaMKII kinase activaty by T286 phosphorylation, 
using smooth muscle myosin light chain as substrate and fluorometric quantyffication 
of kinase activaty, and observed that the majority of kinase activaty induced by T286 
phosphorylation was actually dependent of CaM. Thus, the contradiction between the 
empirical observations of LTP-induced CaMKII kinase activaty (Fujii et al., 2013; Lee et 
al., 2009; Lengyel et al., 2004) and  Miller et al. (2005), Lisman and Goldring (1988a) and 




consider the dependence of T286 induction of CaMKII kinase activaty to CaM availability 
(Tzortzopoulos and Torok, 2004). These models also do not consider how other post-
translational changes also regulate CaMKII kinase activaty. For example, A different 
mechanism of CaMKII CaM-independent activity has been described by Coultrap and 
Bayer (2014). αCaMKII seems to be regulated by nitrosylation of cysteines in the 
positions 280 and 289. These nitric oxide-induced nitrosylations at C280 and C289 
generate an autonomous state of CaMKII activity, which is independent of T286 
autophosphorylation and actually reduces T286 autophosphorylation. Interestingly, this 
mechanism has no impact on T305 autophosphorylation (Coultrap and Bayer, 2014).           
Although Miller et al. (2005), Lisman and Goldring (1988a) and Lisman and 
Goldring (1988b) models are unlikely to be correct they inspired many studies on the 
role of CaMKII autophosphorylation including the generation of knock-in mutant mice 
that contained a single point mutation in position 286, inhibiting the 
autophosphorylation by replacing threonine by an alanine (T286A) (Giese et al., 1998). 
The study of T286A mutant mice revealed that this autophosphorylation of αCaMKII is 
required for the induction of NMDAR-dependent LTP at excitatory hippocampal CA1 
synapses (Giese et al., 1998). Interestingly, in the first two weeks of postnatal life 
αCaMKII autophosphorylation is not required for CA1 LTP. There is a developmental 
switch changing CA1 LTP from protein kinase A (PKA)-dependence to CaMKII-
dependence (Yasuda et al., 2003). Further, LTP in dentate gyrus (DG), a brain area where 
constantly new neurons are born, does not require αCaMKII autophosphorylation. Wu 
et al. (2006) observed that the pharmacological block of CaMKII activity does not impair 
DG LTP. It is necessary to block PKA or MAPK/ERK kinase (MEK) together with CAMKII to 




present in these cells. The same results were observed in T286A DG cells. The mutation 
alone is not capable of blocking LTP. LTP is impaired only when PKA or MEK are also 
blocked in these cells (Cooke et al., 2006). In accordance with this observation, in obese 
Zucker rats, an obesity model, and also in a rat model of hypothyroidism αCaMKII T286 
autophosphorylation is reduced and CA1 LTP is impaired. On the other hand, the same 
models do not have impairred DG LTP (Alzoubi et al., 2005; Gerges et al., 2005).  
It is important to consider that even in a specific area of the hippocampus, like 
CA1, different types of synapses have different dependency of αCaMKII T286 
autophosphorylation for LTP formation. The results presented earlier which show a 
dependency of T286 αCaMKII autophosphorylation for LTP occurrence in CA1 area were 
conducted at excitatory synapses in pyramidal cells (Giese et al., 1998), but NMDAR-
dependent LTP at inhibitory synapses can be induce in the absence of T286 
autophosphorylation (Lamsa et al., 2007). This NMDAR-dependent LTP in inhibitory 
neurons is probably dependent of non-α isoforms of CaMKII, since αCaMKII is expressed 
only in glutamatergic neurons (Liu and Jones, 1996). However, since Lamsa et al. (2007) 
reported in the same article that the induction of this NMDAR-dependent LTP in 
inhibitory neurons can be blocked by unspecific pharmacological inhibition of 
calcium/calmodulin-dependent kinases, the relevance of other CaMKII isoforms cannot 
be discarded. Regarding neocortical cells, in vitro and in vivo experiments, using T286A 
animals, demonstrated a dependency on CaMKII T286 autophosphorylation for LTP 
induction (Hardingham et al., 2003). 
Taken together, functional studies have established that the T286 




NMDAR-dependent LTP, and it is unlikely that autonomous CaMKII activity maintains 
LTP, as this activity lasts only for a very short duration.  
 
1.4 CaMKII and learning 
Considering that CaMKII plays a pivotal role on hippocampal LTP induction, as 
mentioned above, one should expect that this enzyme would also be necessary for 
learning of a hippocampus-dependent task. Indeed the T286A mutant mice have one of 
the most severe learning deficits ever described for mice in the MWM task (Giese et al., 
1998; Need and Giese, 2003). Loss of T286 autophosphorylation seems to block strategy 
and spatial learning (Need and Giese, 2003). Environmental enrichment and handling do 
not overcome the spatial learning deficits in the T286A mutants (Need and Giese, 2003). 
Place cell recordings in T286A mutants have shown that the autophosphorylation is 
required for place cell spatial selectivity, stability and fine tuning (Cacucci et al., 2007; 
Cho et al., 1998). The T286A mutant mice are also impaired in memory formation in 
passive avoidance task, as well as cued and contextual fear conditioning (Irvine et al., 
2005). Gokcek-Sarac et al. (2013) reported that animals with “good” learning 
performance in the 12-arm radial maze have higher levels of T286-autophosphorylated 
αCaMKII in comparison with animals with “poor” performance and this difference is not 
simply the result of altered αCaMKII total levels. Lisman et al. (2012) proposed a model 
for the role of CaMKII in LTP induction based on the modulation of glutamate receptor 
activity. In short, CaM is produced by calcium influx through NMDAR. CaM activates 
CaMKII holoenzymes that are present in the synapse, therefore, initiating T286 and T287 
autophosphorylation. The T287 phosphorylation of βCaMKII subunits and CaM binding 




synapse. Once CaMKII reaches the PSD area, its localization is stabilized by binding to 
the NMDAR. CaMKII can actually bind to two different sites of the NMDAR. One site 
depends on CaMKII’s association to CaM (within residues 1,120-1,480 of the NMDAR) 
and a second binding site depends on T286 phosphorylation (residues 839-1,120) (Bayer 
et al., 2001). Bayer et al. (2001) even showed that, besides being anchored in the PSD 
area by the interaction with the NMDAR, this interaction might actually create an 
autonomous activity state of CaMKII, independent of CaM and also independent of 
autophosphorylation of its subunits. Although this is a very interesting finding by Bayer 
et al. (2001), the data were obtained from in vitro experiments and such mode of 
activation still has not been shown to occur in vivo. Autophosphorylated CaMKII in the 
PSD seems to increase glutamatergic transmission by phosphorylation of the α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit GluA1 at 
serine 831. This phosphorylation increases AMPA receptor conductance (Derkach et al., 
1999). Nevertheless, under basal or stimulated conditions only a minor percentage of 
all the GluA1 subunits in the synapses seems to be phosphorylated at serine 831 
(Hosokawa et al., 2015). CaMKII can also regulate the number of AMPAR in the synapses 
by phosphorylation of the protein stargazin. Stargazin is an AMPAR binding protein and 
once it is phosphorylated it also binds to the scaffold protein PSD-95, enhancing the 
number of AMPAR in the PSD area (Opazo et al., 2010; Tomita et al., 2005). This way an 
initial burst of calcium into the cell would lead to an increase in glutamatergic 
transmission. Such mechanism could be important for the induction of LTP. A schematic 
representation of this process can be seen in Figure 1.5-1. However, if we consider the 
turnover and dephosphorylation of proteins this mechanism is most likely transient and 
it cannot account for LTP maintenance, in accordance with the LTP studies already 




for CaMKII kinase activity is the serine at position 567 (Lu et al., 2010). The 
phosphorylation of this site by CaMKII has been shown to regulate AMPAR trafficking to 
the synapse (Lu et al., 2010). GluA1 S567 phosphorylation is induced by chemical or 
electrical induction of LTD and results in a decrease of AMPAR in the synapse (Coultrap 
et al., 2014; Lu et al., 2010). 
CaMKII interacts not only with the glutamatergic system, as presented above, but 
it also regulates and/or is regulated by other neurotransmitters like serotonin, glycine 
and gamma-aminobutyric acid (GABA). In terms of serotonin, it is known that 
inactivation of CaMKII by KN-93 increases serotonin signalling by decreasing the 
interaction of  plasma membrane serotonin transporter (SERT) with the protein syntaxin 
1A (Ciccone et al., 2008). Colocalization of SERT and αCaMKII has been observed by 
Steinkellner et al. (2015), who also observed that inhibition of αCaMKII impaired 
amphetamine-induced SERT-mediated substrate efflux. Additionally, Asaoka et al. 
(2015) reported that treatment of organotypic raphe slice cultures with the inhibitor of 
histone deacetylases trichostatin A caused an increase in serotonin release and an 
increase in αCaMKII mRNA levels. Inhibition of CaMKII by KN-93 and KN-62 prevented 
the trichostatin-induced increase in serotonin release (Asaoka et al., 2015). It has also 
been shown that pharmacological activation of the serotonin receptor 5-HT1A impairs 
learning of the passive avoidance task and reduces the learning-induced increase in 
hippocampal CaMKII levels, CaMKII T286 phosphorylation, and CaMKII calcium-
independent kinase activity (Moyano et al., 2004). Furthermore, inhibition of 5-HT1A, by 
treatment with the antagonist WAY-100635, reversed the effects of 5-HT1A activation in 




(Moyano et al., 2004). Taken together these observation suggest that CaMKII regulates 
the serotonergic system as it is regulated by it. 
Regarding GABA and glycine, CaMKII inhibition with KN-93, after unilateral 
cochlear ablation, facilitates GABA release in the medial nucleus of the trapezoid body 
and glycine release in the dorsal cochlear nucleus (Zhang et al., 2004). However, KN-93 
treatment after unilateral cochlear ablation decreased glycine release in the ipsilateral 
medial superior olive and in the lateral superior olive, suggesting different function of 
CaMKII on glycine regulation within different regions of the brain (Zhang et al., 2004). 
Moreover, activation of CaMKII in synaptosomal membrane fractions, by treatment with 
calcium and calmodulin, increased muscimol binding to GABAA receptor, and CaMKII 
inhibition with KN-93 reversed this effect (Churn and DeLorenzo, 1998). Blocking of 
CaMKII activity with KN-93 or tatCN21 also blocked learning induced GABAA-mediated 
miniature inhibitory postsynaptic potential in cortical neurons, which is suggested to be 
important for preventing uncontrolled synaptic strengthening and cortical 
overactivation (Ghosh et al., 2015). CaMKII seems to increase GABAA insertion in the 
membrane by phosphorylation of serine 383 within the β3 subunit of the GABAA 
receptor (Saliba et al., 2012). Marsden et al. (2010) has suggested that αCaMKII 
translocates to inhibitory synapses and regulates GABAA levels in the membrane after 
moderate NMDAR activation, while a stronger activation of NMDAR would favour 
CaMKII migration to excitatory synapses.  
It is important, however, to consider that the inhibitors of CaMKII used in most of 
the experiments cited above,  KN-93 and KN-62, have been shown to not be specific 
inhibitors of CaMKII affecting other molecules as well (Enslen and Soderling, 1994; 




Another possible molecular explanation for a role of CaMKII in learning emerges 
from the synaptic tag hypothesis (Figure 1.5-1). The synaptic tag theory proposes that 
during early LTP, a short lasting form of LTP, synapses can be “tagged”. Upon future 
stimulation of the neuron plasticity-related proteins (PRP) can be synthesized in the 
soma, which then freely diffuse into the dendrites but will only be taken up by previously 
tagged synapses to induce long lasting LTP (Frey and Morris, 1997). Redondo et al. 
(2010) have shown that although CaMKII is not necessary for production of PRP it is 
necessary for the tagging of the synapses. Although very interesting, Redondo et al. 
(2010)’s observation has a limitation. KN-93, a pharmacological blocker, was used to 
block CaMKII function. As shown in their article, this inhibitor is not specific for CaMKII, 
so the authors analysed different doses of KN-93 and decided to use a concentration of 
1μM. At this concentration KN-93 has a high affinity for CaMKII but there is still some 
inhibition of CREB phosphorylation. So the effects observed in synapse tagging by KN-
93 treatment cannot be considered to be dependent of CaMKII activity only. For a more 
complete discussion on the matter of the lack of specificity of KN-93 see Wayman et al. 
(2008).  
Another possible learning-related mechanism for CaMKII is metaplasticity. The 
state of activation of a neuron is defined by a balance between excitation and inhibition, 
between LTP and LTD. This balance is taken in account in the metaplasticity theory. 
Metaplasticity, which is commonly defined as “plasticity of synaptic plasticity”, involves 
the alteration of the threshold for LTP and/or LTD induction in response to the previous 
history of synaptic activity from a specific synapse (Hulme et al., 2013). In other words, 
metaplasticity is a shift in the balance between LTP and LTD due to an activity trigger 




stimulated synapses as to filter off subthreshold priming activities at synapses (Abraham 
and Tate, 1997). This learning mechanism has been proposed to be CaMKII dependent 
by Mayford et al. (1995). Those authors have suggested a role for CaMKII autonomous 
activity in metaplasticity by creating a different mutation on the T286 position of 
αCaMKII. Mayford et al. (1995) expressed a transgene that had the threonine in this site 
changed to an aspartic acid (T286D) mimicking the autophosphorylation. The transgene 
was expressed in addition to the endogenous CaMKII gene. As a result a metaplasticity 
phenotype was caused, favouring LTD over LTP. However, a later study conducted by 
Bejar et al. (2002) with the T286D mutant animals revealed that these mutants have 
altered expression of many proteins, including the inhibitory neuropeptide Y. Because 
of this, the metaplasticity phenotype in these mutants cannot be assigned directly to 
altered autonomous activity of CaMKII. Additionally Li et al. (2014) have observed that 
for a priming effect to occur a shift from a CaMKII dependent mechanism to a protein 
kinase Mzeta dependent mechanism may have to occur.  Although it is still too early to 
fully understand the role of CaMKII in metaplasticity phenomenon, the study by Mayford 
et al. (1995) was a very important first step. More recently, Coultrap et al. (2014) have 
shown that αCaMKII is important for both LTP and LTD. In their experiment it was 
observed that T286 phosphorylation was required for the induction of LTP and LTD. 
While in LTP CaMKII appears to phosphorylate the AMPAR subunit GluA1 at S831 
increasing its conductance, after LTD induction CaMKII phosphorylates GluA1 at S567, a 
phosphorylation site known to reduce synaptic GluA1 localization (Coultrap et al., 2014). 
Considering CaMKII as a metaplasticity switch, its control of the balance between LTP 
and LTD should respond to the history of stimulation of a neuron. Indeed continuous 
stimulation of CA1 cells from T286A mutant mice showed a decrease in the slow 




consequence of continued stimulation wild-type cells have an increased after-
hyperpolarisation, which is a negative feedback for neuronal firing. Since T286A neurons 
have a reduced after-hyperpolarisation response, this suggests that T286 
autophosphorylation might be a mechanism for downregulating the excitability of 
neurons as a response to a history of repetitive stimulation (Sametsky et al., 2009). 
Regarding weak stimulation, T286A cortical neurons have a higher threshold for 
intensity of the stimulus required to elicit a post-synaptic response (Pattinson et al., 
2006) corroborating with the hypothesis of a role for CaMKII in metaplasticity. In fact, 
T286 autophosphorylation is widely accepted as important biological substrate for 
learning, so that it is used as a tool to study the neuroanatomical substrates of learning. 
For example, Cox et al. (2014) have used the T286 phosphorylation to assess how 
unrestricted and restricted learning of a new environment leads to different patterns of 
activation in the hippocampus. However, further studies with the T286A mice have 
shown that there might be a non-CaMKII dependent learning mechanism.  
T286A animals show impaired learning but prolonged training can overcome this 
impairment. The mutants are capable of forming memories after contextual and cued 
fear conditioning once they were exposed to prolonged training protocols (Irvine et al., 
2011; Irvine et al., 2005). Furthermore Ohno et al. (2005) observed that T286A animals 
were able to learn trace eyeblink conditioning normally. It is worth noting that trace 
eyeblink conditioning requires a long training protocol. This T286A-independent 
memory formation mechanism seems to be dependent on the generation of multi-
innervated dendritic spines, which are postsynaptic spines that communicate with more 
than one presynaptic spine (Radwanska et al., 2011). It was also observed that long 




stimulation but this LTP was not synapse specific (Villers et al., 2014). The same authors 
also described that synaptse specific LTP can be achieved if the neurons are previously 
incubated for 2 hours with rapamycin, an inhibitor of mTOR-dependent translation, 
suggesting a possible change in the mechanism of LTP induction to a T286-independent 
mechanism (Villers et al., 2014).   
 
1.5 CaMKII and memory  
Although the relevance of CaMKII in learning has been established and widely 
accepted, its role in memory maintenance is still a matter of discussion. Buard et al. 
(2010) has shown that blocking CaMKII activity with systemic injection of the CaMKII 
inhibitor tatCN21, 1 hour before contextual fear conditioning testing session, had no 
effect on memory storage. The transient effect of LTP induction on CaMKII autonomous 
activity (Fujii et al., 2013; Lee et al., 2009; Lengyel et al., 2004), already mentioned, also 
seems to indicate an independence of memory maintenance to CaMKII activity. Despite 
these indications CaMKII has been proposed to be important for memory maintenance. 
The inhibition of CaMKII kinase activity by low doses of the synthetic peptide, CN21, had 
no effect on LTP maintenance. However, higher doses resulted in blocking CaMKII 
binding to the NMDAR and this impaired LTP maintenance, suggesting a more structural 
role for CaMKII (Sanhueza et al., 2011). 
 
1.5.1 Structural roles of CaMKII 
  Sanhueza and Lisman (2013) put forward a model for the molecular basis of 




the enzymatic complex. Once again it all starts with calcium influx through NMDAR, 
which creates CaM that activates CaMKII. Activated CaMKII passes through 
autophosphorylation at T286 and T287 and migrates to the PSD where it binds to 
NMDAR. This first part accounts for the need of kinase activity. When bound to the 
NMDAR in the PSD the CaMKII complex would work like a scaffolding protein, interacting 
with the NMDAR and actinin in the PSD area. This complex would then bind to densin, 
delta-catenin, AMPAR-binding protein (ABP) and N-cadherin in an even larger complex. 
The ABP protein could anchor AMPAR in the PSD area, while N-cadherin creates a 
physical trans-synaptic bound that enlarges synapses both pre and postsynaptically 
(Sanhueza and Lisman, 2013). A schematic representation of this mechanism is 
presented on Figure 1.5-1.  
CaMKII has also been proposed to be important in dendritic spine plasticity, which 
is considered a relevant mechanism for memory maintenance (Hell, 2014; Jourdain et 
al., 2003; McVicker et al., 2015; Okamoto et al., 2009; Okamoto et al., 2007). βCaMKII, 
but not αCaMKII, is capable of binding to and crosslinking F-actin filaments increasing 
their stability (Fink et al., 2003; Lin and Redmond, 2008; Okamoto et al., 2009; Okamoto 
et al., 2007). Upon CaM-dependent activation of βCaMKII and subsequent T287 
autophosphorylation βCaMKII is displaced from F-actin causing the enzymatic complex 
to migrate to the PSD area (Lin and Redmond, 2008; Shen and Meyer, 1999). 
Furthermore this dissociation allows actin polymerization, increasing spine size and 
numbers (Fink et al., 2003; Jourdain et al., 2003; Okamoto et al., 2007). Because of this 
Okamoto et al. (2009) have suggested a model in which in a basal state of activation F-
actin is bundled by βCaMKII. This interaction maintains the stability of spine structure. 




cytoskeleton leading to spine enlargement. Afterwards the T287 site is 
dephosphorylated and CaMKII complex binds again to F-actin and stabilizes the spine in 
this enlarged size. This could be an important mechanism for memory formation and/or 
maintenance by regulating the morphology of dendritic spines (Okamoto et al., 2009). 
A schematic representation of this process can be seen in Figure 1.5-1.  
Structural role of CaMKII in the synapse morphology might also include αCaMKII 
by interaction with α-actinin and densin, other cytoskeleton molecules. Both αCaMKII 
and βCaMKII bind to α-actinin by a segment in the CaMKII autoinhibitory domain, the 
same that binds to CaM (Hell, 2014; Robison et al., 2005b; Walikonis et al., 2001). 
Indeed, CaM and α-actinin compete for binding to CaMKII (Robison et al., 2005a). CaMKII 
binding with α-actinin increases binding of this enzyme with F-actin (Jalan-Sakrikar et 
al., 2012) and is likely to play a role in CaMKII localization at the synapse (Hell, 2014). 
T286 phosphorylation does not affect CaMKII binding with α-actinin but 
phosphorylation of CaMKII at the T306 or T305 sites does (Jalan-Sakrikar et al., 2012; 
Robison et al., 2005a). While phosphorylation of T306 directly blocks binding with α-
actinin, T305 phosphorylation might have an indirect effect, protecting CaMKII binding 
with α-actinin (Hell, 2014; Jalan-Sakrikar et al., 2012). Concerning CaMKII binding to 
densin, densin binds to the kinase domain of αCaMKII and βCaMKII (Jiao et al., 2011) 
and to the C-terminal of αCaMKII but not βCaMKII (Strack et al., 2000). Binding of densin 
to the αCaMKII C-terminal is independent of CaMKII activation, but binding of densin to 
the kinase domain is dependent on either CaM or T286 autophosphorylation (Jiao et al., 
2011). Although the function of densin/CaMKII binding is not well understood a larger 
structure including CaMKII, F-actin, α-actinin and densin has been proposed by Hell 




decrease in CaMKII levels at spines or PSDs under basal conditions (Carlisle et al., 2011), 
since F-actin and/or α-actinin might still be sufficient to regulate properly CaMKII’s 
localization (Hell, 2014).  
1.5.2 CaMKII and memory consolidation 
Learned information needs to undergo a consolidation process to form a long-
term memory. This consolidation process requires gene transcription and protein 
synthesis (Bourtchouladze et al., 1998; Jarome and Helmstetter, 2014; Parsons et al., 
2006; Schafe and LeDoux, 2000). In addition, not only one but at least two separate 
events of protein synthesis are required for memory consolidation (Bourtchouladze et 
al., 1998). It is known that the consolidation process requires the expression of brain 
derived neurotrophic factor (BDNF) (Lee et al., 2004) and also the transcription factor 
CREB (Bernabeu et al., 1997; Souza et al., 2012; Stevens, 1994). BDNF and CREB have 
been suggested to regulate each other by a feedback loop in a process that seems to be 
necessary for memory consolidation (Bambah-Mukku et al., 2014). CaMKII might play a 
role in this consolidation process by regulation of CREB phosphorylation (Souza et al., 
2012). Corroborating with this hypothesis Chen et al. (2012) have observed a memory 
consolidation dependence to CaMKII-BDNF-CREB pathway. By pharmacologically 
blocking the glucocorticoid receptor in the hippocampus Chen et al. (2012) observed an 
amnesic effect on the passive avoidance task. The same animals also presented a 
reduction on CREB and αCaMKII phosphorylation. Additionally, intra-hippocampal 
injection of BDNF rescued the impairment in memory maintenance and αCaMKII and 
CREB phosphorylation (Chen et al., 2012). How the two cytoplasmic enzymes αCaMKII 
and βCaMKII could regulate the nuclear factor CREB has remained a mystery for a long 




γCaMKII, which would transport CaM to the nucleus. Once in the nucleus γCaMKII 
releases CaM causing the activation CaMKK and subsequent activation of CaMKIV. 
Finally CaMKIV can directly phosphorylate CREB (Ma et al., 2014a; Ma et al., 2015). 
CaMKII regulation of CREB activity seem to be directly regulated by calcium influx trough 
Cav1 family of calcium channels (Wheeler et al., 2012).  
Another known biological substrate of memory consolidation is the immediate 
early gene c-fos. C-fos mRNA levels were observed to be up-regulated, in the 
hippocampus, 1 hour after CFC training (Huff et al., 2006). Exploration of a new context 
also increases c-fos levels in the hippocampus after 1 hour (Radulovic et al., 1998). This 
CFC training-induced expression of c-fos seems to be regulated by the extracellular-
regulated kinase (ERK), as observed by concomitant changes in c-fos levels and ERK 
phosphorylation after pharmacological manipulation of NMDAR activation (Gao et al., 
2010). CaMKII interacts with the synaptic GTPase-activating protein (SynGAP). Through 
a cascade of signals SynGAP’s interaction with CaMKII inhibits protein synthesis, with 
SynGAP preventing the ras-guanosine-5'-triphosphate (ras-GTP) formation that is 
necessary for ERK activation (Wang et al., 2013). Additionally, this signalling pathway is 
critical for synaptic plasticity, as shown by SynGAP blocking (Wang et al., 2013). Besides 
activating SynGAP, CaMKII also regulates SynGAP distribution to the PSD area (Yang et 
al., 2013). CaMKII might indirectly regulate c-fos expression throughout SynGAP’s 
regulation of ERK activation. 
Not only protein synthesis but also protein degradation seems to be important 
for memory consolidation (Artinian et al., 2008; Jarome and Helmstetter, 2014; Jarome 
et al., 2011; Lopez-Salon et al., 2001). CaMKII may also play a role in consolidation driven 




proteasome and promotes proteasome recruitment to the PSD area (Bingol et al., 2010). 
CaMKII can also phosphorylate proteasome subunit Rpt6 on serine 120 and increase its 
activity (Djakovic et al., 2009; Jarome et al., 2013). Moreover the phosphorylation of 
Rpt6 seems to decrease synaptic strength by impairing miniature excitatory 
postsynaptic current (Djakovic et al., 2012). CaMKII also phosphorylates the protein 
cylindromatosis (CYLD). Once phosphorylated, CYLD is activated and facilitates 
proteasomal degradation of proteins by removing K63-linked polyubiquitins from target 










Figure 1.5-1 Schematic representation of the molecular mechanisms of CaMKII's function in the dendritic spine 
A schematic representation of possible molecular bases for the effects of CaMKII heteromer complex on the dendritic 
spine function. The figure shows that after activation of the holoenzyme by CaM, this enzymatic complex will start to 
autophosphorylate and dissociate from F-actin (Lin and Redmond, 2008; Shen and Meyer, 1999). This allows the 
diffusion of CaMKII into the PSD as well as F-actin remodelling (Borgesius et al., 2011; Fink et al., 2003). Once 
phosphorylated at position T286 αCaMKII migrates to the PSD, binds to NMDAR (Bayer et al., 2001) and 
phosphorylates the AMPAR (Derkach et al., 1999). The phosphorylation of the AMPAR will increase its conductance 
and stabilize its localization in the PSD area (Derkach et al., 1999; Opazo et al., 2010; Tomita et al., 2005). CaMKII 
could also form a bigger complex involving different proteins that would localize AMAPRs in the PSD as well as create 
a binding between the pre- and post-synaptic terminals (Sanhueza and Lisman, 2013). CaMKII is also important for 
the control of proteasome localization and activity. It regulates proteasome localization in the PSD and activation by 
phosphorylation of the Rpt6 proteasomal subunit (Bingol et al., 2010; Djakovic et al., 2009; Jarome et al., 2013). 
CaMKII also facilitates protein degradation by phosphorylation and consequent activation of CYLD. Activated CYLD 
will facilitate target protein degradation by removing K63-linked polyubiquitins from this protein (Thein et al., 2014). 
Finally, CaMKII might be involved in the synapse tagging mechanism in activated spines trapping plasticity related 
proteins diffusing to these spines. CaMKII could be the tag itself, regulate the migration of tag proteins to a spine or 
phosphorylate different proteins resulting in the tagging of a spine (Redondo et al., 2010). This is still to be 
determined. 
 
Furthermore, Naskar et al. (2014) described a memory consolidation impairment 
due to inhibition of T305 autophosphorylation site of αCaMKII that could be rescued by 
proteasome inhibition. They also observed a decrease in the levels of the AMPA receptor 
subunit GluA1 due to CaMKII inhibition, and this decrease was rescued by proteasome 




regulates consolidation are still not clear, the relevance of this kinase in memory 
consolidation has been shown by pharmacological inhibition of CaMKII immediately 
after training (Gholizadeh et al., 2013). However, the inhibitor of CaMKII used by 
Gholizadeh et al. (2013) was KN-62, which has been shown to also inhibit CaM activation 
of  other members of the CaMK cascade (Enslen and Soderling, 1994; Mochizuki et al., 
1993). CaMKII’s relevance for memory consolidation has also been raised by studies with 
three different mouse models with CaMKII mutations. Heterozygous mice for a null 
mutation of αCaMKII have normal memory 1 to 3 days after training in two different 
hippocampus-dependent tasks, but their memory was impaired 10 to 50 days after 
training (Frankland et al., 2001). Point mutations of CaMKII’s site that interacts with 
NMDAR’s subunit GluN2B also resulted in consolidation impairment. These mutant 
animals can learn the water maze memory task, have a spatial memory 1h after training, 
but loose this memory when tested 1 day after training (Halt et al., 2012). Finally, 
animals with disruption of synaptic/dendritic translation of αCaMKII due to a mutation 
in a non-coding region of the messenger RNA (mRNA) of αCaMKII preventing the 
transport of this mRNA into dendrites show normal learning of MWM task, but impaired 
spatial memory in a probe trial 15 days after last training session. The same mutants also 
have normal cued and contextual fear memory when tested 30 minutes after 
conditioning, but not 1 day after. Similar results were observed in the object recognition 
task were animals have normal memory 1 hour after training, but impaired memory 1 





1.5.3  CaMKII and memory reconsolidation 
Memory reconsolidation follows the retrieval of a memory and is important for 
the maintenance and further strengthening of this memory (Fukushima et al., 2014; Lee, 
2008). Memory reconsolidation was shown to be a different process from memory 
consolidation due to their different biological substrates. Althought the two processes 
are dependent on gene expression, memory consolidation is dependent on hippocampal 
levels of BDNF but not Zif268 while the opposite is true for memory reconsolidation (Lee 
et al., 2004). Furthermore, Lee (2008) observed that the enhancement of a fear response 
due to a second training session, 24 hours after the first training session, was blocked 
by blocking hippocampal Zif268, showing that reconsolidation process was necessary for 
memory strengthening.  
Retrieval of a memory can destabilize the memory, which involves proteasome 
dependent degradation of synaptic proteins, followed by restabilization of this memory, 
a protein synthesis-dependent process named reconsolidation (Kelly et al., 2003; Lee, 
2008; Lee et al., 2004; Lee et al., 2008; Nader, 2003). Indeed pharmacological blocking 
of protein synthesis after retrieval impairs a previously consolidated memory (Nader et 
al., 2000). Blocking the proteasome system reverts the memory impairment effect of 
blocking protein synthesis (Lee et al., 2008), indicating that memory reconsolidation by 
protein synthesis is important to revert memory destabilization by protein degradation.  
Nonetheless, blocking of protein degradation has also been shown to have a 
memory effect without blocking of protein synthesis. Pharmacological blocking of 
protein degradation immediately after retrieval session impairs memory maintenance 
(Artinian et al., 2008). Milton et al. (2013) have suggested that the regulation of these 




GluN2B activation and memory restabilization the NMDAR’s subunit GluN2A, both 
within the basolateral amygdala. CaMKII activity could be important for both, 
destabilization and reconsolidation. In terms of destabilization it has been observed that 
hippocampal inhibition of CaMKII post-retrieval impairs long term memories and that 
this effect is dependent of protein degradation (Da Silva et al., 2013). CaMKII’s 
regulation of the proteasome system described previously in “1.5.2 CaMKII and memory 
consolidation” could explain Da Silva et al. (2013)’s observation. The identification of 
proteins targeted for degradation in this destabilization process is still poorly studied. 
First efforts have identified proteins involved in translational control and synaptic 
structure (Jarome et al., 2011; Lee et al., 2008).  
Regarding synthesis of proteins, the immediate-early gene Zif268 is expressed by 
memory retrieval (Hall et al., 2001) and necessary for memory reconsolidation but not 
consolidation (Besnard et al., 2013; Lee, 2008; Lee et al., 2004). ERK seems to regulate 
the expression of Zif268 after late LTP (L-LTP) induction (Davis et al., 2000). As explained 
in session “1.5.2 CaMKII and memory consolidation” SynGAP’s phosphorylation by 
CaMKII inhibits ERK’s activation (Wang et al., 2013). This could be a mechanism by which 
CaMKII regulates ERK and Zif268 during reconsolidation. However, the relevance of ERK 
in memory reconsolidation is still a matter of debate. There have been conflicting 
findings regarding ERK’s relevance for memory reconsolidation. Reports of both ERK-
independence of memory reconsolidation (Lee and Hynds, 2013) and ERK-dependence 
(Besnard et al., 2013; Kelly et al., 2003) have been reported. A closer analysis of these 
three studies shows that Kelly et al. (2003) differ from the other two studies for not 
having used the CFC paradigm.  Although both Besnard et al. (2013) and Lee and Hynds 




by treatment with mitogen-activated protein kinase kinase (MEK) inhibitors, treatment 
by Lee and Hynds (2013) was focused in the hippocampus while Besnard et al. (2013) 
used a systemic treatment.  
Another molecular pathway that could explain how CaMKII may regulate Zif268-
dependent memory reconsolidation is the IκB kinase (IKK)-Nuclear factor-κB(NF-κB) 
pathway. Such pathway has been shown to be important for memory reconsolidation in 
a Zif268-dependent matter (Lee and Hynds, 2013). Inhibition of CaMKII blocks activation 
NF-κB by depolarization, glutamate signaling or by basal activity (Meffert et al., 2003). 
In addition, the constitutively active CaMKII T286D mutant mice have increased NF-κB 
activation (Meffert et al., 2003). Furthermore, immunological studies revealed that 
CaMKII regulates NF-κB by a mechanism upstream of IKK (Maubach et al., 2013; 
Oruganti et al., 2011). Although the specific details of this mechanism are still unknown, 
it seems that the interaction with and phosphorylation of the signalling adaptor protein 
Bcl10 by CaMKII is an important step of this CaMKII regulation of NF-κB (Oruganti et al., 
2011). Despite the mechanism by which CaMKII regulates Zif268 expression being 
unclear, transfection of dopaminergic cells with a vector containing a constitutively 
active form of CaMKII increased nuclear translocation of Zif268 (Takeuchi et al., 2002). 
Some kind of feedback response may exist between Zif268 and CaMKII, since it was 
observed that blocking of Zif268 expression with antisense oligodeoxynucleotide 
treatment down-regulates the expression and phosphorylation of CaMKII (Ganesh et al., 
2012). Finally, the transcription factor CREB has also been suggested to be important for 
memory reconsolidation. Genetically modified animals expressing inducible CREB 
repressor have impaired memory reconsolidation in the MWM test (Kim et al., 2011). 




reconsolidation and immunohistochemical quantification of CREB showed an increase 
in hippocampal and amygdalar CREB expression after short memory retrieval (Mamiya 
et al., 2009). It has also been observed that artificial activation of CREB-expressing 
neurons in the amygdala induced a reconsolidation-like strengthening of the fear 
memory (Kim et al., 2014). As explained previously, βCaMKII phosphorylation of γCaMKII 
may have an indirect effect on CREB activation. Nevertheless, how CaMKII and all of 
these mechanisms and molecules interact during reconsolidation is still unclear.  
1.5.4  CaMKII and memory extinction 
Prolonged and repetitive retrieval of a memory in the absence of the US determine 
a gradual weakening of the memory, called memory extinction (Eisenberg et al., 2003; 
Pedreira and Maldonado, 2003; Suzuki et al., 2004). Memory extinction is considered to 
be a new learning process, or inhibitory learning, rather than memory erasure (Myers 
and Davis, 2007; Pape and Pare, 2010; Quirk and Mueller, 2008). Memory extinction can 
be identified by its behavioural peculiarities. An extinguished memory can be reinstated 
by a weak US that would not generate a memory in naïve animals (Rescorla and Heth, 
1975; Trent et al., 2015) or by the presentation of an US in a different context (Corcoran 
et al., 2013). Extinguished memories also present spontaneous recovery, which is the 
reappearance of the CR in a memory test executed a long period after memory 
extinction (Archbold et al., 2010; Pavlov, 1927). Molecular analyses of memory 
extinction is an area of much interest for the development of treatments for post-
traumatic stress disorder and addiction (Everitt, 2014; Fitzgerald et al., 2014; Pizzimenti 
and Lattal, 2015). 
 One candidate of a biological substrate of extinction is BDNF. Injection of BDNF in 




memory extinction of conditioned fear memory, even in the absence of fear extinction 
training (Peters et al., 2010; Rodriguez-Serrano et al., 2014). BDNF has also been shown 
to be increased after memory extinction, as well as, BDNF mRNA levels (Xin et al., 2014). 
Furthermore, blocking of BDNF protein function or blocking of BDNF mRNA expression 
seem to impair memory extinction maintenance, inducing the recurrence of the CR 
(Radiske et al., 2015). Memory extinction seems to also be dependent of ERK activation. 
Activation of nuclear ERK was observed and required for contextual fear extinction 
(Chen et al., 2005; Ryu et al., 2008; Tronson et al., 2009).  
Another molecule that seems to be important for memory extinction is the 
immediately early gene c-fos. C-fos expression has been shown to be induced by one 
session of CFC extinction training and decrease throughout the consecutive extinction 
session (Do-Monte et al., 2010). Furthermore, between-session extinction of auditory-
cued fear memory was accompanied by an increase in the number of c-fos-positive 
neurons within the basolateral amygdala, the cingulate cortex, and the DG of mice 
(Plendl and Wotjak, 2010). Increase in c-fos expression seems to be important for 
consolidation of the extinguished memory (Santini et al., 2004) and to reduce 
spontaneous recovery of the memory (Herry and Mons, 2004). Nonetheless, after 
repeated fear extinction sessions c-fos levels are significantly reduced (Guedea et al., 
2011; Tronson et al., 2009). In terms of the hippocampus, one prolonged (55 minutes) 
auditory extinction session induces an increase in c-fos expression in the DG, only if the 
session is performed in the trained context. Hippocampal sub-regions CA1 and CA3, on 
the other hand, presented increased c-fos expression after prolonged auditory 
extinction session in the trained or in a novel context (Knapska and Maren, 2009). More 




expression levels during and after memory extinction. Although ERK activation seems to 
cause an increase in c-fos production in the CA1 area of the hippocampus during 
memory consolidation (Gao et al., 2010), the activation of ERK seems to coordinate a 
decrease in CA1 c-fos levels after memory extinction (Guedea et al., 2011). Guedea et 
al. (2011) have proposed two separate molecular pathways involving ERK activation 
during memory formation and extinction, with decrease in c-fos expression and 
phosphorylation of the transcription factor c-Jun only in memory extinction. 
Furthermore, ERK activation has been observed to happen without consequent increase 
in c-fos expression (Cook et al., 1999; Nakakuki et al., 2010). Additionally, Cook et al. 
(1999) reported that ERK independency to c-fos expression was related to intra-cellular 
calcium levels, leaving the question of which molecule regulates c-fos expression during 
and after memory extinction.  
The transcription factor CREB could also be a biological substrate of memory 
extinction. Indeed, mutant mice expressing an inducible CREB repressor have impaired 
memory extinction(Mamiya et al., 2009). In fact, Mamiya et al. (2009) reported an 
increase only in amygdalar CREB expression after long, extinction inducing, contextual 
fear memory retrieval, with no changes in hippocampal CREB expression. Looking at 
different time points after different moments of memory extinction protocol, in the 
MWM, Porte et al. (2011) observed an increase in hippocampal CREB levels, in the CA1 
sub-region, 60 minutes after first memory retrieval. However after five memory retrieval 
sessions CA1’s CREB level were normal at 60 minutes after the last test and decrease 15 
minutes and 8 hours after the last test (Porte et al., 2011).  
Regarding CaMKII and extinction, the partial reduction of CaMKII 




fear memory (Kimura et al., 2008). What is more, blocking of hippocampal CaMKII by 
KN-62 impairs memory extinction (Szapiro et al., 2003), as well as, inhibition by intra-
hippocampal injection of the inhibitor autocamtide-2-related inhibitory peptide (AIP) 
blocks extinction enhancement by novelty exposure (de Carvalho Myskiw et al., 2014). 
However, the molecular pathways by which CaMKII might regulate or be regulated by 
other molecular substrates of extinction are still unknown.  
 
1.6 CaMKII, hippocampus and CFC 
The study of hippocampal molecules has led to the discovery of various molecular 
bases of memory formation and maintenance. For example the observation by Giese et 
al. (1998)  that T286A mutant animals have impaired LTP formation was on hippocampal 
cells. The establishment of BDNF as an extinction inducing molecule by Peters et al. 
(2010) was based on injection of this molecule in the hippocampus. Pharmacological 
manipulation of hippocampal protein synthesis and protein degradation were the bases 
for the first report by Lee et al. (2008) of protein degradation as an important process 
for memory reconsolidation. Concerning CaMKII in the hippocampus it is known that 
neuronal activity can change the patterns of expression of αCaMKII and βCaMKII in to 
opposite directions, resulting in increased expression of the first and decrease 
expression of the second (Thiagarajan et al., 2002). It has also been established that 
spatial memory formation is a process dependent of the phosphorylation of 
hippocampal CaMKII at the T286 site (Cox et al., 2014; Giese et al., 1998). Additionally, 
it was also reported that blocking of CaMKII kinase activity in the hippocampus blocks 
spatial memory reconsolidation (Da Silva et al., 2013) and extinction enhancement due 




Concerning the hippocampus-dependent task CFC, T286A mutant animals present 
CFC memory formation impairment and impaired short term memory when trained with 
one or three shocks. However if trained with five shocks T286A animals have normal CFC 
memory (Irvine et al., 2011; Irvine et al., 2005). Conditional deletion of αCaMKII from 
neural progenitor cells and their progeny, in adult mice, impaired CFC memory 
formation with one or three shocks (Arruda-Carvalho et al., 2014). Furthermore, 
heterozygotes T286A mice have CFC extinction impairment (Kimura et al., 2008) and 
blocking of hippocampal CaMKII kinase activity, by AIP injection, blocks novelty-induced 
CFC extinction memory enhancement (de Carvalho Myskiw et al., 2014). 
   
1.7  CaMKII endogenous inhibitors 
Given its importance it seems intuitive that CaMKII needs to be tightly regulated. 
However, the regulation is not well understood. Using yeast two-hybrid screen Chang et 
al. (2001; 1998) have described for the first time the existence of 2 endogenous CaMKII 
inhibitor proteins, CaMK2N1 and CaMK2N2, which are encoded by different genes. 
These authors have shown that CaMK2N1 and CaMK2N2 are 65% identical in their 
putative open-reading frame and 95% identical in its inhibitory domain. However 
CaMK2N2 but not CaMK2N1, requires constant presence of CaM to ligate to CaMKII 
(Chang et al., 2001). CaMK2N1 is a protein with 78 amino acids, expressed in the whole 
brain and with higher levels at the frontal cortex, hippocampus and inferior colliculus. 
On the other hand, CaMK2N2 has 79 amino acids, and it is expressed in testis and brain, 
where it has a higher expression in cerebellum and hindbrain. The two isoforms of 
CaMKII inhibitors are able to inhibit αCaMKII and βCaMKII, but their different pattern of 




of target and function (Chang et al., 2001; Chang et al., 1998). As αCaMKII, CaMK2N1 is 
mainly expressed in forebrain and hippocampus whereas CaMK2N2 is enriched in 
cerebellum, as βCaMKII (Chang et al., 2001; Chang et al., 1998; Cheng et al., 2006; 
Erondu and Kennedy, 1985; Peng et al., 2004). But it is important to remember that 
CaMK2N2 is present throughout the brain, with considerable amounts in various regions 
like the hippocampus, prefrontal and piriform cortices, amygdala and thalamus (Chang 
et al., 2001; Radwanska et al., 2010). Hence the independency of function between 
CaMK2N2 and CaMK2N1 is still a matter of debate. Regarding their subcellular 
localization both isoforms have been shown to be present at the cell bodies and 
dendrites, but expression at synapses is still controversial since there have been claims 
both that it occurs in this region (Lucchesi et al., 2011; Saha et al., 2007; Saha et al., 
2006) as that it does not (Chang et al., 1998; Radwanska et al., 2010). The articles that 
claimed that the inhibitors are not presented at synapses used CaMKIIN1 fused with 
fluorescent protein (Chang et al., 1998) or immunohistochemistry (Radwanska et al., 
2010) to analyse by microscopy the localization of the inhibitors. On the other hand, 
articles that reported the presence of the inhibitors of CaMKII at synapses are based on 
western blot analyses of PSD fraction (Saha et al., 2007; Saha et al., 2006) or crude 
synaptosomal fraction (Lucchesi et al., 2011).  
The endogenous inhibitors selectively block CaMKII CaM-dependent and 
autonomous enzymatic activity without significant inhibition of other kinases such as 
CaMKIV, PKC and PKA (Chang et al., 2001; Vest et al., 2007). Besides inhibiting CaMKII 
kinase activity, the inhibitors also block T305 autophosphorylation and the interaction 
with the NMADR subunit GluN2B, whilst they do not affect T286 autophosphorylation 




the CaMKII endogenous inhibitors seem to be related to the binding of these proteins 
to a hydrophobic region of the kinase domain, the T-site, and blocking by sterical 
inhibition the access of substrates to the S-site as well as binding of NMDAR to the T-
site (Vest et al., 2007) (Figure 1.2-1). When Chang et al. (1998) described the first CaMKII 
endogenous inhibitor, CaMK2N1, they also produced by clonal expression a peptide 
based on 28 amino acids region of the CaMK2N1 situated near its COOH terminus. This 
peptide seems to have the same inhibitory effects as CaMK2N1 (Chang et al., 1998; Vest 
et al., 2007). It was called by the authors by the name of CaMKIINtide (Chang et al., 
1998). CaMKIINtide was then optimized to shorter sequence of 21 amino acids (CN21) 
(amino acids 43-63 of CaMK2N1) (Vest et al., 2007) and later fused with trans-acting 
activator of transcription (tat) domain, increasing cell penetration, therefore been called 
tatCN21 (Buard et al., 2010; Vest et al., 2007). These two new generations of CaMK2N1-
based inhibitors, as well as, CaMKIINtide are commonly used to study CaMKII functions 
(Buard et al., 2010; Chang et al., 1998; Gouet et al., 2012; Illario et al., 2003; Vest et al., 
2007). Recently even shorten peptides have been proposed, which are thought to be 
more potent. These are the 19 amino acid version CN19 (Coultrap and Bayer, 2011) and 
the 17 amino acids CN17 (Gomez-Monterrey et al., 2013). It is worth noting that 
inhibition of CaMKII kinase activity only can also be achieved by substrate-based 
inhibitors, available under the name of AIP and AC3-I (Braun and Schulman, 1995b; 
Ishida et al., 1995; Pellicena and Schulman, 2014). These substrate based inhibitors are 
based on CaMKII substrates autocamtide-2 and autocamtide-3 (Hanson et al., 1989), but 
with a substitution of the threonine to an alanine (Braun and Schulman, 1995b; Ishida 
et al., 1995; Pellicena and Schulman, 2014).  These inhibitors have also been used in 
studies involving CaMKII (Bian and Yu, 2015; Da Silva et al., 2013; Sag et al., 2014). 




debate. The inhibitor AC3-I has been shown to inhibit cellular actions of protein kinase 
D1 (PKD1) as well as those of CaMKII (Backs et al., 2009). Furthermore, AIP and AC3-I 
only block CaMKII kinase activity, there for they are unlike to have the same effects as 
the CaMKII endogenous inhibitors. The CaMK2N1-based inhibitors of CaMKII have been 
reported to inhibit CaMKII kinase activity specifically (Chang et al., 1998; Vest et al., 
2007), as well as, block the binding to the NMDAR (Vest et al., 2007), reduce levels of 
CaMKII at the synapse (Sanhueza et al., 2011), inhibit T305 autophosphorylation (Vest 
et al., 2007), block binding to densin (Jiao et al., 2011), decrease clustering of this kinase 
in the dendrites (Tao-Cheng et al., 2013), induce the  formation of aggregates of CaMKII 
and polyribosomes near the PSD and in dendrites (Tao-Cheng et al., 2013) and block 
binding to Cav2.1 calcium channels (Magupalli et al., 2013). Regarding 
electrophysiological effects, a study using the CaMK2N1-derived peptides showed 
persistent depression of synaptic strength and reversion of LTP saturation after 
application of these fragments in rat hippocampal slices (Gouet et al., 2012). Gouet et 
al. (2012) were unable to explain the molecular bases of these electrophysiological 
phenotypes, which seem to be independent of glutamatergic synaptic activity, calcium 
signalling, protein synthesis or proteasome-mediated degradation. They have also 
revealed that CaMKIINtide’s depression of synaptic strength is not related to NMDAR-
induced LTD, leaving the question of what is the molecular pathway of the 
electrophysiological effects observed in the presence of CaMK2N1-derived peptides. In 
accordance with this data, Wan et al. (2010) reported that the injection of CaMKIINtide 
in the invertebrate Lymnea, 24 hours after learning, blocks memory consolidation by a 
mechanism independent of NMDAR activation. Nevertheless, reversion of LTP 
saturation and reduced basal activity due to treatment with CaMK2N1-derived peptide 




decrease in synaptic strength was only observed with concentrations of the inhibitor 
peptide necessary to disrupt the CaMKII/NMDAR complex, quantified by 
coimmunoprecipitation, but not at lower concentrations sufficient to inhibit CaMKII 
kinase activity only (Sanhueza et al., 2011). In fact, this observation is an important base 
for the model proposed by Sanhueza and Lisman (2013) that CaMKII must have a 
structural role in a big protein complex formed at the PSD that maintains NMDAR and 
AMPAR in this area of the synapse, explained previously in sub-chapter “1.5.1 Structural 
roles of CaMKII”. Finally, the inhibition of CaMKII kinase activity by AIP treatment of 
hippocampal-neuronal culture and hippocampal slices impairs LTP induction and 
reduces NMDAR’s sub-unit GluN2B levels in the synapse (Gardoni et al., 2009). As for 
AMPAR, treatment of hippocampal slices with CaMKIINtide blocks the increase in 
AMPAR conductance and in PSD GluA1 levels that occur in animals with benzodiazepine 
withdrawal (Shen et al., 2010). Similarly, CaMKIINtide injection in snail Lymnaea 
stagnalis significantly reduced the learning-induced elevation of GluA1 levels and 
impairs associative memory consolidation (Naskar et al., 2014). Additionally, this 
CaMKIINtide reduction of GluA1 levels was blocked by pharmacological inhibition of the 
proteasome system, indicating degradation of GluA1 induced by CaMKIINtide treatment 
(Naskar et al., 2014). Treating rat hippocampal slices with the peptide tatCN21, Buard et 
al. (2010) observed impairment of LTP induction but not impact on LTP maintenance. In 
the same study Buard et al. (2010)  also observed that treatment with tatCN21 before 
contextual fear conditioning training session impaired memory acquisition, but 
treatment before the memory test had no effect on memory retrieval. As mentioned 
before, Wan et al. (2010) reported that the injection of CaMKIINtide 24 hours after 
learning blocked reward memory consolidation in Lymnaea stagnalis. As for memory 




blocked spatial memory reconsolidation and this effect can be reversed by proteasome 
inhibition (Da Silva et al., 2013). Intra-hippocampal AIP injection also blocked memory 
extinction enhancement due to novelty exposure (de Carvalho Myskiw et al., 2014). One 
should remember that AIP only blocks CaMKII kinase activity, therefore it is different 
from the endogenous inhibitors of CaMKII. To my knowledge, until this date no study 
has addressed the function of the endogenous inhibitors of CaMKII in memory 
reconsolidation or extinction. To summarize, the references presented above show that 
the inhibition of CaMKII by substrate-based or CaMK2N1-based peptides blocks memory 
formation, consolidation, reconsolidation, extinction, LTP induction, LTP saturation and 
synaptic basal activity. Although CaMKIIN1-based peptides have been widely used for 
studying CaMKII’s function very little is known about the function of the endogenous 
inhibitors of CaMKII and when are they expressed in neurons. Two studies by our group 
have reported an increase in the expression of the endogenous CaMKII inhibitors after 
fear conditioning training, in brain regions related to the task (Lepicard et al., 2006; 
Radwanska et al., 2010). Whilst CaMK2N1 mRNA expression in the hippocampus was 
increased after contextual fear conditioning, CaMK2N2 mRNA levels were unchanged 
(Lepicard et al., 2006; Radwanska et al., 2010). The function of this CaMK2N1 increase 
is unknown. Buard et al. (2010) have observed that treatment with tatCN21, a 
CaMK2N1-based inhibitor, previous to CFC training session blocks memory formation, 
in mice. While CaMK2N1 mRNA levels were increased afer CFC training (Lepicard et al., 
2006), CaMK2N2 protein levels were increased in the hippocampus after novel context 
exploration (Radwanska et al., 2010). Lucchesi et al. (2011) suggested that the inhibitors 
would play different roles in learning and memory. While CaMK2N1 would be important 
to block active CaMKII (autonomous CaMKII or CaMKII bound to the NMDA receptor), 




necessary to fully understand the CaMKIIN1 and CaMKIIN2 mechanism of action in 
learning and memory. Finally, the amyotrophic lateral sclerosis (ALS)-causing mutation, 
R495X, in the FUS gene (also known as FUS-ΔNLS) causes an overexpression of 
CaMK2N2, at mRNA and protein level, in vitro (Convertini et al., 2013). This observation 


















1.8 Aims & Objectives 
Molecular mechanisms of learning and memory is an area of intensivy research as 
much is still unknown. 
CaMKII has long been proposed to be a molecular basis of memory (Lisman, 1994; 
Lisman and Goldring, 1988a; Lisman and Goldring, 1988b). CaMKII role as an important 
molecule for learning and LTP induction has been well established (Giese et al., 1998), 
however it has been suggested that CaMKII is not necessary for memory (Buard et al., 
2010) or LTP maintenance (Fujii et al., 2013; Lee et al., 2009; Lengyel et al., 2004). 
Nonetheless, the relevance of CaMKII for memory maintenance is still a matter of 
debate. Heterozygous T286A mice show impairment in contextual fear memory 
extinction (Kimura et al., 2008). Additionally, the CaMKII inhibitor CaMKIINtide blocks 
memory consolidation in the invertebrate Lymnea. Blocking of CaMKII kinase activity in 
the hippocampus by treatment with AIP blocks memory reconsolidation in mice (Da Silva 
et al., 2013). Therefore is still unclear if CaMKII is necessary for memory maintenance, 
but the use of CaMKII specific inhibitors might help clarifying this question. 
Whilst it has been established that there are two endogenous CaMKII inhibitor 
proteins, and while corresponding peptides have been used to study CaMKII function in 
different systems, it remains unclear what are the physiological roles of the endogenous 
CaMKII inhibitors in learning and memory. Expression studies have suggested that the 
regulation of expression of these inhibitors has a role in regulating CaMKII during 
memory formation (Lepicard et al., 2006; Radwanska et al., 2010) but nothing has been 




 To investigate the relevance of hippocampal endogenous inhibitors of CaMKII in 
learning and memory after contextual fear conditioning, by knocking down 
CaMKIIN1 and overexpressing CaMKIIN2 in the hippocampus of mice. 
 To understand the molecular mechanisms involved in the behavioural 
phenotypes observed after manipulation of the expression of the inhibitors, by 
quantifying CaMKII total levels and phosphorylation, GluA1 total levels and 
phosphorylation, protein degradation and gene expression. 
 
 
Chapter 2 Materials & Methods 
2.1 Animals 
For the experiments presented in this thesis we have used male, 10-12 week-old 
C57BL/6J mice. The subjects were housed in a 12-h light-dark cycle with food and water 
ad libitum. They were housed in groups of 3-5 animals per cage with sawdust, bedding 
material and a cardboard tube changed once a week. During the experiments animals 
were divided between the treatments so that each cage would include animals from all 
the treatments. During the collection of behavioural and molecular data the 
experimenter was blinded to the animal’s treatment. All experiments were undertaken 
in accordance with the UK Animals (Scientific Procedures) Act 1986, under the project 





2.2 Viral vector 
During this work we used recombinant adeno-associated virus (rAAV), serotype 
2/9, as vector for gene expression manipulation in the dorsal hippocampus of mice. 
rAAV vectors have been shown to be a safe and efficient way to transfect cells in the 
central nervous system (CNS), having a high vector production yield, expression onset 
of 1-2 weeks, expression duration of more than six months and very low chance of virus 
replication or gene insertion mutagenesis (Edry et al., 2011; Murlidharan et al., 2014; 
Ojala et al., 2015). The adeno-associated virus (AAV) is a non-enveloped, single stranded 
deoxyribonucleic acid (DNA) virus that can only replicate in the presence of a helper 
virus (Srivastava et al., 1983). Viral vectors used in this experiment had their viral genes 
rep (which encodes proteins important for replication of the genome) and cap (which 
encodes structural proteins of the virus) removed. The following three plasmids were 
constructed in our group by Dr. Walter Lucchesi and sent for viral production to Penn 
Vector Core (University of Pennsylvania, Philadelphia, PA, USA). 
2.2.1 Control virus 
Our control virus plasmid contained an ampicillin resistance gene for clonal 
selection. This gene encodes for the enzyme β-lactamase, which neutralises antibiotics 
in the penicillin group (Citri and Pollock, 1966). Our plasmid also contained 5’ and 3’ 
inverted terminal repeats (ITR), required by AAV for correct integration of the viral 
genetic information (Wang et al., 1995). Between the ITRs there was a scrambled 
sequence of a short hairpin ribonucleic acid (shRNA) without a target on mammal’s 
genome. The expression of this shRNA was under the control of U6 promoter. The U6 
promoter is a polymerase III promoter existent in human cell for the expression of small 




responsible for the expression of small RNAs, the U6 promoter has been shown to retain 
full activity following deletion of all sequences downstream of +1 position (Das et al., 
1988) and it had previously been reported to be effective in the expression of different 
small RNAs (Ma et al., 2014b; Miyagishi and Taira, 2002; Paul et al., 2002). Additionally 
this plasmid carried a reporter gene expressing the fluorescent protein ZsGreen, under 
the synapsin 1 promoter. The synapsin 1 promoter is a neuron specific promoter driving 
high levels of expression (Kumar et al., 2015; McLean et al., 2014).  We obtained the 
cloned synapsin 1 promoter region from Dr. Marco Peters, Darts Neuroscience, San 
Diego, USA. A schematic view of the plasmid is shown on Figure 2.2-1 and the sequence 
for all the inserts mentioned above can be found in Table 7.1-1 in the appendix. Viral 
production yielded a final titre of 1.213 genome copies per millilitre (GC/mL).   
 
Figure 2.2-1 Schematic map of control plasmid 
This circular plasmid was used to create the control rAAV. As the map show it contains a shRNA without any target in 
the genome (shRNACTRL), under the U6 promoter and ZsGreen reporter gene under the synapsin 1 promoter. The 
map also shows the location of the 5’ and 3’ ITR and the ampicillin resistance gene (AmpR). It also indicates some 
restriction enzymes that could be used for sub-cloning with this plasmid.  
 
2.2.2 ShCaMK2N1 virus 
In order to knock-down expression of the gene for the inhibitor CaMK2N1 a 




(Appendix, Table 7.1-1). The plasmid also contained a ZsGreen gene under the control 
of synapsin 1 promoter, ampicillin resistance gene and the 5’ and 3’ ITRs needed (Figure 
2.2-2). The resulting virus titre was 1.3913GC/mL.    
 
Figure 2.2-2 Schematic map of ShCaMK2N1 plasmid 
This plasmid was used to generate a rAAV to knock-down CaMK2N1. As shown in the map it contains a sequence for 
a shRNA against CaMK2N1 mRNA (shRNAvsCaMKIIN1), under a U6 promoter and ZsGreen reporter gene under a 
synapsin promoter. It also shows the location of the 5’ and 3’ ITR and the ampicillin resistance gene (AmpR). It 
indicates as well some restriction enzymes that could be used for sub-cloning with this plasmid.  
 
2.2.3 CaMK2N2 overexpression virus 
To manipulate the expression of CaMK2N2 we have used a rAAV bicistronic 
vector based on the synapsin 1 promoter driving the independent expression of the 
human CaMK2N2 gene and the GFP reporter gene, both separated by an internal 
ribosome entry site (IRES) sequence (Appendix, Table 7.1-1). An IRES sequence carries 
internal ribosomal entry site region, which attracts the translation complex in the 
internal region creating multiple protein products from a single mRNA sequence (Jang 
et al., 1988; Pelletier and Sonenberg, 1988). The plasmid also contained the ITRs regions 
and the ampicillin resistance gene. A schematic view of the plasmid can be seen on 





Figure 2.2-3 Schematic map of CaMK2N2 plasmid 
This plasmid was constructed for gene manipulation of the expression of CaMK2N2. In light blue is the synapsin 
promoter that controls the bicistronic region composed by the CaMK2N2 gene, the IRES and the GFP reporter gene. 
The 5’ and 3’ ITR and the ampicillin resistance gene (AmpR) are also indicated in the scheme. It indicates as well 
restriction enzymes that could be used for sub-cloning with this plasmid.  
 
 
2.3 Stereotaxic surgery 
For the injection of virus solutions in dorsal hippocampus animals were subjected 
to stereotaxic surgery procedure as follow. Before the beginning of a surgery sheets, 
surgical gown, scissors and forcipes used during the surgery were autoclaved for asepsis. 
The experimentator washed his hand thoroughly with antimicrobial skin cleanser 
(chlorhexidine gluconate 4% w/v, Mölnlycke Health Care Limited, Bedfordshire, UK; 
10009249). During the surgery an autoclaved gown, face mask, hair net and sterile 
gloves (Mölnlycke Health Care Limited, Bedfordshire, UK; 96270) were used to avoid 
contamination. The mouse was anaesthetized with a mixture of isoflurane (Abbott, 
Kent, UK; 05260-05) and O2. The scalp was shaved and them the animal was positioned 
on a stereotaxic frame (David Kopf Instrument, Tujunga, CA; Model 963 Ultra Precise 
Small Animal Stereotaxic Instrument) over an electric heated blanket. At this moment 




(Buprenorphine - 0.3mg/mL – RECKITT BENCKISER Healthcare, Hull, UK) and the eyes of 
the animal were lubricated with lacri-lube (Allergan, Bucks, UK). The scalp was them 
cleaned with Povidone-Iodine solution (0.75%w/w – Animalcare, York, UK; XHG 012) for 
asepsis. A sterile disposable scalpel size 10 (Swann-Morton Limited, Sheffield, UK; 0501) 
was used to make an incision along the midline, exposing the skull. The skull was then 
cleaned with phosphate buffered saline (PBS) solution (Life Technologies, Paisley, UK; 
10010-023) and bregma was identified.  A round head micro drill steel burr of 0.5mm 
(Hager & Meisinger GmbH, Neuss, Germany; 19007-05) was used to make two holes on 
the skull over the hippocampus of both hemispheres. The coordinates used to 
determine the injection sites were anterior-posterior: +2.1mm; medio-lateral: ±1.5mm; 
dorso-ventral: -1.8mm from bregma. The total volume of injection was 0.75 μL of viral 
solution at a rate of 0.25μL/min, using a 2.5μL Hamilton syringe (Hamilton Medical, 
Reno, NV; 87942) and a microsyringe pump controller (UltraMicroPump (UMP3) with 
SYS-Micro4 Controller - World Precision Instruments, Sarasota, UK; UMP3-1). After 
injection the syringe was left without moving for 1 minute to allow for the injected 
solution to diffuse and was removed afterwards slowly from the brain (around 0.4mm 
every 15 seconds). Animals were then sutured (4-0 – FS-3 CONV – Mersilk® – Ethicon, 
Puerto Rico, USA; W501H), received a topical local anaesthesia (EMLA® cream 5% - 
Lidocaine 25mg/g – Prilocaine 25mg/g – Astra Zeneca, Luton, UK) and were taken to a 
recovery chamber with controlled temperature. After recovery from the anaesthesia the 
animal was housed again in his original cage. Mice were left two weeks without been 
subjected to any other procedure for recovery and also to wait for the genetic 
information of the virus to be expressed. During this period animals were checked for 
signs of pain and/or distress such as increasing loss of weight, self-inflicted injury, 




2.4 Contextual fear conditioning  
To study learning and memory ability of the animals the CFC paradigm was used. 
The CFC is a Pavlovian conditioning task in which a neutral context [conditioned stimulus 
(CS)] is associated with an aversive US. After conditioning the CS evokes a learned fear 
response known as CR (Maren, 2008; Pavlov, 1926). This paradigm has previously been 
used successfully by our research group (Mizuno et al., 2012; Radwanska et al., 2010). 
All experiments were performed during light cycle. During the training session of the 
CFC the mouse was placed into the conditioning chamber (30.5 cm x 24.1 cm x 21.0 cm) 
(MedAssociates, Loughborough, UK; VFC-008-LP) containing a tissue wet with a small 
spray of 70% v/v ethanol (Sigma-Aldrich, St. Louis, MO, USA; 34935) under a metal grid 
on the floor in a soundproof box. The animal was exposed to the chamber context, the 
CS, for 40 seconds after which he received a foot shock of 0.7mA for 2 seconds, the US. 
The mouse was then left in the conditioning chamber for 30 seconds to distress. This 
was defined as the training session. To test for the memory of the association between 
the CS and the US animals were returned to the same conditioning chamber with the 
same 70% v/v ethanol olfactory stimulus and their behaviour was recorded for 5 
minutes. Their freezing behaviour was used as CR and was scored every 5 seconds for 2 
seconds. Freezing was positively scored if no movement other than respiratory 
movements were observed. To control the shock and record animals’ behaviour VFreeze 
software was used (MedAssociates, Loughborough, UK). Scoring was done blind to 
treatment. In the first two experiments scoring was done twice by two different 
experimenters to test the precision of my scoring. Time points for the training and 
memory test sessions varied according to the aim of the experiment and are described 





2.5 Animal sacrifice and sample collection  
2.5.1 Collection of samples for gene or protein expression 
For analyses of gene or protein expression, after behavioural test animals were 
sacrificed by asphyxiation with increasing concentration of CO2. Each animal was then 
decapitated, the skull was opened and the brain was immediately placed over a petri 
dish with absorbent paper soaked in saline solution, 0.9% w/v NaCl (VWR International, 
Radnor, PA, USA; BDH8014-500G), which was previously placed over ice. The brain was 
washed with saline solution and both hippocampi were dissected. Hippocampal samples 
were divided into dorsal and ventral as well as in right and left hippocampus. After 
dissection samples were kept in dry ice and subsequently stored at -80°C. 
2.5.2 Collection of samples for fluorescent imaging  
For samples used for fluorescent microscopy, animals were sacrificed by overdose 
with pentobarbital derived Euthatal® (Merial, Toulouse, France). Each animal received 
an intraperitoneal injection of Euthatal® in a dose of 1g/kg. Once analgesia was 
confirmed by pressing of tail and foot animals were attached by the back to a Styrofoam 
board. The animals rib cage was opened and a small cut was done at the heart in the 
right atrium. Simultaneously a needle connected by a Pumpsil® Platinum cured silicone 
tubing (3.2mm bore x 1.6mm wall thickness - Watson-Marlow, Falmouth, Cornwall, UK) 
to a 520U series IP31 pump (Watson-Marlow, Falmouth, Cornwall, UK) was introduced 
into the animal’s heart in the left ventricle. The animal’s blood was washed out by 
injection of approximately 10mL of PBS solution (Life Technologies, Paisley, UK; 10010-
023) in a rate of approximately 10mL/min. Initial wash was followed by perfusion with 




(Table 7.3-1) at approximately 10mL/min for 8 minutes. Animal’s brain was dissected 
and incubated overnight at 4°C. In the following day the brain was placed in 30% w/v 
sucrose (Calbiochem® - Merck Millipore, Darmstadt, Germany; 5737) solution diluted in 
PBS (Life Technologies, Paisley, UK; 10010-023) with 0.05% sodium azide (Sigma-Aldrich, 
St. Louis, MO, USA; 438456) at 4°C and stored until future analysis.      
 
2.6 Fluorescence microscopy 
As described in subchapter 2.2, the viral vectors used in this thesis had reporter 
genes that express one of the two fluorescent proteins, GFP or ZsGreen. Expression of 
these fluorescent proteins by transfection with all the three viral vectors used was 
accessed as a control for the surgery precision and viral effective transduction of genetic 
material. For that propose previously perfused samples were frozen over dry ice in 
optimal cutting temperature (OCT) compound (VWR international, Radnor, PA, USA; 
25608-930) and sliced in a MicromHM 560 Cryostat-Series (Thermo Scientific, Waltham, 
MA, USA) in coronal sections of 40µm at a temperature of approximately -20°C. Sections 
were mounted in Superfrost® plus slides (VWR International, Radnor, PA, USA; 48311-
703), covered with Vectashield® mounting medium for fluorescence with 4',6-
diamidino-2-phenylindole (DAPI) (Vector Laboratories, Inc., Burlingame, CA, USA; H-
1200) and cover glass (22mm x 64mm)(VWR International, Radnor, PA, USA; 631-0880). 
Sections were visualized in a Zeiss AxioImager.Z1 fluorescent microscope (Zeiss, 
Oberkochen, Germany) with AxioVision software (Zeiss, Oberkochen, Germany) and a 
monochrome AxioCam MRm Rev.3 camera (Zeiss, Oberkochen, Germany). Images from 




area, by image analyses software ImageJ (National Institute of Mental Health, Bethesda, 
MD, USA).  
 
2.7 Gene expression 
In order to assess CaMK2N1 and CaMK2N2 expression levels quantitative real-
time polymerase chain reaction (RT-qPCR) was used. RT-qPCR is a combination between 
a polymerase chain reaction (PCR) and a fluorescent based reaction. In brief, the 
technique is based on transcription of the mRNA of a sample to complementary DNA 
(cDNA) by the enzyme reverse transcriptase. This step is followed by repetitive steps of 
amplification in high temperature with the enzyme taq polymerase and simultaneous 
detection and quantification of the amplified region of interest by use of fluorescent 
labelled oligonucleotides in the reaction (Higuchi et al., 1993). This technique has the 
unique ability to detect and simultaneously quantify the amplified gene of interest in 
real time with relatively good speed, accuracy and requirement of very small amounts 
of sample (Higuchi et al., 1993). 
2.7.1 RNA extraction and quantification 
All the procedures described in this section were executed using Gibco® 
DNase/RNase free water (Life Technologies, Paisley, UK; 10977035) and all equipment 
(pipettes, tube holders, gloves...) were clean with Ambiom® RNaseZap® (Life 
Technologies, Paisley, UK; AM9780). For this analysis right or left hippocampus of each 
mouse was picked randomly. The sample was then homogenized in 600μL of TRIzol® 
buffer (Life Technologies, Paisley, UK; 15596-026) using polytron homogenizer 
PowerGen 125 (Fisher Scientific International, Inc., Hampton, NH, USA; 12396727) 30 to 




chloroform (Sigma-Aldrich, St. Louis, MO, USA; 528730) was added to the sample and 
the sample was shacked for 30 seconds. Sample was left incubating for 10 to 30 min at 
RT before been centrifuged at 10,000 revolutions per minute (rpm) for 20 minutes at 
4°C in table centrifuge (Heraeus™ Biofuge Fresco™ - Thermo Scientific, Waltham, MA, 
USA; 75002420). Aqueous phase was then transfered to a clean tube and RNA was 
precipitated by incubating the solution for 15 to 30 minutes at RT with 300μL of 
isopropanol (VWR International, Radnor, PA, USA; 700002-600). Following incubation 
the sample was centrifuged again at 10,000rpm for 20 minutes at 4°C and supernatant 
was discharged. Precipitated pellet was washed with 600μL of 75% v/v ethanol (Sigma-
Aldrich, St. Louis, MO, USA; 34935) and centrifuged at 10,000rpm for 5 minutes at 4°C. 
Supernatant was discharged again followed by a second 10,000rpm for 5 minutes at 4°C 
centrifugation step. Any left supernatant was disposed and the precipitated pellet was 
diluted in 30μL of Gibco® nuclease-free water (Life Technologies, Paisley, UK; 
10977035). Sample was quickly vortexed and left to stand on ice for 1 hour. After this 
last incubation each sample was quantified and their 260nm/280nm ratio was obtain by 
spectrophotometer analyses using NanoDrop ND1000 spectrophotometer (Thermo 
Scientific, Waltham, MA, USA). The ratio of absorbance at 260 nm and 280 nm was used 
to assess the purity of RNA, a ratio of 2.0 was considered to be approximately 100% 
purity. All the samples (approximately 200ng of each) were submitted to electrophoresis 
for 40-45 minutes at 85V in a 1.2% w/v agarose (Life Technologies, Paisley, UK; 16500-
500) gels and visualised in BioSpectrum® imaging system (UVP, Upland, CA, USA) to 






Figure 2.7-1 Example of 18S and 28S ribosomal RNA fractions 
Figure shows an example of the separation and visualisation of the ribosomal RNA fractions of 18S and 28S. All RNA 
extracted samples were subjected to this analysis to confirm the success of the RNA extraction. Samples were run in 
1.2% w/v agarose gel for 40-45 minutes at 85V. Visualization of the RNA fractions was achieved true mixture with 
ethidium bromide (Sigma-Aldrich, St. Louis, MO, USA; E1510) and visualisation at BioSpectrum® Imaging System 
running VisionWorks® LS Image Acquisition and Analysis Software (UVP, Upland, CA, USA). 
 
2.7.2 First Strand cDNA Synthesis 
Reverse transcription of RNA to cDNA was performed using SuperScript® II 
Reverse Transcriptase (Life Technologies, Paisley, UK; 18064-014) according to 
published protocol(Lepicard et al., 2006). In brief, 1.3μg of sample RNA template was 
diluted in nuclease free water (Life Technologies, Paisley, UK; 10977035) to a final 
volume of 10.5μL and mixed with 1μL of oligo(dT)12-18 primer (Life Technologies, Paisley, 
UK; 18418-012), which targeted polyA mRNA. The solution was then incubated for 10 
minutes at 70°C on Applied Biosystems® GeneAmp® PCR System 9700 (Life 
Technologies, Paisley, UK). The resulting solution was mixed with 10mM 
deoxynucleotide (dNTP) mix (Qiagen, Hilden, Germany; 201900), 0.1M dithiothreitol 
(DTT) (Life Technologies, Paisley, UK; D-1532), RNasin® Inhibitor (Promega, Fitchburg, 
WI, USA; N2115), SuperScript® II Reverse Transcriptase (Life Technologies, Paisley, UK; 
18064-014) and 5x first strand buffer (Life Technologies, Paisley, UK; 18064-014) as 
described in Appendix Table 7.3-2 . The mixture was incubated at 42°C for 50 minutes  
before inactivation step of 10 minutes at 70°C using an Applied Biosystems® GeneAmp® 
PCR System 9700 (Life Technologies, Paisley, UK). Reactions were diluted 1 in 10 with 
nuclease-free water to a final volume of 180μl and stored at -20°C prior to use as 





2.7.3 RT-qPCR primer and cDNA dilution 
Primers complementary to CaMK2N1, CaMK2N2 and the housekeeping gene 
hypoxanthine phosphoribosyl transferase (HPRT) were previously designed using Primer 
Express 2.0 software (Applied Biosystems, Foster City, CA, USA) and tested for specificity 
by sequencing of the amplification product as described in Lepicard et al. (2006). 
Primers’ sequences can be seen in Table 7.2-1  of the Appendix. Optimum dilution for 
each primer was determined by a bigger difference between a random control sample 
and a blank solution in the number of cycles needed to reach exhaustion of the reaction. 
The concentration chosen for each primer is presented in Table 7.2-1. HPRT was selected 
as the housekeeping gene due to his higher efficiency of amplification with a random 
control cDNA sample as compared to glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH). The sequence used as primer for HPRT (Table 7.2-1) was also compared in 
terms of efficiency with a different primer sequence for HPRT. Dilution of the cDNA 
samples was determined by equal amplification efficiencies of both the template and 
HPRT throughout a range of cDNA dilutions. The best dilution for the samples was 
calculated by doing a linear regression with the logarithmic value of the different sample 
dilutions and the difference between the cycles of housekeeping gene and the gene of 
interest. Different points of the obtained line were taken out of the regression with the 
aim of decreasing the “a” value of the equation describing the line. Optimum sample 
dilution was defined as a middle point in the line which the equation describing it had 
an “a” value smaller then 0.1. The best dilutions for the cDNA samples using CaMK2N2 





RT-qPCR was performed in 0.2mL non-skirted low profile 96-well PCR plate (Life 
Technologies, Paisley, UK; AB-0700) capped with an ultra-clear qPCR caps (Life 
Technologies, Paisley, UK; AB-0866). Each well contained 5μL of the cDNA template 
solution and 15μL of RT-qPCR solution, composed of forward and reverse primers, 
nuclease free water and the fluorescent marker 2x qPCR MasterMix with SYBRGreen 
and ROX (PrimerDesign Ltd., Hants, UK; Precision-R) with concentrations of each reagent 
as described in Table 7.3-3 of the Appendix. The amplification of the PCR product was 
continuously measured by Chromo4™, real-time PCR detector using a DNA Engine® (Bio-
Rad, Hemel Hempstead, UK; CFB-3240) during 45 cycles. The reaction started with one 
step of 95°C for 10 minutes, followed by 45 cycles of 20 seconds at 95°C, 20 seconds at 
60°C and 20 seconds at 72°C. The number of cycles needed to reach exhaustion of the 
reaction, as well as, the melting points of paired cDNA strands made in the reactions 
was calculated for each well with the analysis software Opticon Monitor, version 3.1.32 
(Bio-Rad, Hemel Hempstead, UK).  Every sample was performed in triplicates, and mean 
threshold cycle (CT) was determined. The CT value of each sample was normalized to 
the CT value of HPRT and calibrated to the CT value in the control group. This was 
achieved by subtracting the CT value of the housekeeping gene from de CT value of 
CaMK2N1 or CaMK2N2, ΔCt. The ΔCt of each sample was them transformed in Power 
(2, - ΔCt). The average power for the control group was calculated, and the average and 
error obtain for each group was divided for the average of the control group. 
2.8 Protein analysis 
To determine the regulation and expression of different proteins western blotting 




to adapt to the quantification of different proteins (Kurien and Scofield, 2015). In brief,  
proteins were extracted from the tissue, their tertiary and secondary structure were 
disrupted, proteins were coated with negative charges, separated by molecular weight 
in an electrical field, transferred to a membrane and detected with specific antibodies 
(Renart et al., 1979; Towbin et al., 1979).  
2.8.1 Protein extraction and fraction separation 
For protein extraction the right and left hippocampus of each mouse were 
combined into one sample. This sample was homogenized in 300µL of homogenization 
buffer described on Table 7.3-4 of the Appendix. The homogenization buffer contained 
protease and phosphatase inhibitors (Table 7.3-4) but no detergent, to allow collection 
of different fractions of the cells. Homogenization was made on ice and by douncing by 
hand 20 times in a borosilicate glass tissue grinder (Kimble Chase, Vineland, NJ, USA; 
K885300/0002). The resulting solution was centrifuged at 4°C for 5 min at 2000rpm in 
a table centrifuge (Heraeus™ Biofuge Fresco™ - Thermo Scientific, Waltham, MA, USA; 
75002420). The pellet was separated and re-diluted in 100µL of homogenization 
buffer. This fraction of the sample was named P1 and used for analysis of nuclear 
proteins. The supernatant fraction was collected and centrifuged at 13.000rpm for 15 
minutes at 4°C. The resulting supernatant was collected and was identified as fraction 
S2, which is enriched for  cytosolic protein. The pellet was re-diluted in 100µL of 
homogenization buffer. This solution, the P2 fraction, is a crude synaptosomal fraction. 
Similar fraction separation protocols can be found in Drakulic et al. (2013), Stanojlovic 
et al. (2015) and Han et al. (2014). P1, S2 and P2 were frozen at -20°C for further 
analyses. It is important to notice that animals’ asphyxiation with CO2, used to sacrifice 




might had lost some CaMKII in the first fraction, P1, which was not analysed for CaMKII 
content. However this effect was not enough to make the quantification of CaMKII in 
the S2 and P2 fraction unfeasible, therefore it was ignored.    
2.8.2 Protein quantification 
Total protein concentration of each sample was determined with the Pierce™ BCA 
Protein Assay Kit (Life Technologies, Paisley, UK; 23225). In brief, the sample was diluted 
10X with ultrapure water and 25µL of this solution was plated on 96-well Corning® 
Costar® cell culture plates (Sigma-Aldrich, St. Louis, MO, USA; CLS3997) with 200µL of 
50:1 mix of reagent A and reagent B from Pierce™ BCA Protein Assay Kit (Life 
Technologies, Paisley, UK; 23225). The detection of the proteins in this kit was based on 
a colorimetric change in the solution due to a valence change in copper as a result of the 
reaction between copper and these proteins. A standard curve of bovine serum albumin 
(BSA), going from 2000µg of protein to 0µg, was also plated and mixed with reagent A 
and reagent B. After 30 minutes incubation at 37°C the plate was read at DTX 880 
Multimode Detector (Beckman coulter®, Brea, CA, USA) with absorbance at 595nm. 
Linear regression between the observed absorbance of the standards with their known 
concentrations gave the equation that determined each sample’s concentration. A 
regression would only be used for determine samples’ concentration if the observed R2 





2.8.3 Western blot 
2.8.3.1 Gel electrophoresis and transfer 
Samples were diluted in ultrapure water and 4X sample buffer (Table 7.3-5) as so 
that every sample had in the same volume the same quantatie of total protein. Total 
protein quantities used were 20µg or 50µg, depending on the protein to be analysed 
(for more details see Table 7.4-1). The samples were heated to 95°C for 5 to 10 minutes. 
Immediately after, the samples were placed on ice for at least 5 minutes. After a quick 
spin-down of the samples they were then blotted in 18-wells Criterion TGX AnykD gel 
(Bio-Rad Laboratories, Hemel Hempstead, UK; 567-1124) or 18-wells Criterion TGX Gel, 
4-15% gel (Bio-Rad Laboratories, Hemel Hempstead, UK; 567-1084). If the number of 
samples surpassed the number of wells in the gel more than one gel was used, but the 
control samples were evenly distributed through the gels. In the first and last well of 
each gel 7µL of Spectra™ multicolour broad range protein ladder (Life Technologies, 
Paisley, UK; 26634) were added. Loaded gels were run on running buffer (Table 7.3-6) in 
two different conditions. For samples from P1 fraction the samples were run in the gel 
for approximately 15 minutes at 120V and 1 hour and 20 minutes at 100V. For P2 and 
S2 fractions the samples were run for approximately 1 hour and 50 minutes at 80V. After 
separation of proteins by size the proteins in the gel were transferred to a nitrocellulose 
membrane (Immun-Blot® PVDF Membrane – Bio-Rad Laboratories, Hemel Hempstead, 
UK; 162-0177) previously activated in methanol (Fisher Scientific International, Inc., 
Hampton, NH, USA; A4124) for 5 minutes. The gel and the membrane were placed above 
each other and the proteins were transferred at 150V for 1 hour and 15 minutes on 
transfer buffer (Table 7.3-7). Afterwards the membrane was washed with 30mL of tris-




NH, USA; BP337100) (TBST) (see Table 7.3-8 for tris-buffered saline (TBS) composition) 
for 10 minutes at 45 oscillations per minute (osc/min) on a see-saw rockers SSL4 shaker 
(Bibby Scientific Limited, Staffordshire, UK) and used for different immunostaining 
procedures.      
2.8.3.2 Immunostaining and detection 
After the membrane was washed it was blocked by shacking at 25 osc/min for 1 
hour with 30mL of blocking buffer 5% w/v milk, composed of 1.5g of skim milk powder 
(Merck Millipore, Darmstadt, Germany; 115363) in 30mL of TBST 0.05% v/v. 
Membrane was subsequently incubated overnight at 4°C shacking at 55rpm in a 
Scientific C10 platform shaker (New Brunswick Scientific Co., Inc., Edison, NJ, USA) with 
10-30mL of primary antibody solution. Primary antibody solution contained blocking 
buffer 5% w/v, sodium azide 0.05% w/v and the primary antibody of interest. A 
detailed list of the primary antibodies used in this thesis can be found in Table 7.4-1 of 
the Appendix. At the following day the membrane was washed three times with TBST 
at 45 osc/min at room temperature. Thereafter, the membrane was incubated at room 
temperature for 2 hours at a constant shack of 25 osc/min with secondary antibody 
solution composed of blocking buffer 5% w/v and the correct secondary antibody to 
bind the primary antibody of interest with the according dilution as described on Table 
7.4-1 of the Appendix. This incubation was followed by three rounds of washing with 
30mL of TBST for 10 minutes each. For quantification of pRPT6 the antibody used was 
kindly donated by Professor Fred J. Helmstetter (Department of Psychology, University 
of Wisconsin-Milwaukee, WI, USA) and is listed on Table 7.4-1. To fit our protocol to 
the previous used with this antibody, as described in Jarome et al. (2013), the TBST 




3% w/v BSA. The primary antibody for p-c-jun was also diluted in 3% w/v BSA. For 
detection of all the secondary antibodies the Pierce™ ECL western blotting substrate 
(Thermo Scientific, Waltham, MA, USA) was used. In brief, the staining of the 
secondary antibody was based on the reaction between the horseradish peroxidise 
attached to the secondary antibody and enhanced luminol-based chemioluminescent 
substrate provided by the kit. The membrane was incubated for 5 minutes at 25 
osc/min with 10mL of reagent 1 and 10mL of reagent 2. After incubation the 
membrane was quickly allocated inside a light proof recipient and taken to a dark 
room where a light sensitive Amersham Hyperfilm™ ECL™ (GE healthcare, Little 
Chalfont, UK; 28-9068-36) was exposed to it for detection of the chemioluminescence. 
Exposition time varied between the different antibodies. Quantification of bands was 
done after exposure in the linear range. The images obtained were analysed in ImageJ 
software (National Institute of Mental Health, Bethesda, MD, USA) for quantification of 
intensity of each band, by integration of the area of the graph obtain from the 
threshold analyses. For normalization the results of every protein of interest were 
divided by the results from the same membrane, after stripping, of a housekeeping 
protein, or the total protein of interest, if the antibody of interest was targeting a 
phosphorylated protein. Example membranes can be seen on Appendix “7.5 Example 
images of western blot membranes”. The results were also calibrated to the control 
value by multiplying the value of each sample by a factor created from dividing 1 to the 
average of the control samples in each gel separately. The average of each group was 




2.8.3.3 Membrane stripping 
For reuse of the membranes with a different primary antibody the following 
stripping protocol was used. Membrane was washed for 10 minutes at 45osc/min with 
30mL of TBST 0.05% v/v, followed by an incubation of 1 hour at 45osc/min with 20mL of 
buffer A and 200µL of buffer B from western blot stripping buffer (Santa Cruz 
Biotechnology Inc., Dallas, TX, USA; sc-281698). After this incubation the membrane was 
washed with 30mL of TBS for 5 minutes at 45osc/min. Thereafter the membrane was 
washed again with 3 rounds of 30mL of TBST 0.05% v/v for 10 minutes at 45osc/min. 
One final washed of 5 minutes at 45osc/min with 30mL of TBS was done before the 
membrane was blocked and used again for staining for a different protein.   
2.9 Statistical analysis 
Data was checked for normal distribution by Q-Q plot analysis, Kolmogorov-Smirnov 
and/or Shapiro-Wilk normality test. In case of non-normal distribution outliers were 
excluded from experiment as a normalization strategy. Outliers were defined as values 
that fall more than 1.5 times the interquartile range above the third quartile or below 
the first quartile. The only data remained not normally distributed after this 
normalization strategy was phosphorylation of CREB, so it was analysed with the non-
parametric Kruskal-Wallis test. Animals treated with shCaMK2N1 virus were also 
excluded from the experiment if the RT-qPCR analysis showed that the level of 
expression of CaMK2N1 was outlier in his group. This was considered to be an indication 
of treatment failure. The same principal was applied for animals treated with CaMK2N2 
virus but with RT-qPCR analysis of CaMK2N2 levels of expression. One-way analysis of 
variance (ANOVA) was used for analysis of dependent variables if the experiment had 




dependent variables were analysed by two-way ANOVA, with repeated measures if 
necessary (for example when comparing behavioural results from first and second 
memory test). Student-Newman-Keuls (SNK) test was used when necessary as planned 
comparisons. P values bellow 0.05 were considered to be significant in every analysis. 
Data was presented in scatterplot graphs where every dot represented the value of one 
animal and a line indicated the average of the group. The use of such graphical 
representation has been recommended by Weissgerber et al. (2015) as more 
representative of the data and giving more information for a more complete analyses. 
Non-normally distributed data was presented in box-and-whisker plot with group 
median value, lower quartile and upper quartile represented in the box and lowest and 
higher values indicated by the whisker. This type of graph representation is the most 













Chapter 3 Results with shCaMK2N1 virus 
3.1 Fluorescent images after viral vector transfection 
Images presented on Figure 3.1-1 and Figure 3.1-2 were taken from the brain of 
animals sacrificed 2 weeks after viral solution injection. As can be observed the 
fluorescence is restricted to the hippocampus, indicating that the virus effectively 
transfected neuronal cells only in the hippocampus.    
 
 
Figure 3.1-1 Fluorescent images for control virus 
Pictures of a mouse brain injected with the control viral solution. Panels A to C show a sequence of images from 
coronal sections of the same hippocampus in an anterior-posterior order. The hippocampus is outlined inside the 
white line. Panel D shows an image of the amygdala of the same animal where one can notice the lack of ZsGreen 
fluorescence. The amygdala is outlined inside the white line. All the pictures show DAPI nuclear staining in blue and 












Figure 3.1-2 Fluorescent images for shCaMK2N1 virus 
Pictures of a mouse brain injected with shCaMK2N1 viral solution. Panels A to C show a sequence of images from 
coronal sections of the same hippocampus in an anterior-posterior order. The hippocampus is outlined inside the 
white line. Panel D shows an image of the amygdala of the same animal where one can notice the lack of ZsGreen 
fluorescence. The amygdala is outlined inside the white line. All the pictures show DAPI nuclear staining in blue and 
ZsGreen fluorescence in green. Pictures were taken with a 2.5X objective and the scale can be seen on the bottom 
right corner. 
 
3.2 Virus effect in dorsal and ventral hippocampus 
Knowing that the transfection of the hippocampus was working we decided to 
verify the efficiency of the knockdown treatment. For that either control or shCaMK2N1 
viral solution was injected into the dorsal hippocampus. After 2 weeks the animals were 
sacrificed and dorsal and ventral hippocampus were collected separately. A qPCR 
analysis examined the level of CaMK2N1 mRNA expression (Figure 3.2-1). Two-way 
ANOVA test showed a significant effect of virus treatment (F1,22=13.1; P=0.002) and 
significant difference between regions (F1,22=37.1; P<0.001), with no interaction effect 
(F1,22=1.9; P=0.184). SNK planned comparisons showed that ventral hippocampus had 
higher levels of CaMK2N1 mRNA than dorsal hippocampus within the shControl group 








that the virus treatment resulted in a significant decrease of mRNA levels of CaMK2N1 
within dorsal hippocampus (q=5.0; P=0.003) but not ventral hippocampus (q=2.2; 
P=0.131). Based on this last result we have decided to work only with dorsal 
hippocampal samples. This means that all results from hippocampal analyses presented 
from now on in this thesis are only based on dorsal hippocampus samples. 
 
Figure 3.2-1 CaMK2N1 mRNA in dorsal and ventral hippocampus 
Quantitative analysis of CaMK2N1 mRNA levels for dorsal and ventral hippocampus. All results are normalized to the 
average of the dorsal hippocampus of shControl group.** P<0.01; *** P<0.001   
 
3.3 Effect of CaMK2N1 knockdown on memory maintenance  
Figure 3.3-1 shows the experimental design used to study the effect of 
hippocampal CaMK2N1 knockdown in the CFC paradigm. Briefly, animals were injected 
intra-hippocampally either with shCaMK2N1 virus solution or shControl virus solution. 
Two weeks later animals were placed in the conditioning chamber and received a mild 
foot shock, the US. Animals’ memory of the context was tested by re-exposure to the 






Figure 3.3-1 Experimental design CaMK2N1 knockdown 
The figure shows the experimental design for the first test done on the effect of CaMK2N1 knockdown in the animals’ 
freezing score at the CFC paradigm. Animals were first injected with shControl or shCaMK2N1 virus solution. Two 
weeks later they were trained with one shock of 0.7 mA. Animals were then re-exposed to the context in two memory 
tests of 5 minutes each. The tests occurred 24 hours and 4 days after training. Animals were sacrificed two hours after 
second memory test.     
 
Animals freezing score during the two memory tests can be seen in Figure 3.3-2. 
Two-way ANOVA showed a significant effect of the two consecutive memory tests 
(F1,24=9.0; P=0.006) with no effect of virus treatment alone (F1,24=1.4; P=0.234) but a 
significant effect of interaction (F1,24=8.1; P=0.009). SNK planned comparisons revealed 
a significant difference between the freezing score of animals from shControl group and 
shCaMK2N1 group in the 4 days memory test (q=3.4 ; P=0.019) but no difference in the 
24 hours memory test (q=0.4 ; P=0.769). This result indicated that CaMK2N1 knockdown 
has an effect on memory maintenance rather than on memory formation. A significant 
difference between first and second memory test was observed on animals from 
shCaMK2N1 group (q=3.7 ; P=0.012) but not on animals from shControl group (q=0.1 ; 





Figure 3.3-2 Freezing scores from experiment with CaMK2N1 knockdown 
The graph above shows the average of freezing scores of animals from shControl and shCaMK2N1 groups, in the first 
(24h) and second (4 days) memory tests. Freezing scores are presented in the ordinate axis as percentage of freezing 
time in the 5 minutes of test. *P<0.05; ***P<0.001 
 
RT-qPCR analyses of dorsal hippocampus confirmed an effective knockdown of 
CaMK2N1 (Figure 3.3-3). One-way ANOVA showed a significant decrease of CaMK2N1 
mRNA levels in shCaMK2N1 group (F1,25=17.7; P<0.001). Interestingly, CaMK2N2 mRNA 
levels were significantly increased in animals from shCaMK2N1 group (F1,25=13.3; 
P=0.001) (Figure 3.3-4). This increased expression of CaMK2N2 could be interpreted as 
a compensation for the knocking-down of CaMK2N1 and it was studied in more detail in 




   
Figure 3.3-3 CaMK2N1 mRNA levels from experiment with CaMK2N1 knockdown 
Quantitative analysis of the levels of CaMK2N1 mRNA. CaMK2N1 mRNA levels were normalized by HPRTL mRNA 
levels. All results were standardized to shControl group average. *** P<0.001  
 
 
Figure 3.3-4 CaMK2N2 mRNA levels from experiment with CaMK2N1 knockdown 
Quantitative analyses of the levels of CaMK2N2 mRNA. CaMK2N2 mRNA levels were normalized by HPRTL mRNA 








3.4 Effect of CaMK2N1 knockdown on memory maintenance is retrieval 
dependent  
Considering the behavioural phenotype observed (Figure 3.3-2) the memory 
impairment could be dependent on two variables, they being time and re-exposure. The 
first memory test is closer in time to the learning session but also animals have not been 
exposed to a previous memory test when executing the first memory test. To test these 
two possibilities we subjected animals to only one memory test 4 days after learning 
session, as can be seen in Figure 3.4-1.  
 
Figure 3.4-1 Experimental design one memory test 
The figure shows the experimental design for testing time or re-exposure dependence of the CaMK2N1 knockdown 
induced memory impairment. Animals were first injected with shControl or shCaMK2N1 virus solution. Two weeks 
later they were trained with one shock of 0.7 mA. Animals were then re-exposed to the same context for 5 minutes. 
The test took place 4 days after training session. Animals were sacrificed two hours after the memory test. 
 
If the memory impairment is time-dependent and retrieval-independent, then, 
4 days after training the animals should have a memory impairment. However, if the 
memory impairment is dependent solely on re-exposure to the context we should not 
observe a memory impairment when the animals are tested only once. As shown in 
Figure 3.4-2, there was no significant difference between shControl and shCaMK2N1 
group if the animals were tested only once (F1,38=1.0; P=0.319). This indicates that the 






 Figure 3.4-2 Freezing scores from experiment with one memory test 
This figure shows the average of freezing scores of animals from shControl and shCaMK2N1 groups in one memory 
test executed 4 days after training. Freezing scores are presented in the ordinate axis as percentage of freezing time 
in the 5 minutes of test.  
 
RT-qPCR analyses confirmed the efficiency of gene knockdown with a significant 
decrease of CaMK2N1 mRNA levels in animals treated with shCaMK2N1 virus solution 
(F1,38=66.1; P<0.001) (Figure 3.4-3) and no significant change in CaMK2N2 mRNA levels 






Figure 3.4-3 CaMK2N1 mRNA levels from experiment with one memory test 
Quantitative analyses of the levels of CaMK2N1 mRNA. CaMK2N1 mRNA levels were normalized by HPRTL mRNA 
levels. All results were standardize to shControl group average. *** P<0.001  
 
 
Figure 3.4-4 CaMK2N2 mRNA levels from experiment with one memory test 
Quantitative analyses of the levels of CaMK2N2 mRNA. CaMK2N2 mRNA levels were normalized by HPRTL mRNA 









3.5 Retrieval-induced expression of CaMKII inhibitors 
To further investigate the relevance of CaMK2N1 and CaMKIIN2 after retrieval of 
a memory we applied the experimental design showed in Figure 3.5-1 to naïve mice. The 
aim of this experiment was to look for any retrieval induced change in the expression of 
the inhibitors of CaMKII. Briefly, animals were placed in the conditioning chamber and 
received 3 mild foot shocks. One day later animals were either re-exposed to the 
conditioning chamber for 5 minutes and contextual fear memory tested (TR+TE), or just 
been trained (TR) in the CFC paradigm. 
 
Figure 3.5-1 Experimental design retrieval induced changes on CaMKII inhibitors 
The image above presents the experimental design for testing the effects of re-exposure in the expression levels of 
CaMK2N1 and CaMK2N2. Naïve animals were trained with three shocks of 0.7 mA, for 2 seconds each. Animals from 
TR+TE group were then re-exposed to the context for one memory tests of 5 minutes. The test took place 24 hours 
after training session. All animals were sacrificed 30 minutes after the memory test of group TR+TE. 
 
This experiment was previously executed by Dr. Keiko Mizuno, hence the 
differences in number of shocks and time point of the sacrifice. Dorsal hippocampal 
samples collected by Dr. Mizuno were used in this thesis to test by RT-qPCR the mRNA 
levels of CaMK2N1 and CaMK2N2. As shown in Figure 3.5-2, animals subjected to a 
memory test of 5 minutes (TR+TE) presented an increase in CaMK2N1 mRNA levels when 
compared to animals without memory test (TR) (F1,9=21.8; P=0.002). No significant 





Figure 3.5-2 CaMK2N1 mRNA levels after memory retrieval 
Quantitative analyses of the levels of CaMK2N1 mRNA with or without a memory test. Animals from group TR were 
just trained with the CFC paradigm whilst animals from group TR+TE were trained and tested with the CFC paradigm. 
CaMK2N1 mRNA levels were normalized by HPRTL mRNA levels. All results were standardize to shControl group 




Figure 3.5-3 CaMK2N2 mRNA levels after memory retrieval 
Levels of CaMK2N2 mRNA with or without a memory test are presented in the graph. Animals from group TR were 
just trained with the CFC paradigm whilst animals from group TR+TE were trained and tested with the CFC paradigm. 






On the other hand, RT-qPCR analyses of samples from a CFC experiment with 5 
shocks, also previously executed by Dr. Keiko Mizuno, revealed a different regulation of 
the inhibitors. Experimental design for this five shocks experiment can be seen in Figure 
3.5-4. It is the same experimental design as for  training with three shocks.  
 
Figure 3.5-4 Experimental design retrieval with 5 shocks learning session 
As the experimental design in Figure 3.5-1 the scheme above shows an experimental design to test the effect of the 
memory test but after a 5 shocks learning session. Naïve animals were trained with five shocks of 0.7 mA, for 2 seconds 
each. Animals from TR+TE group were then re-exposed to the context for one memory tests of 5 minutes. The test 
took place 24 hours after training session. All animals were sacrificed 30 minutes after the memory test of group 
TR+TE. 
 
RT-qPCR analyses shows no significant difference between the groups on the 
levels of CaMK2N1 mRNA (F1,11=1.8; P=0.206) (Figure 3.5-5). However, a significant 
increase in the mRNA levels for CaMK2N2 was observed in animals from group TR+TE 
(F1,11=5.4; P=0.041) (Figure 3.5-6). This difference on the effect of memory retrieval in 
the regulation of the inhibitors dependent of the intensity of the US can be interpreted 






Figure 3.5-5 CaMK2N1 mRNA levels after 5 shocks memory retrieval 
Quantitative analyses of the levels of CaMK2N1 mRNA with or without a memory test, after a 5 shocks memory test. 
Animals from group TR were just trained with a 5 shocks learning session, whilst animals from group TR+TE were 
trained and tested with in the CFC paradigm. CaMK2N1 mRNA levels were normalizes by HPRTL mRNA levels. All 
results were standardize to shControl group average.  
 
 
Figure 3.5-6 CaMK2N2 mRNA levels after 5 shocks memory retrieval 
CaMK2N2 mRNA levels are presented in the graph above. Animals from group TR were just trained with 5 shocks 
learning session the CFC paradigm. Animals from group TR+TE were trained and tested. CaMK2N2 mRNA levels were 








3.6 Molecular effects of CaMK2N1 knockdown 
To better understand the molecular changes caused by CaMK2N1 knockdown we 
analysed the expression and phospho-regulation of different proteins by western blot. 
The analysis consisted of 4 groups of experiments. The first group of western blots aimed 
to study the effect of shCaMK2N1 treatment on CaMKII signalling. The second group of 
experiments looked at the effect of CaMK2N1 knockdown on expression of the AMPA 
receptor subunit GluA1. The third group of western blots studied changes in protein 
degradation. The last group of studies investigated changes in molecules involved in 
regulation of gene expression.     
3.6.1 Effects of CaMK2N1 knockdown on CaMKII  
Mice were either injected with shControl or shCaMK2N1 virus solution. Two 
weeks later animals were subjected to the CFC paradigm, as presented in Figure 3.6-1. 
The animals were divided between does just trained (TR) and does trained and tested 
(TR+TE) in the CFC paradigm. Two hours after the end of the memory test session their 
dorsal hippocampus was collected for western blot analyses. 
  
Figure 3.6-1 Experimental design for western blot analyses 
The image above presents the experimental design applied to the animals used for western blot analyses. Naïve 
animals were trained with one shocks of 0.7 mA, for 2 seconds each. Animals from TR+TE group were then re-exposed 
to the context for one memory tests of 5 minutes whilst animals from TR group were not tested. The test took place 






Western blot analyses showed no significant change in total αCaMKII expression 
in crude synaptosomal fraction (P2) when normalized to synaptotagmin, as shown of 
Figure 3.6-2. Two-way ANOVA found no significant effect of memory test (F1,27=0.02; 
P=0.889), CaMK2N1 knockdown (F1,27=0.4; P=0.488) or interaction (F1,27=0.1; P=0.748). 
However, analyses of P2 fraction showed a significant difference in levels of T286-
phosphorylated αCaMKII (Figure 3.6-3). Two-way ANOVA test showed a significant 
effect of CaMK2N1 knockdown (F1,26=6.6; P=0.017). No significant effect for memory 
test (F1,26=3.8; P=0.064) or interaction between the memory test and CaMK2N1 
knockdown (F1,26=1.8; P=0.185) was observed. SNK planned comparisons showed a 
significant decrease in phosphorylated αCaMKII after memory test within the shControl 
group (q=3.1; P=0.035) but not shCaMK2N1 group (q=0.6; P=0.670). A significant 
difference in αCaMKII autophosphorylation level was also observed between shControl 
and shCaMK2N1 after memory retrieval (q=3.7; P=0.014) but not without it (q=1.2; 




   
Figure 3.6-2 P2 αCaMKII levels after CaMK2N1 knockdown 
This figure shows the levels of αCaMKII for animals trained (TR) or trained and tested (TR+TE) in the CFC paradigm. 
Animals of both groups also received intra-hippocampal injection of shControl or shCaMK2N1 viral solution. Levels of 
αCaMKII were normalized by the internal loading control, Synaptotagmin. The results of all the groups were 
standardized to TR shControl average. Images on the bottom of the figure show example bands of αCaMKII and 











Figure 3.6-3 P2 T286 phosphorylated αCaMKII levels after CaMK2N1 knockdown 
This figure shows the levels of T286 phosphorylated αCaMKII (pαCaMKII) for animals trained (TR) or trained and tested 
(TR+TE) in the CFC paradigm. Animals of both groups also received intra-hippocampal injection of shControl or 
shCaMK2N1 viral solution. Levels of phosphorylated αCaMKII were normalized by total αCaMKII levels. The results of 
all the groups were standardized to TR shControl average. Images on the bottom of the figure show example bands 
of pαCaMKII and αCaMKII for all groups. *P<0.05   
 
 
We also analysed the levels of total (Figure 3.6-4) and T286 autophosphorylated 
(Figure 3.6-5) αCaMKII in cytosolic fraction (S2). There was no significant effect of 
memory test (F1,26=1.1; P=0.300), virus treatment (F1,26=2.2; P=0.145) or interaction 
effect (F1,26=3.3; P=0.079) in total αCaMKII levels. We also observed no effect of memory 
test (F1,24=0.7; P=0.389), CaMK2N1 knockdown (F1,24=4.0; P=0.058) or interaction 
between factors (F1,24=0.4; P=0.512) when measuring phosphorylated αCaMKII levels in 
S2 fraction. As can be deduced by the results above presented, although some tendency 
effects in αCaMKII levels and phosphorylation were seen in the S2 samples, the effects 
of memory retrieval and CaMK2N1 were more pronounced in the synaptosomal fraction 






Figure 3.6-4 S2 αCaMKII levels after CaMK2N1 knockdown 
This figure shows the levels of αCaMKII in the S2 fraction of animals trained (TR) or trained and tested (TR+TE) in the 
CFC paradigm. Animals of both groups also received intra-hippocampal injection of shControl or shCaMK2N1 viral 
solution. Levels of αCaMKII were normalized by the internal loading control, Synaptotagmin. The results of all the 
groups were standardized to TR shControl average. Images on the bottom of the figure show exemple bands of 








Figure 3.6-5 S2 T286 phosphorylated αCaMKII levels after CaMK2N1 knockdown 
This figure shows the levels of T286 phosphorylated αCaMKII (pαCaMKII) in the S2 fraction of animals trained (TR) or 
trained and tested (TR+TE) in the CFC paradigm. Animals of both groups also received intra-hippocampal injection of 
shControl or shCaMK2N1 viral solution. Levels of phosphorylated αCaMKII were normalized by total αCaMKII levels. 
The results of all the groups were standardized to TR shControl average. Images on the bottom of the figure show 
example bands of pαCaMKII and αCaMKII for all groups.   
 
3.6.2 Effects of CaMK2N1 knockdown on GluA1   
It is known that the AMPAR subunit GluA1 is a phosphorylation target of CaMKII 
(Derkach et al., 1999), and that CaMKII can regulate the distribution of AMPAR at the 
synapse (Opazo et al., 2010). Both processes of AMPAR regulation by CaMKII have been 
suggested to be important for memory formation and maintenance (Lisman et al., 2002; 
Lisman et al., 2012; Sanhueza and Lisman, 2013). Therefore, it was relevant to study the 
effect of CaMK2N1 knockdown on total (Figure 3.6-6) and S831-phosphorylated (Figure 
3.6-7) levels of GluA1. The same samples which were used for the CaMKII western blot 
studies were probed to invesitgate GluA1 expression and regulation (Figure 3.6-1). 
Western blot results indicated a significant effect of CaMK2N1 knockdown in total GluA1 




P=0.468) and no interaction between both factors (F1,25=1.3; P=0.261) was observed. 
SNK planned comparisons showed a significant difference in GluA1 levels between 
shControl and shCaMK2N1 animals only when animals were trained and tested (TR+TE) 
(q=3.2; P=0.030), but not when they were only trained (TR) (q=1.0; P=0.448). No 
significant effect of memory test within shControl (q=1.7; P=0.220) or shCaMK2N1 
(q=0.4; P=0.757) groups was observed (Figure 3.6-6).  
  
Figure 3.6-6 P2 GluA1 levels after CaMK2N1 knockdown 
This figure shows the levels of GluA1 in the P2 fraction of animals injected with shControl or shCaMK2N1 virus solution 
(as indicated on coordinate axe). Animals were also divided between those subjected to only training at CFC paradigm 
(TR) and those trained and tested for memory of context (TR+TE). Levels of GluA1 were normalized by the internal 
loading control, Synaptotagmin. The results of all the groups were standardized to TR shControl average. Images on 
the bottom of the figure show exemple bands of GluA1 and Synaptotagmin for all groups. *P<0.05 
 
P2 levels of phosphorylated GluA1 presented a significant decrease as effect of 
ShCaMK2N1 virus treatment (F1,25=6.9; P=0.015) (Figure 3.6-7). Once more, SNK planned 
comparisons shows this decrease to be significant only in TR+TE animals (q=3.0; 
P=0.046) but not in TR animals (q=2.2; P=0.124). Two-way ANOVA also showed no effect 




difference between TR and TR+TE animals was observed within the shControl animals 




Figure 3.6-7 P2 Phosphorylated GluA1 levels after CaMK2N1 knockdown 
The figure above shows the levels of S831 phosphorylated GluA1 in the P2 fraction of animals injected with shControl 
or shCaMK2N1 virus solution (as indicated on coordinate axe). Animals were also divided between those subjected 
to only training at CFC paradigm (TR) and those trained and tested for memory of context (TR+TE). Levels of pGluA1 
were normalized by total GluA1 levels. The results of all the groups were standardized to TR shControl average. Images 
on the bottom of the figure show exemple bands of pGluA1 and GluA1 for all groups. *P<0.05 
 
The fact that the effects of CaMK2N1 knockdown on total and phosphorylated 
GluA1 levels were only significant in TR+TE animals seems to indicate that these effects 
are dependent on memory retrieval. However, since both groups, TR and TR+TE, were 
subjected to CFC training it was not possible to investigate any baseline effect of 
shCaM2N1 virus treatment on GluA1 levels and phosphorylation. To test for any GluA1 
alterations induced by CaMK2N1 knockdown in naïve animal we tested the effect of 





Figure 3.6-8 Experimental design for western blot of naive animals 
The image above presents the experimental design applied to study the effects of CaMK2N1 knockdown in naïve 
animals. Naïve animals received an intra-hipocampal injection of either shControl virus solution of shCaMK2N1 virus 
solution. All animals were sacrificed 15 days after injection. 
 
 
Treatment with shCaMK2N1 virus solution in naïve animals had no effect on total 
GluA1 (F1,16=2.1; P=0.161) (Figure 3.6-9) or pGluA1 (F1,17=0.6; P=0.443) (Figure 3.6-10) 
levels. This indicated that the GluA1 alterations induced by CaMK2N1 knockdown are 
not due to baseline alterations but rather a learning/memory dependent effect.  
 
  
Figure 3.6-9 P2 GluA1 levels after CaMK2N1 knockdown in naive animals 
This figure shows the levels of GluA1 in the P2 fraction of naive animals injected with shControl or shCaMK2N1 virus 
solution. Levels of GluA1 were normalized by the internal loading control, Synaptotagmin. The results were 
standardized to shControl average. Images on the bottom of the figure show exemple bands of GluA1 and 






Figure 3.6-10 P2 pGluA1 levels after CaMK2N1 knockdown in naive animals 
The figure above shows the levels of S831 phosphorylated GluA1 in the P2 fraction of naive animals injected with 
shControl or shCaMK2N1 virus solutiont. Levels of pGluA1 were normalized by total GluA1 levels. The results were 
standardized to shControl average. Images on the bottom of the figure show exemple bands of pGluA1 and GluA1 for 
all groups. 
 
3.6.3 Effects of CaMK2N1 knockdown on protein degradation  
Protein degradation by the proteasome system has been shown to be an 
important process for memory consolidation (Jarome et al., 2011; Lopez-Salon et al., 
2001) and reconsolidation (Artinian et al., 2008; Lee et al., 2008). Additionally, CaMKII 
has been show to regulate proteasome activity by phosphorylation of the Rpt6 subunit 
(Djakovic et al., 2009; Jarome et al., 2011) and proteasome localization in the PSD area 
of the synapse by acting as a scaffold protein (Bingol et al., 2010). These memory related 
processes of protein degradation have a few known targets like GluA1 (Naskar et al., 
2014) and the scaffolding protein Shank (Lee et al., 2008). In the case of Shank, Lee et 
al. (2008) have observed an increase in Shank degradation 2 hours after CFC memory 
retrieval session. Due to the similarity of the experimental design used by Lee et al. 




the P2 fraction as an indirect measure of protein degradation at the synapses. For that 
propose P2 fraction of the dorsal hippocampus of animals subjected to the experimental 
design described in Figure 3.6-1 were used for western blot analysis. Three bands, 
probably corresponding to the three known isoforms of Shank, were detected and 
analysed together. The effect of viral treatment, memory retrieval session and 
interaction between these two factors were tested by two-way ANOVA. No significant 
effect of virus treatment (F1,27=0.6; P=0.419), memory test (F1,27=0.05; P=0.811), or 
interaction between both factors (F1,27=0.7; P=0.393) were observed (Figure 3.6-11). 
Analyses of each one of the three bands separately also showed no significant result 
[Top band: virus effect (F1,27=0.3; P=0.580), memory effect (F1,27=0.2; P=0.652), 
interaction effect (F1,27=0.7; P=0.382); Middle band: virus effect (F1,27=0.2; P=0.616), 
memory effect (F1,27=0.3; P=0.573), interaction effect (F1,27=0.5; P=0.479); Lower band: 






     
Figure 3.6-11 P2 Shank levels after CaMK2N1 knockdown 
The figure above shows the levels of Shank protein in the P2 fraction of animals injected with shControl or shCaMK2N1 
virus solution (as indicated on coordinate axe). Animals were also divided between those subjected to only training 
at CFC paradigm (TR) and those trained and tested for memory of context (TR+TE). Levels of Shank were normalized 
by Synaptotagmin levels. The results of all the groups were standardized to TR shControl average. Images on the 




Proteasome degradation of proteins is regulated by ubiquitination of target 
proteins (Ciechanover and Stanhill, 2014). In the same article that Lee et al. (2008) 
reported the memory retrieval induced degradation of Shank an increase in 
ubiquitination of synaptosomal proteins was also reported. Increased ubiquitination of 
proteins following memory retrieval has also been shown to occur by Fukushima et al. 
(2014). Therefore, we decided to quantify polyubiquitination levels at the P2 fraction of 
our samples. Two-way ANOVA test showed no significant effect of memory retrieval 
(F1,27=0.1; P=0.747), CaMK2N1 knockdown (F1,27=0.4; P=0.530) or interaction (F1,27=0.1; 





Figure 3.6-12 P2 Ubiquitinated proteins levels after CaMK2N1 knockdown 
The image shows the levels of ubiquitinated proteins in the P2 fraction of animals injected with shControl or 
shCaMK2N1 virus solution. Animals were also divided between those subjected to only training at CFC paradigm (TR) 
and those trained and tested for memory of context (TR+TE). Levels of ubiquitineted proteins were normalized by 
Synaptotagmin levels. The results of all the groups were standardized to TR shControl average. Images on the bottom 
of the figure show example bands of ubiquitinated proteins (seen as a smear band due to the various size of proteins 
been ubiquitinated) and Synaptotagmin for all groups. 
 
Finally, we measured the levels of phosphorylated (Figure 3.6-14) and total 
(Figure 3.6-13) proteasome subunit Rpt6. There was no significant effect of shCaMK2N1 
treatment (F1,26<0.001; P=0.987), memory retrieval (F1,26=0.2; P=0.639) or interaction 
(F1,26=0.02; P=0.876) in the levels of total Rpt6 (Figure 3.6-13). Two-way ANOVA test also 
showed no effect of virus treatment (F1,22=0.3; P=0.543), memory test (F1,22=0.8; 
P=0.383) or interaction between these two factors (F1,22=0.6; P=0.424) in the levels of 




   
Figure 3.6-13 P2 Rpt6 levels after CaMK2N1 knockdown 
The figure above shows the levels of the proteasome sub-unit Rpt6 in the P2 fraction of animals injected with 
shControl or shCaMK2N1 virus solution (as indicated on coordinate axe). Animals were also divided between those 
subjected to only training at CFC paradigm (TR) and those trained and tested for memory of context (TR+TE). Levels 
of Rpt6 were normalized by Synaptotagmin levels. The results of all the groups were standardized to TR shControl 












Figure 3.6-14 P2 phosphorylated Rpt6 levels after CaMK2N1 knockdown 
This image shows the levels of phosphorylated Rpt6 in the P2 fraction of animals injected with shControl or 
shCaMK2N1 virus solution. Animals were also divided between those subjected to only training at CFC paradigm (TR) 
and those trained and tested for memory of context (TR+TE). Levels of pRpt6 were normalized by total Rpt6 levels. 
The results of all the groups were standardized to TR shControl average. Images on the bottom of the figure show 
example bands of pRpt6 and total Rpt6 for all groups. 
 
Taken together, our indirect and direct observations of the proteasome system 
seems to indicate that the behavioural phenotype observed as a consequence of 
CaMK2N1 knockdown is not related to protein degradation by the proteasome system.  
 
3.6.4 Effects of CaMK2N1 knockdown on gene expression  
Gene expression and protein synthesis have been shown to be necessary for 
memory maintenance after a retrieval session(Kelly et al., 2003; Lee et al., 2004). Gene 
expression is known to be regulated by CaMKII kinase activity via different pathways 
(Chen et al., 2012; Takeuchi et al., 2002; Wang et al., 2013), hence gene expression 
changes are a good candidate for a molecular basis of the behavioural phenotype 




CaMK2N1 knock down in retrieval-induced gene expression we used an earlier time 
point after retrieval session, of 1 hour after, and extracted P1 fraction of the samples. In 
order to do so, the experimental design explained in Figure 3.6-15 was applied. It is 
basically the same experimental design used previously for other western blot analysis 
with the difference that animals from group TR+TE were sacrificed 1 hour after memory 
retrieval session. 
 
Figure 3.6-15 Experimental design for western blot analyses of P1 fraction 
The image above presents the experimental design applied to the animals used for western blot analyses of P1 
fraction. Naïve animals were trained with one shocks of 0.7 mA, for 2 seconds each. Animals from TR+TE group were 
then re-exposed to the context for one memory tests of 5 minutes whilst animals from TR group were not tested. The 




We first analysed the levels of the transcription factor CREB, which is known to 
be regulated by CaMKII (Ma et al., 2014a). Total levels of CREB (Figure 3.6-16) and its 
phosphorylation at S133 (Figure 3.6-17) in P1 fraction of all animals were studied by 
western blot analysis. Two-way ANOVA showed no significant effect of the virus 
treatment (F1,34=1.9; P=0.172), memory test (F1,34=1.8; P=0.183) or interaction between 
both factors (F1,34=0.03; P=0.858) in total CREB levels. There was also no significant 
difference between the groups in terms of CREB S133 phosphorylation (P=0.818), as 





 Figure 3.6-16 P1 CREB levels after CaMK2N1 knockdown 
The image above shows the levels of CREB in the P1 fraction of animals injected with shControl or shCaMK2N1 virus 
solution. Animals were also divided between those subjected to only training at CFC paradigm (TR) and those trained 
and tested for memory of context (TR+TE). Levels of CREB were normalized by nuclear lamin. The results of all the 
groups were standardized to TR shControl average. Images on the bottom of the figure show example bands of CREB 












Figure 3.6-17 P1 phosphorylated CREB levels after CaMK2N1 knockdown 
This figure shows the levels of phosphorylated CREB in the P1 fraction of animals injected with shControl or 
shCaMK2N1 virus solution. Animals were also divided between those subjected to only training at CFC paradigm (TR) 
and those trained and tested for memory of context (TR+TE). Levels of pCREB were normalized by total CREB levels. 
The results of all the groups were standardized to TR shControl average. Images on the bottom of the figure show 
example bands of pCREB and CREB for all groups. The image presents a box plot graph since the distribution of the 
data was not normal. Median,  2nd and 3rd quartiles, and maximum and minimum values are presented in the graph.  
 
We then analysed the levels of the immediate early gene Zif268 (Figure 3.6-18), 
a transcription factor important for memory maintenance after retrieval (Lee, 2008; Lee 
et al., 2004). Two-way ANOVA of the western blot data from P1 fraction showed no 
significant effect of CaMK2N1 knockdown (F1,33=0.02; P=0.887) or memory retrieval 
(F1,33=0.04; P=0.842). However, there was a significant interaction between virus 
treatment and memory test (F1,33=5.7; P=0.023). Although a significant effect of 
interaction was observed, SNK planned comparisons did not show any significant 
difference. There was no significant effect of memory retrieval in shControl group 
(q=2.2; P=0.126) or in shCaMK2N1 group (q=2.5; P=0.079). There was also no significant 
effect of CaMK2N1 knockdown between trained animals (q=2.4; P=0.094) or in trained 





Figure 3.6-18 P1 Zif268 levels after CaMK2N1 knockdown 
This figure shows the levels of Zif268 in the P1 fraction of animals injected with shControl or shCaMK2N1 virus 
solution. Animals were also divided between those subjected to only training at CFC paradigm (TR) and those trained 
and tested for memory of context (TR+TE). Levels of Zif268 were normalized by Lamin. The results of all the groups 
were standardized to TR shControl average. Images on the bottom of the figure show example bands of Zif268 and 
Lamin for all groups. 
 
 
Another immediate-early gene analysed was the transcription factor c-fos 
(Figure 3.6-19). This transcription factor has been show previously to be important for 
memory consolidation and extinction (Guedea et al., 2011; Huff et al., 2006; Tronson et 
al., 2009). Again, P1 fraction was extracted from dorsal hippocampus samples and 
analysed by western blot. Two-way ANOVA revealed no significant effect of virus 
treatment alone (F1,31=0.08; P=0.779) or memory test (F1,31=2.7; P=0.110), but there was 
a significant interaction between these two factors (F1,31=10.7; P=0.003). SNK planned 
comparisons showed a significant effect of memory retrieval within shControl group 
(q=4.7; P=0.003) but not within shCaMK2N1 group (q=1.7; P=0.239). Additionally, a 
significant difference between shControl and shCaMK2N1 groups was observed within 




seems to indicate that c-fos is a good candidate for explaining the behaveoural effect of 
CaMK2N1 knockdown observed. This hypothesis will be discussed in detail at the 
Discussion section of this thesis. 
   
Figure 3.6-19 P1 c-fos levels after CaMK2N1 knockdown 
The figure above shows the levels of c-fos in the P1 fraction of animals injected with shControl or shCaMK2N1 virus 
solution. Animals were also divided between those subjected to only training at CFC paradigm (TR) and those trained 
and tested for memory of context (TR+TE). Levels of c-fos were normalized by nuclear lamin. The results of all the 
groups were standardized to TR shControl average. Images on the bottom of the figure show example bands of c-fos 
and Lamin for all groups. *P<0.05; **P<0.01 
 
 
To further understand the effect of CaMK2N1 knockdown on c-fos expression we 
decided to look for any alterations of c-fos after CaMK2N1 knockdown on non-trained 
animals. This experiment was executed to look for baseline alterations in c-fos 
expression after CaMK2N1 knockdown. For this purpose samples from the experimental 
design explained on Figure 3.6-8 were used. One-way ANOVA showed no significant 




P=1.000) (Figure 3.6-20). This result indicated that the alterations in c-fos expression 
observed (Figure 3.6-19) are behaviourally induced.  
  
Figure 3.6-20 P1 c-fos levels after CaMK2N1 knockdown in naive animals 
The figure above shows the levels of c-fos in the P1 fraction of naive animals injected with shControl or shCaMK2N1 
virus solution. Levels of c-fos were normalized by the internal loading control, Lamin. The results were standardized 
to shControl average. Images on the bottom of the figure show example bands of c-fos and Lamin for all groups. 
 
Guedea et al. (2011) have suggested that the phosphorylation of the 
transcription factor c-jun might regulate c-fos expression during memory extinction. 
Therefore, we analysed the levels of phosphorylated c-jun in the P1 fraction of our 
samples (Figure 3.6-21). Two-way ANOVA revealed no significant effect of virus 
treatment (F1,30=0.2; P=0.637), of memory retrieval (F1,30=2.6; P=0.116) and interaction 





Figure 3.6-21 P1 phosphorylated c-jun levels after CaMK2N1 knockdown 
This image shows the levels of phosphorylated c-jun in the P1 fraction of animals injected with shControl or 
shCaMK2N1 virus solution. Animals were also divided between those subjected to only training at CFC paradigm (TR) 
and those trained and tested for memory of context (TR+TE). Levels of pc-jun were normalized by nuclear lamin. The 
results of all the groups were standardized to TR shControl average. Images on the bottom of the figure show example 













3.6.5 Effects of CaMK2N1 knockdown 
Significant results obtain in the western blots and the behavioural studies performed 
are summarized in Table 3.6-1. These results are discussed in detail on the Discussion 
session of this thesis. Example membranes of the western blot analyses can be seen on 
Appendix “7.5 Example images of western blot membranes”. 
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Table 3.6-1 Significant results from western blot and behavioural analyses 
The table above summarize all the significant results obtain in the western blot and behavioural analyses. The 
significance of the results was obtained from SNK planned comparisons. First column shows the name of the 
dependent variable analysed. Second and third column show the significant effects of memory retrieval in shControl 
group and shCaMK2N1, respectively. The fourth and fifth column show the effects of CaMK2N1 knockdown with or 
without memory retrieval, respectively. Arrows indicate a significant result and its direction shows if the effect was 









Chapter 4 Results with CaMK2N2 virus 
4.1 Fluorescent images after viral vector transfection 
Images presented on Figure 4.1-1 were taken from the brain of animals sacrificed 
2 weeks after injection of viral solution containing the genes for CaMK2N2 an the 
fluorescent protein GFP. As can be observed the fluorescence is restricted to the 
hippocampus, indicating that the virus effectively transfected neuronal cells only in the 
hippocampus.  
    
    
Figure 4.1-1 Fluorescent images for CaMK2N2 virus 
Pictures of a mouse brain injected with CaMK2N2 viral solution. All the pictures show DAPI nuclear staining in blue 
and GFP fluorescence in green. Panels A to C show a sequence of images from the same hippocampus in an anterior-
posterior order. The hippocampus is outlined inside the white line. Panel D shows an image of the amygdala of the 
same animal where one can notice the lack of GFP fluorescence. The amygdala is outlined inside the white line. 









4.2 Effect of CaMK2N2 overexpression on learning  
The experimental design used to study the effect of hippocampal CaMK2N2 
overexpression in the CFC paradigm was the same used for CaMK2N1 knockdown, 
presented on Figure 3.3-1. Briefly, animals were injected in both dorsal hippocampi, 
either with CaMK2N2 virus solution (CaMK2N2 virus) or control solution (Control virus). 
Two weeks later animals were placed in the conditioning chamber and received a mild 
foot shock, the US. Fear memory of the context was tested by re-exposure to the 
conditioning chamber without US for 5 minutes, 24 hours and 4 days after the 
conditioning session. Freezing score for animals from CaMK2N2 virus and Control virus 
groups are presented on Figure 4.2-1. Two-way ANOVA with repeated measures showed 
a significant effect of CaMK2N2 overexpression (F1,19=4.7; P=0.043), significant effect of 
the memory tests (F1,19=10.3; P=0.004), but no interaction (F1,19=0.01; P=0.923). SNK 
planned comparisons showed a significant decrease of freezing behaviour in CaMK2N2 
virus group when compared with Control virus group only in the 24 hours memory test 
(q=2.9; P=0.049), but not in the 4 days memory test (q=2.8; P=0.056). This result 
suggests that, different from CaMK2N1 knockdown, CaMK2N2 overexpression in the 
hippocampus causes a learning impairment phenotype. SNK planned comparisons also 
presented a significant effect of the memory tests within Control virus (q=3.4; P=0.027) 




      
Figure 4.2-1 Freezing scores from experiment with CaMK2N2 overexpression 
The graph above shows the average of freezing scores of animals from Control virus and CaMK2N2 virus group in the 
first (24h) and second (4 days) memory tests. Freezing scores are presented in the ordinate axis as percentage of 
freezing time in the 5 minutes of test. *P<0.05 
 
To evaluate the efficiency and specificity of our overexpression treatment animals 
were sacrificed 2 hours after the last memory test, their dorsal hippocampus was 
dissected and used for RT-qPCR analyses of the mRNA levels of CaMK2N2 (Figure 4.2-2) 
and CaMK2N1 (Figure 4.2-3). One-way ANOVA test shows a significant increase in 
CaMK2N2 mRNA levels (F1,20=48.6; P<0.001) with no effect on CaMK2N1 (F1,20=3.1; 





Figure 4.2-2 CaMK2N2 mRNA levels from experiment with CaMK2N2 overexpression 
Quantitative analyses of the levels of CaMK2N2 mRNA. CaMK2N2 mRNA levels were normalized by HPRTL mRNA 




Figure 4.2-3 CaMK2N1 mRNA levels from experiment with CaMK2N2 overexpression 
Quantitative analyses of the levels of CaMK2N1 mRNA. CaMK2N1 mRNA levels were normalized by HPRTL mRNA 









4.3 Effect of CaMK2N2 overexpression after training session 
Considering that CaMK2N2 overexpression in the hippocampus caused a learning 
impairment (Figure 4.2-1) we decided to access the behavioural effect of CaMK2N2 
overexpression after training in the CFC paradigm. To do so the experimental design 
presented on Figure 4.3-1 was used. In resume, animals were first trained in the CFC 
paradigm with one mild foot-shock. On the following day animals were injected intra-
hippocampal with either Control or CaMK2N2 virus solution. Two weeks later animals 
were tested for the contextual memory followed by a second memory test 3 days later. 
  
Figure 4.3-1 Experimental design CaMK2N2 overexpression after CFC training 
The figure shows the experimental design for testing the effect of CaMK2N2 overexpression in the animals’ freezing 
score after training in the CFC paradigm. Animals were first trained with one shock of 0.7 mA in the contextual 
chamber. One day later animals were injected with Control or CaMK2N2 virus solution. Two weeks later they were 
re-exposed to the context in two memory tests of 5 minutes each. The tests occurred 15 days and 18 days after 
training. Animals were sacrificed two hours after second memory test.  
 
Freezing scores for animals from group Control virus and CaMK2N2 virus can be 
seen on Figure 4.3-2. Two-way ANOVA with repeated measures shows a significant 
effect of the repeated memory tests (F1,13=39.1; P<0.001), but no effect of virus 
treatment (F1,13=1.4; P=0.256) or interaction between these two factors (F1,13=0.04; 
P=0.842). SNK planned comparisons shows a significant difference between the freezing 
scores on the first and second memory test in Control virus group (q=6.6; P<0.001) and 




overexpression was observed in the first (q=1.6; P=0.256) or second (q=1.4; P=0.322) 
memory tests. 
   
Figure 4.3-2 Freezing scores from experiment with CaMK2N2 overexpression after CFC training 
The graph above shows the average of freezing scores of animals from Control virus and CaMK2N2 virus groups, in 
the first (15 days) and second (18 days) memory tests. Animals were treated in virus solution 24 hours after training 
in the CFC paradigm. Freezing scores are presented in the ordinate axis as percentage of freezing time in the 5 minutes 
of test. **P<0.01; ***P<0.001 
 
RT-qPCR analyses of the dorsal hippocampus of the mice revealed a significant 
increase in the mRNA levels of CaMK2N2 (F1,14=45.9; P<0.001) (Figure 4.3-3) with no 





Figure 4.3-3 CaMK2N2 mRNA levels from experiment with CaMK2N2 overexpression after CFC training 
Quantitative analyses of the levels of CaMK2N2 mRNA. CaMK2N2 mRNA levels were normalized by HPRTL mRNA 
levels. All results were standardize to Control virus group average. *** P<0.001 
 
 
Figure 4.3-4 CaMK2N1 mRNA levels from experiment with CaMK2N2 overexpression after CFC training 
Quantitative analyses of the levels of CaMK2N1 mRNA. CaMK2N1 mRNA levels were normalized by HPRTL mRNA 







4.4 Modelling CaMK2N2 overexpression 
As presented on Figure 3.3-4, when we first knockdown CaMK2N1 we also 
observed a significant increase in CaMK2N2 mRNA levels of approximately 2X the 
control level. So far, the experiments presented here with CaMK2N2 overexpression 
caused an increase of 50-80X the level of the control. This increase is more than 10X the 
increase observed after CaMK2N1 knockdown, and unlikely to have the same 
behavioural effect. So, in order to study any possible behavioural effect of a smaller 
increase in CaMK2N2 we first did a dose-effect curve of our virus solution. The mRNA 
levels of CaMK2N2 in the dorsal hippocampus were measured in different animals after 
control virus injection or CaMK2N2 virus solution injection diluted 100X, 60X, 30X and 
10X. The original CaMK2N2 virus solution was diluted with autoclaved PBS. As can be 
observed on Figure 4.4-1 the dilution of 60X was the one that presented an increase in 
CaMK2N2 mRNA levels closer to the increase observed after CaMK2N1 knockdown (see 
Figure 3.3-4 for comparison). 
   
Figure 4.4-1 Dose-effect curve for CaMK2N2 virus solution 
Quantitative analyses of CaMK2N2 mRNA levels after treatment with different dilutions of CaMK2N2 virus solution. 





To study the effects of the 60X diluted CaMK2N2 virus solution on mice behaviour 
at the CFC paradigm we used the experimental design represented on Figure 4.4-2. It 
was the same experimental design used to study the effect of CaMK2N1 knockdown. 
Briefly, mice were first injected with Control or CaMK2N2 60X virus solution. Two weeks 
later animals were trained in the CFC paradigm. One and four days later their fear 
memory was tested in the same context without the shock. 
 
 Figure 4.4-2 Experimental design 60X CaMK2N2 virus solution 
The image shows the experimental design for testing the effect of a 60X diluted CaMK2N2 virus solution in the 
animals’ freezing score in the CFC paradigm. Animals were first injected with Control or 60X CaMK2N2 virus solution. 
Two weeks later mice were trained with one shock of 0.7 mA in the contextual chamber. One day later they were re-
exposed to the context in two memory tests of 5 minutes each. The tests occurred 24 hours and 4 days after the 
training session. Animals were sacrificed two hours after second memory test.  
 
The freezing scores of animals from group Control virus and CaMK2N2 virus 60X 
can be seen on Figure 4.4-3. Two-way ANOVA with repeated measure showed a 
significant effect of memory test (F1,22=11.2; P=0.003), but no effect of virus treatment 
(F1,22=3.0; P=0.096) or interaction effect (F1,22=0.3; P=0.589). SNK planned comparisons 
shows no significant effect for no comparison. There was no effect of the two memory 
tests within Control virus (q=2.9; P=0.051) or CaMK2N2 virus 60X (q=1.5; P=0.292) 
groups. There was also no effect of virus treatment in the first (q=0.5; P=0.713) or the 
second (q=0.9; P=0.523) memory test. This results indicates that the behavioural 
phenotype observed after CaMK2N1 knockdown (see Figure 3.3-2) was not caused by 






Figure 4.4-3 Freezing scores from experiment with CaMK2N2 virus solution diluted 60X 
The graph above shows the freezing scores of animals from Control virus and CaMK2N2 virus 60X group in the first 
(24h) and second (4 days) memory tests. Freezing scores are presented in the ordinate axis as percentage of freezing 
time in the 5 minutes of test.  
 
To confirm specificity and efficiency of the 60X diluted CaMK2N2 virus solution, 2 
hours after the last memory test animals were sacrificed and their mRNA levels of 
CaMK2N2 (Figure 4.4-4) and CaMK2N1 (Figure 4.4-5), in the dorsal hippocampus, was 
measured by RT-qPCR. Treatment with 60X diluted CaMK2N2 virus solution caused a 
significant increase in CaMK2N2 mRNA levels of approximately 3X (F1,20=81.1; P<0.001). 




   
Figure 4.4-4 CaMK2N2 mRNA levels after treatment with 60X diluted CaMK2N2 virus solution 
Quantitative analyses of the levels of CaMK2N2 mRNA. CaMK2N2 mRNA levels were normalized by HPRTL mRNA 
levels. All results were standardize to Control virus group average. *** P<0.001 
 
 
Figure 4.4-5 CaMK2N1 mRNA levels after treatment with 60X diluted CaMK2N2 virus solution 








Chapter 5 Discussion  
One of the aims of this thesis was investigate the function of the endogenous 
CaMKII inhibitors in CFC memory formation and maintenance. Our results show that 
changes in hippocampal levels of the inhibitors of CaMKII cause impairments in memory 
formation and maintenance. However the effects of knocking down or overexpressing 
an inhibitor of CaMKII are different. Knockdown of a CaMKII inhibitor reveals the 
relevance of the endogenous expression of this inhibitor in CFC learning/memory. This 
experimental approach tests whether the inhibitor needs to be normally expressed to 
fulfil a physiological function or if the inhibitor has a homeostatic function, a baseline 
effect. The overexpression of an inhibitor, distinctively, focuses on the functions of 
CaMKII in CFC learning and memory. Although, such approach also studies the effects of 
the inhibitor in CaMKII (effects in phosphorylation, kinase activity, and binding to other 
proteins) the behavioural effects of an overexpression of the inhibitor may not reflect 
the inhibitor’s physiological function. Therefore, the results obtained for CaMK2N1 
knockdown and CaMK2N2 overexpression will be discussed first separately in this thesis 
and then considered together. The last session of the Discussion will approach possible 








5.1 CaMK2N1 knockdown 
We have shown here for the first time that CaMK2N1 is required for maintenance 
of CFC memory after retrieval. Interestingly, this endogenous inhibitor of CaMKII is not 
required for memory formation or maintenance without retrieval. We have also shown 
that CaMK2N1 regulates the glutamatergic system and gene expression after retrieval. 
These observations will be discussed in detail bellow.   
Our results indicate that CaMK2N1 expression in the dorsal hippocampus is 
increased after the retrieval of contextual fear memory. More specifically, after the 
retrieval of a weak contextual fear memory (3 shocks) (Figure 3.5-2), but not after 
retrieval of a stronger contextual fear memory (5 shocks) (Figure 3.5-5). Furthermore, 
we have shown that blocking of hippocampal CaMK2N1 expression results in memory 
impairment in a second memory test (Figure 3.3-2) but not in a first memory test 
executed either 24 hours (Figure 3.3-2) or 4 days (Figure 3.4-2) after CFC training. This 
implies that the physiological induction of CaMK2N1 expression, after memory retrieval, 
has a key role in CFC memory maintenance after retrieval.  
Although based on our results we can conclude that the CFC memory impairment 
observed after hippocampal CaMK2N1 knockdown is dependent on a previous exposure 
of the animal to a first memory test, hence is retrieval-dependent, some specific details 
of this behavioural phenotype are yet to be defined. It is still unclear if the memory of a 
5 shocks learning session will present the same behavioural phenotype after 
hippocampal CaMK2N1 knockdown. Our results on CaMK2N1 dorsal hippocampal 
expression seems to suggest that this might not be the case, since CaMK2N1 expression 
is not elevated after retrieval of a 5-shock-induced contextual fear memory. 




It is also unknown if the duration between the learning session and the first 
memory test has any relevance for the behavioural phenotype observed. Fukushima et 
al. (2014) observed that the amnesic effect of a systemic blocking of protein synthesis, 
after retrieval of an inhibitory avoidance memory, can be achieved with memory 
retrieval sessions performed 1 day or 3 days after learning session. In the case of CFC, 
Trent et al. (2015) reported an amnesic effect of zif268 blocking in the dorsal 
hippocampus due to memory retrieval session performed 2 days after training session. 
Furthermore, intra-amygdalar injection of anisomycin has an retrieval-induced amnesic 
effect, on tone fear conditioning memory, even for memories retrieved 14 days after 
training session (Nader et al., 2000). However, Hall et al. (2001) observed that retrieval 
of CFC memory induced an increase in hippocampal CA1 Zif268 expression only for 
retrieval of a 24 hours memory but not a 28 days old memory. Additionally,  systemic 
treatment with anisomycin impaired inhibitory avoidance memory only if the first 
memory test was executed 1 day or 7 days after training but not if it was executed 14 
days or 24 days after training (Milekic and Alberini, 2002). It has also been reported that 
different time points for tone fear memory retrieval session will induce an increase in c-
fos expression in different circuits within the same subregion of the brain (Do-Monte et 
al., 2015). For example, the basolateral nucleus of the amygdala showed a significant 
increase in c-fos expression if retrieval session occurred 6 hours or 24 hours, but not 7 
days, after training. The central nucleus of amygdala, on the other hand, showed an 
increase of c-fos expression only if memory was retrieved 7 days after tone fear memory 
training session (Do-Monte et al., 2015). Is still unclear if such activation changes within 
subregions of the hippocampus can also be observed due to different time points for 




determine the relevance of temporal variations on the memory retrieval session for the 
behavioural phenotype observed in this thesis.  
Another important future experiment would be to test this retrieval-induced 
memory impairment in a different behavioural paradigm. As discussed by Fukushima et 
al. (2014), the inhibitory avoidance test is a good test to study retrieval induced memory 
effects. When testing memory retrieval in most paradigms, as for example in the CFC, 
re-exposure of the animal to the context can induce memory reconsolidation but it can 
also induce memory extinction since the animal is exposed to the CS (the context) 
without the US (shock). However during training in the inhibitory avoidance task the 
animal is first placed in a light compartment and only when it enters the dark 
compartment it receives a shock. Therefore, if we test the animal after conditioning by 
just placing it in the light compartment the context would induce reconsolidation 
without memory extinction, since the animal would not have any contact with the dark 
compartment (Fukushima et al., 2014). It would be interesting to test the behavioural 
phenotype observed after hippocampal CaMK2N1 knockdown in the inhibitory 
avoidance paradigm proposed by Fukushima et al. (2014).  
 To better understand the downstream molecular effects of hippocampal 
CaMK2N1 knockdown we analysed the total levels and phosphorylation levels of 
different proteins by western blot technique. Our first set of western blots looked at the 
effects of CaMK2N1 knockdown in total αCaMKII levels and T286 phosphorylation. Our 
results seems to indicate that CaMK2N1 plays a major role in regulating αCaMKII T286 
phosphorylation within the synapses (Figure 3.6-3) with no significant effect of 
CaMK2N1 knockdown in T286 phosphorylation in cytosolic fraction (Figure 3.6-5). 




cytosolic αCaMKII T286 phosphorylation levels was observed (Figure 3.6-5). Been that 
the case, it is in the opinion of this author that more studies are needed to clarify if 
CaMK2N1 plays any role in regulation of cytosolic αCaMKII phosphorylation. The 
analyses of samples collected in different time points after memory retrieval and the 
utilization of different analysis techniques (for example immunohistochemistry) would 
be important next steps. Regarding αCaMKII T286 phosphorylation at the synapses, a 
significant decrease in T286 phosphorylation levels after memory retrieval in shControl 
group animals, but not in shCaMK2N1 animals was found (Figure 3.6-3). In fact, after 
one memory test αCaMKII T286 phosphorylation levels in shControl animals were 
significantly lower to αCaMKII T286 phosphorylation in shCaMK2N1 animals (Figure 
3.6-3). This result shows for the first time that a decrease in T286 phosphorylation is 
triggered by CFC memory retrieval. We also observed in a separate experiment (Figure 
3.5-1) an increase in the expression of CaMK2N1 mRNA after CFC memory retrieval 
(Figure 3.5-2). It is likely that the decrease in T286 phosphorylation observed after 
memory retrieval in one experiment is related to the increase in CaMK2N1 mRNA levels 
observed after retrieval in the other experiment. This hypothesis is corroborated by the 
lack of changes in αCaMKII T286 phosphorylation levels of shCaMK2N1 animals after 
memory retrieval (Figure 3.6-3).  
Our second set of western blot analyses was focus at a known CaMKII substrate, 
the sub-unit GluA1 of the AMPAR. We observed that the total levels of GluA1 in the P2 
fraction were significantly higher in shCaMK2N1 group compared with shControl group, 
only if fear memory was retrieved (Figure 3.6-6). Animals from shControl group had a 
retrieval-induced decrease in synaptosomal GluA1 levels when compared to 




Ruiz et al. (2011) also observed a decrease of synaptosomal GluA1 levels in the dorsal 
hippocampus, 1 hour after retrieval of CFC memory (executed 24 hours after training). 
Additionally, they also reported this decrease to be transient, with synaptosomal levels 
of GluA1 been normal 4 or 7 hours after memory retrieval session (Rao-Ruiz et al., 2011). 
Rao-Ruiz et al. (2011) hypothesis is that a decrease AMPAR at the synapses would be 
induced transiently after memory retrieval, given a momentary liability to the memory. 
It is known that CaMKII activation, trough pharmacological activation of NMDAR, 
stabilizes AMPAR localization in the PSD (Opazo et al., 2010). ShControl animals 
presented a retrieval-induced reduction on synaptosomal GluA1 levels (Figure 3.6-6) but 
also a retrieval-induced decrease in CaMKII T286 phosphorylation levels (Figure 3.6-3). 
These results, taken together with Opazo et al. (2010) observation, suggests that CaMKII 
inactivation after memory retrieval is necessary to block any activity induced increase in 
AMPAR synaptosomal levels. Corroborating with this hypothesis, CaMK2N1 knockdown 
resulted in higher levels of synaptosomal CaMKII T286 phosphorylation (Figure 3.6-3) 
and GluA1 levels (Figure 3.6-6) after retrieval of a memory. This results is in agreement 
with Opazo et al. (2010) observation that increasing CaMKII inhibition by CN21 
treatment blocks NMDAR-induced stabilization of AMPR in the PSD (Opazo et al., 2010). 
Furthermore, it also suggests that the retrieval-induced memory labialization due to a 
reduction on AMPAR synaptosomal levels observed by Rao-Ruiz et al. (2011) might be 
regulated by CaMK2N1. In terms of GluA1 phosphorylation at S831, a significant 
decrease in GluA1 phosphorylation after CaMK2N1 knockdown was observed only in 
animals subjected to the memory test (Figure 3.6-7). Recent observations made by 
Hosokawa et al. (2015) have shown that only a minor percentage of all the GluA1 
subunits in the synapses seems to be phosphorylated at serine 831. Therefore, is unlikely 




quantified total GluA1 and S831 phosphorylation in naïve animals treated with 
shControl or shCaMK2N1 virus solutions. No significant effect of CaMK2N1 knockdown 
was observed in total GluA1 levels (Figure 3.6-9) and levels of phosphorylation at S831 
(Figure 3.6-10) if animals were not subjected to any behavioural paradigm, suggesting 
that CaMK2N1 does not play a role in GluA1 regulation during basal activity. More 
experiments are necessary to also study the phosphorylation of GluA1 at serine 567. 
CaMKII has been show to phosphorylate GluA1 S567 after the induction of LTD, resulting 
in a decrease in the number of AMPAR within the synapses (Coultrap et al., 2014; Lu et 
al., 2010). 
It is also known that inhibition of CaMKII with CaMKIINtide decreases total GluA1 
levels by regulation of protein degradation (Naskar et al., 2014). Furthermore, CaMKII 
has been shown to regulate the activation of the proteasome system (Djakovic et al., 
2009; Jarome et al., 2013), its localization in the PSD (Bingol et al., 2010) and 
polyubiquitination of proteasomal targets (Thein et al., 2014). Hence, our next set of 
western bots analysed protein degradation and the proteasome system. The scaffolding 
protein Shank has been shown to be degraded 2 hours after CFC memory retrieval 
session (Lee et al., 2008). However, no significant effect of CaMK2N1 knockdown in the 
levels of Shank protein (Figure 3.6-11) was observed in our experiments. 
Polyubiquitination of proteins has also been observed to be increased after memory 
retrieval (Fukushima et al., 2014; Lee et al., 2008). Again, no significant effect of 
CaMK2N1 knockdown was observed in the levels of ubiquitinated proteins (Figure 
3.6-12). Finally we also quantified total levels (Figure 3.6-13) and phosphorylation at 
S120 of the proteasomal subunit Rpt6 (Figure 3.6-14). CaMKII has been showed to 




Jarome et al., 2013). Nonetheless, no significant effect of CaMK2N1 knockdown was 
observed in Rpt6 phosphorylation (Figure 3.6-14) or total levels (Figure 3.6-13) in our 
experiment. Taken together, these results suggest that the behavioural phenotype 
observed due to CaMK2N1 knockdown was not related to protein degradation. Despite 
this, more studies are necessary to clarify if CaMK2N1 plays any role in the regulation of 
protein degradation. It has not been addressed in this thesis, for example, the molecular 
effects of our treatment immediately after the training session, or at different time 
points after memory retrieval. The lack of any commercially available antibody against 
phosphorylated Rpt6 also presents an obstacle for more studies.  
Our final set of western blot analyses concentrated on the analysis of molecules 
that regulate gene expression. Gene expression has been shown to be a necessary 
process for memory maintenance after retrieval (Kelly et al., 2003; Lee et al., 2004). No 
significant changes on total levels of the transcription factor CREB (Figure 3.6-16) and its 
phosphorylation at S133 (Figure 3.6-17) were observed 1 hour after memory retrieval 
with or without CaMK2N1 knockdown.  
We also quantified the nuclear levels of Zif268 (Figure 3.6-18), a known biological 
substrate of memory reconsolidation (Lee, 2008; Lee et al., 2004). Although two-way 
ANOVA test showed a significant effect of interaction between virus treatment and 
memory test (F1,33=5.776; P=0.023), no significant result was obtained with SNK planned 
comparisons. Since the interaction effect observed was not maintained after planned 
comparison not much conclusion can be draught from this data. The higher tendency of 
effect observed after planned comparisons was in the comparison between trained (TR) 
and trained and tested (TR+TE) animals from shCaMK2N1 group (q=2.575; P=0.079). 




effect of hippocampal CaMK2N1 knockdown on Zif268 expression. An important next 
experiment would be the analyses of Zif268 expression within different subregions of 
the hippocampus. Using in situ hybridization technique, Hall et al. (2001) reported an 
increase in Zif268 expression only in hippocampal CA1 area but not in the DG, after 
retrieval of CFC memory. Lee et al. (2004) observed, by western blot analyses, a CFC 
memory retrieval-induced increase in Zif268 expression of 200% in CA1 area, but only a 
50% increase in DG/CA3 areas. Furthermore, Lee et al. (2004) also showed that blocking 
of Zif268 expression in hippocampal CA1 area, before retrieval session, is sufficient to 
impair CFC memory reconsolidation.  
Another regulator of gene expression analysed was c-fos. C-fos is known to be a 
biological substrate of memory consolidation (Huff et al., 2006) and extinction (Do-
Monte et al., 2010; Guedea et al., 2011; Plendl and Wotjak, 2010; Tronson et al., 2009). 
However, very little is known about what is the function of c-fos expression in retrieval-
dependent memory maintenance or extinction. Our results show a significant decrease 
in c-fos expression in trained only animals (TR) when comparing shCaMK2N1 animals to 
shControl animals (Figure 3.6-19). In this case, CaMK2N1 seems to be important for 
maintaining c-fos expression after CFC training session. Nonetheless, the lack of a 
memory impairment in shCaMK2N1 animals during the first memory test (Figure 3.3-2) 
indicates that the animals had normal learning and consolidation of the CFC task. 
Hippocampal c-fos expression has been shown to be up-regulated 1 hour after CFC 
training session (Huff et al., 2006), but it is unknown if any CFC training-induced 
alteration in hippocampal c-fos expression would still be significant at the time point 
used in our experiments, 25h after training session. Any training-induced c-fos 




not resulted in a behavioural phenotype. von Hertzen and Giese (2005) proposed the 
existence of a greater functional redundancies during consolidation than during 
reconsolidation. This greater function redundancy of memory consolidation may explain 
why Lee et al. (2004) saw a reconsolidation impairment but not a consolidation 
impairment after blocking of hippocampal Zif268 expression, even though Zif268 has 
been shown to be involved in consolidation and reconsolidation of CFC task (Hall et al., 
2001; Hall et al., 2000). The possibility of less redundancy in CFC memory 
reconsolidation may also explain why, although CaMK2N1 knockdown impacts on c-fos 
expression both after training and after testing there was an impairment in memory only 
after memory retrieval. No significant effect of CaMK2N1 knockdown in dorsal-
hippocampal on c-fos expression was observed in naïve animals. Therefore, it is likely 
that hippocampal CaMK2N1 does not regulate basal expression of c-fos.       
A significant reduction in dorso-hippocampal c-fos expression of shControl 
animals after memory retrieval was observed. ShCaMK2N1 animals, on the other hand, 
had an increase in c-fos expression after memory retrieval (Figure 3.6-19). This seems to 
indicate that CaMK2N1 is important for inhibition of c-fos expression 1 hour after a first 
memory test, and this inhibition might be important for memory maintenance. The 
opposite direction of the effects of CaMK2N1 knockdown if the animals are just trained 
or if they are trained and tested (Figure 3.6-19) implies that CaMK2N1 might play 
different roles during memory formation and memory maintenance. The retrieval-
dependent increase in c-fos expression, observed after CaMK2N1 knockdown, could be 
related to the retrieval-dependent memory impairment observed previously (Figure 
3.3-2). That being the case, one would assume that a decrease in hippocampal c-fos 




maintenance. At first this hypothesis might seem a little different from the usual 
accepted functions of c-fos. For example, hippocampal c-fos expression has been shown 
to be down-regulated after fear memory extinction (Guedea et al., 2011; Tronson et al., 
2009). Nonetheless, shControl animals presented a decrease in hippocampal c-fos 
expression 1 hour after memory retrieval (Figure 3.6-19). To make sense of this apparent 
contradiction it is important to analyse the role of c-fos expression within the different 
subregions of the hippocampus. For example, Fukushima et al. (2014) observed an 
increase in c-fos expression, after inhibitory avoidance memory retrieval, in 
hippocampal CA1 and CA3 areas but no in the DG. Furthermore, different regulation of 
c-fos expression in the CA1 and DG can also be observed during tone fear memory 
extinction. While CA1 c-fos expression is increased after tone memory extinction in the 
trained context or in a novel context, DG c-fos levels are increased only if the tone 
memory is extinguished in the trained context (Knapska and Maren, 2009). Regarding 
the CFC paradigm, Wheeler et al. (2013) reported a retrieval-induced increase in CA1 c-
fos expression, but a decrease in c-fos expression within the DG. With a similar 
experimental design from the one used in this thesis, Besnard et al. (2014)  saw that 1 
hour after 5 min retrieval session, executed 24 hours after a previous session of 
contextual fear conditioning with one 0.7 mA shock, there was a significant decrease in 
DG c-fos expression when comparing animals only trained and trained and tested 
animals. The significant decrease in c-fos expression observed in this thesis within 
shControl animals after CFC memory retrieval (Figure 3.6-19) is in accordance with the 
retrieval-induced decrease in c-fos expression observed within the DG on the 
experiments performed by Besnard et al. (2014) and Wheeler et al. (2013). The samples 
probed in our western blot analyses are of dorsal hippocampus, which will include 




aproximatly 5X more neurons then CA1 or CA2/CA3 areas, accounting for the majority 
of neurons in the hippocampus (West et al., 1991). Therefore, it is likely that the western 
blot analyses presented in this thesis are more representative of the hippocampal 
surbregion DG than of the other hippocampal subregions. This hypothesis is 
corroborated by the similarity of our observations with the retrieval-induced alterations 
in c-fos expression observed within the DG neurons by Besnard et al. (2014) and 
Wheeler et al. (2013). To further test this hypothesis an important next step would be 
to quantify c-fos expression in the different subregions of the hippocampus separately. 
The necessity of a separate analysis for the DG and CA1 areas is reinforced by the 
different dependence of αCaMKII T286 autophosphorylation for LTP induction between 
this areas. Whilst CA1 glutamatergic neurons required αCaMKII T286 
autophosphorylation for induction of NMDAR-dependent LTP (Giese et al., 1998), DG 
glutamatergic neurons does not (Cooke et al., 2006). 
Taken together, the western blot analyses of αCaMKII T286 phosphorylation 
(Figure 3.6-3), synaptosomal GluA1 levels (Figure 3.6-6) and nuclear c-fos expression 
(Figure 3.6-19) we observed a similar effect of decrease of these three variables after 
memory retrieval in control animals. In contrast, animals from shCaMK2N1 group show 
a retrieval-induced increase in the levels of αCaMKII T286 phosphorylation (Figure 
3.6-3), synaptosomal GluA1 levels (Figure 3.6-6) and nuclear c-fos expression (Figure 
3.6-19). Based on this observation we raise the hypothesis that retrieval-induced 
expression of CaMK2N1 causes a decrease in neuronal activity that seems to be 
important for memory maintenance. A schematic representation of this hypothesis can 




It is our hypothesis that this inhibition of CaMKII after memory retrieval happens 
on the DG, where the inhibition of CaMKII activity would be important to block a new 
memory from be acquired. Been that the case, the endogenous inhibitors of CaMKII 
would play a key role in this retrieval-induced blocking of CaMKII. This hypothesis is been 
proposed for the first time in this thesis, so it is necessary to further investigate this 
question to consolidate this hypothesis. In the CA1 area of the hippocampus this might 
not be the case. It has been well established that after memory retrieval this area is 
activated, with an increase in transcription factors that is necessary to keep the memory 
(Hall et al., 2001; Lee et al., 2004; Wheeler et al., 2013). The function of the CaMKII 
endogenous inhibitors after memory retrieval in the CA1 area is still unknown. 
Furthermore, one should consider that in different time points the activation or 




























Figure 5.1-1 CaMK2N1 function after CFC memory retrieval 
The schematic figure above summarizes the retrieval-induced molecular and behavioural effects observed after 
hippocampal CaMK2N1 knockdown. The only significant retrieval-induced effects of CaMK2N1 knockdown not 
presented in this scheme are in Glua1 S831 phosphorylation (Figure 3.6-7) and in Zif268 expression (Figure 3.6-18). 
Zif268 alterations were not represented in this figure due to the fact that no significant effect was seen after planned 
comparisons.  GluA1 S831 phosphorylation has been shown to be presented in only a minor percentage of GluA1 
subunits in the synapses (Hosokawa et al., 2015). Therefore, is unlikely that this effect is related to the behavioural 
phenotype observed and it was not represented in this scheme. The scheme presents the results according to the 
following hypothesis. After CFC memory retrieval hippocampal glutamatergic neurons (likely from the DG) have an 
increase in CaMK2N1 expression. CaMK2N1 will block activation of CaMKII within the synapse, with consequent 
decrease in synaptosomal AMPAR and nuclear c-fos levels. This process is necessary for memory maintenance and is 
likely to be transient. After hippocampal CaMK2N1 knockdown the lack of CaMKII inhibition resulted in an increase 
in CaMKII T286 autophosphorylation, synaptosomal GluA1 levels and c-fos nuclear levels. This excessive activation 
after memory retrieval resulted in memory impairment in animals from shCaMK2N1 group. Molecules presented in 
the images of this scheme are identified on the top left corner of every image.     
 
This dependence of memory maintenance to a decrease in neuronal activity, likely 
to be in the DG, after CFC memory retrieval could be interpreted by two different 
perspectives. One possibility is that the retrieval-induced memory impairment observed 
after CaMK2N1 knockdown is an increase in memory extinction. In other words, 
CaMK2N1 knockdown resulted in a quicker learning of the new environmental 
conditions, the box context no longer comes associated with the shock, thus suppressing 
the previously learned CR in a second memory test. Therefore, the retrieval induced 
reduction in neuronal activity observed in the shControl group maintains the fear 
memory by inhibiting the extinction of the associative memory between the US and the 
CS. Such hypothesis is corroborated by Plendl and Wotjak (2010) observation that  
between-session extinction of tone fear memory was accompanied by an increase in the 
number of c-fos-positive neurons in the DG of mice. Furthermore, Santini et al. (2004) 
have shown that there is an increase in c-fos expression at the medial prefrontal cortex 
after extinction and blocking of protein synthesis in this region does not impair the effect 
of one memory extinction trial but blocks the accumulative effect of repetitive extinction 
trials. Based on this observations Santini et al. (2004) proposed that c-fos function in 




effect of CaMK2N1 knockdown would be understood as an increase in memory 
extinction due to the increase in c-fos expression.   
The retrieval-induced memory impairment observed after CaMK2N1 knockdown 
could also be interpreted as a destabilization impairment. Part of the memory 
reconsolidation hypothesis, destabilization of a memory has been shown to be a 
necessary process for memory maintenance after retrieval (Artinian et al., 2008). We 
could interpret the decrease in αCaMKII T286 phosphorylation (Figure 3.6-3), 
synaptosomal GluA1 levels (Figure 3.6-6) and nuclear c-fos expression (Figure 3.6-19) 
observed in control animals as part of the destabilization of a memory. That been the 
case, we could expect that the increase in the same factors observed in shCaMK2N1 
group would result in a retrieval-induced memory impairment due to blocking of 
memory destabilization. It is also too early to discard the possibility of reconsolidation 
impairment. The reconsolidation of a memory after destabilization requires the 
synthesis of new proteins (Lee et al., 2008).  At the time point observed in our 
experiments, control animals showed no retrieval induced increase in the expression of 
any of the transcription factor quantified in this thesis, but rather a retrieval induced 
decrease. This implies that these molecules at this time point are not a good target for 
studying memory re-stabilization. However the analyses of other molecules and 
different time points might show different results. The first step to study any possible 
re-stabilization impairment in CaMK2N1 knockdown animals is to find a molecule that 
has a retrieval induced increase in control animals subjected to our experimental 
conditions. 
Nevertheless, the clear separation of any retrieval-induced amnesic phenotype 




matter of debate. Reconsolidation impairment and memory extinction differ from each 
other by their molecular bases, like the specificity of Zif268 to reconsolidation (Lee et 
al., 2004), and their behavioural peculiarities, like the possibility of reinstatement only 
in extinguished memories (Rescorla and Heth, 1975). However, Trent et al. (2015) 
reported the reinstatement of CFC memory impaired by hippocampal Zif268 blocking. 
Raising the question if extinction and memory reconsolidation are two independent 
processes or are only two different outcomes of the same process. Based on the 
similarity of molecules shown to be relevant for memory reconsolidation and extinction, 
Almeida-Correa and Amaral (2014) also proposed a common biological substrate for 
both process. As mentioned by Almeida-Correa and Amaral (2014) molecules like the 
cannabinoid receptor type 1, the ubiquitin-proteasome system, the sub-unit GluA2 of 
the AMPAR and others, have been shown to be relevant for memory extinction (Dalton 
et al., 2008; Marsicano et al., 2002; Pick et al., 2013; Suzuki et al., 2004) and for retrieval-
induced memory destabilization (Hong et al., 2013; Lee et al., 2008; Suzuki et al., 2008). 
It is also known that a memory reconsolidation session facilitates the extinction of the 
same memory. For example, a 3 minutes retrieval session (capable of inducing 
reconsolidation but not extinction) executed 1 hour before memory extinction session, 
has been shown to enhance extinction reducing spontaneous or induced recovery of 
cued fear memory (Monfils et al., 2009). Similar observation have also been made for 
contextual fear memory (Rao-Ruiz et al., 2011). Almeida-Correa and Amaral (2014) also 
based their hypothesis of a common mechanism for memory reconsolidation and 
extinction on the existence of molecules that are important for this enhancement of 
memory extinction due to a previous quick retrieval session, been GluA1 one of this 
molecules. Almeida-Correa and Amaral (2014) refers to the observations of Clem and 




mutation, impairs enhancement of memory extinction by a previous retrieval session. 
This shows that GluA1 is an important molecule for the interaction between memory 
reconsolidation and memory extinction.  
The separation between this two possible interpretations for our results is an 
important next step, however it will be time consuming, requiring many different 
experiments, and escapes the aims set for this thesis. To separate between a 
destabilization impairment and memory extinction enhancement more molecular data 
(as for example expression of BDNF and ERK) and behavioural data (test for 
reinstatement of memory and spontaneous recovery) are necessary. Even in the 
possession of new data we are still not certain to be able to separate this two hypothesis, 
since they might be different interpretations of the same phenomenon (Almeida-Correa 
and Amaral, 2014; Trent et al., 2015).  
Independent of the hypothesis used to explain the retrieval-induced memory 
impairment observed after hippocampal injection of shCaMK2N1 virus solution, the 
phenotype observed (Figure 3.3-2) still implicates in a clinical potential of CaMK2N1 
knockdown in the treatment of PTSD and addiction. PTSD, as defined in the DSM V 
(Association, 2013 ), is an axis I anxiety disorder that develops as a result of experiencing 
intense stressor, usually involving threat of serious injury or death to oneself or to 
someone nearby. Patients with PTSD have been observed to have a decrease in 
hippocampal volume (Bremner et al., 1995; Gurvits et al., 1996; Stein et al., 1997). 
Memory impairments have also been reported in PTSD patients (Bremner et al., 1993; 
Horner and Hamner, 2002; Vasterling et al., 1998). Based on experiments with twin 
patients, Gilbertson et al. (2007) and Gilbertson et al. (2002) have proposed that pre-




Moreover, PTSD patients have been observed to maintain the conditioned fear 
responses to the traumatic stimuli even 40–50 years after the event (Orr et al., 1993). 
Different molecules have been tested as therapeutic targets to pharmacologically erase 
or block the traumatic memory (Fitzgerald et al., 2014; Pizzimenti and Lattal, 2015). 
Based on the retrieval-dependent fear memory impairment observed on this thesis 
(Figure 3.3-2) we proposed the inhibitors of CaMKII to be a possible therapeutic target 
for PTSD. Exposure of animals to a single prolonged stress (SPS), a paradigm used as 
animals model of PTSD, has been shown to decrease hippocampal levels of αCaMKII one 
day after SPS exposure (Han et al., 2013; Liu et al., 2013). A decrease in prefrontal cortex 
αCaMKII levels was also observed 1 day after SPS (Wen et al., 2012). Similar results were 
also reported for the basolateral amygdala (Xiao et al., 2009). Moreover, intraperitoneal 
injection of the histone deacetylase inhibitor vorinostat facilitates CFC memory 
extinction and increases hippocampal αCaMKII and βCaMKII levels in SPS exposed 
animals (Matsumoto et al., 2013). Thus, testing the effects of hippocampal inhibition of 
CaMK2N1 in PTSD animal models could help understand the diseases and find molecular 
pathways for treating PTSD.   
The same principle could be applied for addicted patients. Drug seeking behaviour 
could be interpreted as a CR to the stimulus of the drug. In other words, the associative 
memory between the pleasure sensation of the drug and the intake of it, or the 
association of the displeasure of the withdrawal and not taking the drug, are strong 
memories that result in craving and increase drug intake even long into abstinence 
(Everitt, 2014). Treatments able to block or erase these memories might be an effective 
way of treating addicted patients (Everitt, 2014; Pizzimenti and Lattal, 2015). Therefore, 




behaviour. To my knowledge the knockdown of any CaMKII endogenous inhibitor has 
never been tried as a treatment for addiction. It is known though that CaMKII expression 
is increased in the nucleus accumbens (NAc) after chronic cocaine (Robison et al., 2013) 
and amphetamine (Loweth et al., 2010) intake. It has also been shown that 
pharmacological blocking of CaMKII activity in the NAc reduces locomotor response to 
cocaine (Pierce et al., 1998) and amphetamine (Loweth et al., 2008). Additionally, 
overexpression of αCaMKII in the NAc, by viral transfection, increases amphetamine 
self-administration (Loweth et al., 2010). Not much is known about the function of 
hippocampal CaMKII in cocaine and amphetamine addiction. Recent publication by 
Schopf et al. (2015) showed that cocaine and alcohol treatment induced an increase in 
c-fos expression in the DG that was blocked by T286A mutation.  
Regarding alcohol, it has been observed that T286A mutants have a decrease in 
initial alcohol intake and decrease in locomotor response for low doses of alcohol (2 
g/Kg) (Easton et al., 2013b). Furthermore, T286A mutants also present an increase in c-
fos expression in the rostral region of the ventral tegmental area (Easton et al., 2013b). 
T268A mutants also have a facilitation in learning of conditioned place preference using 
alcohol as reinforcement (Easton et al., 2013c). Moreover, increase in locomotor activity 
induced by the test context was abolished by alcohol in T286A mutants, but not in 
control mice (Easton et al., 2013c). Easton et al. (2013b) also reported a significant 
correlation between alcohol dependence in humans and a single nucleotide 
polymorphism within an autophosphorylation-related area of αCaMKII gene. 
Considering the relevance of CaMKII and its autophosphorylation in alcohol, 
amphetamine and cocaine intake and addiction, it is probable that the inhibitors of 




solutions could help understand the function of CaMKII inhibitors in the effects of 
cocaine, alcohol and amphetamine addiction.       
5.2 CaMK2N2 overexpression 
CaMK2N2 hippocampal overexpression, induced by treatment with CaMK2N2 
virus solution, resulted in a learning impairment of CFC task (Figure 4.2 1). This result is 
in accordance with Buard et al. (2010) observations that treatment with tatCN21 inhibits 
LTP induction and impairs learning of CFC task. We also observed that hippocampal 
CaMK2N2 overexpression after learning of the CFC task did not affect memory 
maintenance (Figure 4.3-2). The same results were also obtained by Buard et al. (2010) 
using intraperitoneal injection of tatCN21. This indicates that CaMKII activation is 
necessary for memory formation but not memory maintenance. However, is important 
to notice that this does not mean that CaMKII is not relevant for memory maintenance. 
As presented in the last section of this discussion (5.1 CaMK2N1 knockdown), it seems 
that although activation of CaMKII is not important for CFC memory maintenance its 
inactivation is. It is important to consider as well that CaMKII has been suggested to also 
have a structural function relevant to memory maintenance. CaMKII binding to elements 
of the cytoskeleton could be relevant for changes in synapse morphology that may have 
a direct impact in memory maintenance (Fink et al., 2003; Jiao et al., 2011; Okamoto et 
al., 2009; Robison et al., 2005b). CaMKII may also act as a scaffolding protein, binding to 
NMDAR at the PSD and regulating the numbers of AMPAR at the synapses, which could 
also be important for memory maintenance (Sanhueza and Lisman, 2013). In this regard, 
the CaMK2N2 virus solution used in this thesis can be used as an efficient and selective 
way of studying CaMKII structural roles. It is known that the endogenous inhibitors of 




be propoused to link memory maitaince to the molecular mechanisms suggested. For 
example, Sanhueza and Lisman (2013) theory could be tested by using co-
imunoprecptation analysis to check if CaMK2N2 overexpression after CFC training has 
any effect on CaMKII binding to AMPAR. Since CaMK2N2 hippocampal overexpression 
had no effect on memory maitainance, based on Sanhueza and Lisman (2013) 
hypothesis it should also not have affeted CaMKII and AMPAR co-preciptation.  
The lack of effect of CaMK2N2 overexpression in memory maintenance (Figure 
4.3-2) could also be explained by the longer duration between training and memory test 
(15 days as opposed to 24 hours). A more classical interpretation of the function of the 
hippocampus in memory is that memories would only persist in the hippocampus for a 
short period of time, “migrating” later to other regions (Anagnostaras et al., 1999; Kim 
and Fanselow, 1992). If that was the case, it implies that the lack of effect of our 
treatment would be a result of it been focus on the hippocampus, a region that would 
no longer be involved in the maintenance of the memory at a later time point. However, 
Buard et al. (2010) treated animals with intraperitoneal injection of tatCN21 and also 
observed no effect in memory maintenance. Furthermore, the classical transient role of 
the hippocampus in memory has been challenged by the report of an amnesic effect of 
optogenetic-induced hippocampal inactivation even for older memories (Goshen et al., 
2011). As proposed by Goshen et al. (2011), the hippocampus seems to be important for 
the maintenance of older memories, however if lesioned or inactivated for a prolonged 
period of time other regions of the brain could replace his function.  
By comparing the behavioural results obtained for CaMK2N2 overexpression 
before (Figure 4.2-1) and after training (Figure 4.3-2) there is a noticeable difference in 




overexpression before training, control animals froze approximately 30% of the time in 
the first memory test. On the other hand, when testing the effects of CaMK2N2 
overexpression after training control animals froze approximately 70% in the first 
memory test. This difference in freezing scores is not related to CaMK2N2 
overexpression since the effect is present in control animals. Therefore, the difference 
duration between training and memory testing might cause distinct freezing levels in 
the memory test (24 hours in the first experiment and 15 days in the second). Indeed it 
has been shown that a longer period of separation between the memory formation and 
memory test increases the occurrence of the CR during the test, a phenomenon that 
was called memory incubation (Brady, 1951; Eysenck, 1968; Houston et al., 1999). 
A closer look at these two behavioural results (Figure 4.2-1 and Figure 4.3-2) also 
brings to the attention the occurrence of an effect of the memory tests in both 
experiments. Once again, this effect was not related to CaMK2N2 expression since it was 
also present in the control group and no significant effect of interaction was observed. 
These results seem to indicate that both, animals from Control virus group and from 
CaMK2N2 virus group, had a small extinction of the memory from the first to the second 
memory test. During the performance of these two experiments a new building was 
been constructed next door to our animals facilities unit. It is possible that the noise of 
the construction may have caused some level of stress to the animals. This stress might 
be responsible for inducing memory extinction in the animals. In fact, injection of 
corticosterone, a stress-induced molecule, has been show to facilitate extinction of CFC 
memory (Cai et al., 2006). Nonetheless, the results obtained in our experiments are in 
accordance with previous data published by Buard et al. (2010) and both groups (Control 




stress-induced effect on memory did not have any relevant impact in the conclusions 
draw from our experiments.     
  Mutation R495X in the FUS gene (also known as FUS-ΔNLS), an ALS causing 
mutation (Renton et al., 2014), has been shown to induce an overexpression of 
CaMK2N2, in vitro (Convertini et al., 2013). Furthermore, TAR DNA binding protein-43 
(TDP-43) mutated animals, an animal model for ALS and frontotemporal lobar 
degeneration (FTLD) (Barmada and Finkbeiner, 2010; Janssens and Van Broeckhoven, 
2013), has also been observed to present an increase in CaMK2N2 expression 
(unpublished data from Dr. Shou-Chien Ling at National University of Singapore). TDP-
43 accumulation with RNA molecules forming inclusions inside neurons, has been shown 
to occur in ALS and FTLD (Arai et al., 2006; Bentmann et al., 2013; Neumann et al., 2006; 
Wolozin, 2012). Wang et al. (2008) has reported the mRNA of αCaMKII to be among the 
mRNAs trapped in TDP-43 inclusions. Additionally, mutation inducing loss of function in 
progranulin protein, a FTLD animal model known to induce the appearance of TDP-43 
inclusions, has been show to induce increase in CaMKII T286 phosphorylation (Alquezar 
et al., 2014). Therefore, it is likely that the inhibitors of CaMKII, specifically CaMK2N2, 
play a role in ALS and FTLD. Experiments with CAMK2N2 virus solution as a possible 
model for some of the symptoms of these diseases would be an important next step. 
ALS is a neurodegenerative disorder characterized by selective death of motor neurons 
in the brain and spinal cord. The initial symptoms are paralysis of voluntary muscles 
followed, rapidly, by death from respiratory failure, with a typical onset in adult life 
(Mulder, 1982; Rowland and Shneider, 2001). FTLD is described as neurodegenerative 
diese characterized by the relatively selective death of neurons in the anterior and 




are related due to this prevalence of imapriment in the anterior and frontal temporal 
lobes. FTLD is a presenile dementia, with onset usually before 65 years old (Josephs, 
2008; Josephs et al., 2011; Neary et al., 2005; Rabinovici and Miller, 2010; Whitwell and 
Josephs, 2011). ALS and FTLD are multifactorial neurodegenerative diseases (Josephs et 
al., 2011; Ling et al., 2013; Pasinelli and Brown, 2006; Renton et al., 2014; Sieben et al., 
2012), and have been proposed to be part of a continuum spectrum of the same 
biological pathology (Geser et al., 2009; Ling et al., 2013). This hypothesis is 
corroborated by existence of motor neuron dysfunction in FTLD patients (Burrell et al., 
2011) and impaired performance in frontal lobe tests in ALS patients (Ringholz et al., 
2005). No efficient treatment for these diseases are known (Janssens and Van 
Broeckhoven, 2013; Ludolph et al., 2007; Whitwell and Josephs, 2011). Studies to 
understand CaMK2N2’s role in ALS and FTLD might help revealing new therapeutic 











5.3 CaMK2N1 and CaMK2N2 
During the first behavioural experiment with shCaMK2N1 virus solution it was 
observed to cause an effective CaMK2N1 knockdown (Figure 3.3-3) but it also increased 
CaMK2N2 expression (Figure 3.3-4). This increase could be interpreted as plastic 
compensation of the brain to our virus treatment. In order to exclude the possibility of 
the behavioural phenotype observed after hippocampal CaMK2N1 knockdown (Figure 
3.3-2) been an effect of the compensatory increase in CaMK2N2 expression, we 
modelled the increase of CaMK2N2 observed, using a 60X diluted version of our 
CaMK2N2 virus solution (Figure 4.4-2). Our results seem to indicate that an increase of 
up to approximately 3X in CaMK2N2 mRNA levels in the dorsal hippocampus (Figure 
4.4-4) does not have any effect on CFC learning and memory (Figure 4.4-3). Therefore, 
it is unlikely that the retrieval-induced memory impairment observed after CaMK2N1 
knockdown (Figure 3.3-2) is induced by the CaMK2N2 increase (Figure 3.3-4) also 
observed.    
This suggests that although the animals’ brain tried to compensate the virus-
induced decrease in CaMK2N1 with an increase in CaMK2N2 expression, it was not 
enough to replace CaMK2N1 function. Hence, is likely that CaMK2N1 and CaMK2N2 
have different roles in memory maintenance. This hypothesis is further corroborated by 
the observation that different intensities of the US, during training session, resulted in 
different regulation, in the dorsal hippocampus, of CaMK2N1 (Figure 3.5-2 and Figure 
3.5-5) and CaMK2N2 (Figure 3.5-3 and Figure 3.5-6) expression after memory retrieval. 
Considering that CaMK2N2 requires constant presence of CaM to ligate to CaMKII 
(Chang et al., 2001) a stronger US (5 shocks) might generate a stronger and/or longer 




expression. CaMK2N1, on the other hand, might be expressed when the stimulus 
produces a smaller influx of calcium and less CaM avaiblity, since this inhibitor does not 
require CaM to ligate to CaMKII (Chang et al., 2001) and is expressed after weaker US 
presentation (3 shocks). It has been demonstrated in this thesis that CaMK2N1 has a 
function in regulating CaMKII autophosphorylation (Figure 3.6-3), AMPAR synaptosomal 
levels (Figure 3.6-6), and gene expression (Figure 3.6-19) after CFC memory retrieval. 
CaMK2N1 seems to inhibit synapse activation and consequent gene expression in order 
to maintain CFC memory after retrieval (Figure 5.1-1).  
CaMK2N2’s function in memory maintenance is still to be determined. The 
knockdown of CaMK2N2 by viral vector injection in the hippocampus, after and before 
5 shocks CFC task, might be a good experiment to help understand CaMK2N2 function 
in memory maintenance. During the executeon of this thesis we have tried to 
knockdown CaMK2N2 expression, in the hippocampus, with viral vector treatment. 
However, in vivo experiments showed that the treatment had no effect on CaMK2N2 
expression (Appendix Figure 7.6-1). The construct of more viral vectors, with shRNA 
sequences that target different regions of CaMK2N2 mRNA, is required. We have also 
attempted to overexpress CaMK2N1 by viral vector treatment and failed (Appendix 
Figure 7.7-1). Possession of 4 viral vectors, to overexpress and knockdown both 
endogenous inhibitors of CaMKII, would provide a good tool to test overlapping 
functions between CaMK2N1 and CaMK2N2. Experiments knocking down one inhibitor 
and overexpressing the other could access the ability of one inhibitor in compensate for 
the function of the other. It would also be relevant to test the effects of knocking down 




Another possible approach for studying CaMK2N1 and CaMK2N2 functions is the 
generation of mice with mutations in the genes encoding the inhibitors. Nonetheless, 
the use of mutant animals for studying the functions of any molecule brings the caveat 
of causing alterations in every cell that this molecule is expressed and it might as well 
cause development disorders. For example, βCaMKII knockout mice have motor 
impairments that restrict the number of possible cognitive tests that can be used in 
these animals, as they also present a developmental delay in body weight that could 
interfere with behavioural studies at earlier stages of development (Bachstetter et al., 
2014; Borgesius et al., 2011; van Woerden et al., 2009). Additionally, CaMKII has been 
shown to play a role in neuronal proliferation and neurite growth, which implies that 
mutations in CaMK2N1 or CaMK2N2 genes may possibly result in brain development 
problems. Saito et al. (2013) has observed that knockdown of βCaMKII, but not αCaMKII, 
suppressed neuritogenesis, while βCaMKII activation increases neuritogenesis. This 
βCaMKII effect on neuritogenesis was related to the phosphorylation of LIM-kinase 1, at 
threonine 508, by βCaMKII, promoting the activation of LIM-kinase 1 (Saito et al., 2013). 
It has also been reported that mice heterozygous for a null mutation of αCaMKII have 
an increase in bromodeoxyuridine (BrdU) incorporation in DG cells but a decrease in the 
number of mature neurons in the same hippocampal area, as well as alterations in the 
expression of more than 2000 genes (Yamasaki et al., 2008). One should also consider 
that CaMK2N2 is expressed in testis (Chang et al., 2001), where its function is still 
unknown. Mutations in CaMK2N2 gene may have deleterious consequence in hormonal 
production in the testis that could cause behavioural and development alterations. 
Viral vectors like the ones used in this thesis, on the other hand, have the 




point desired, avoiding side effects in other areas and in development. In fact, the use 
of viral vectors has been suggested to be an efficient tool to study mechanisms 
underlying neuropsychiatric disorders as well as to be possibly useful for treatment of 
such  disorders (Edry et al., 2011; Ginn et al., 2013; Murlidharan et al., 2014; Ojala et al., 
2015). The use of AAV vectors has received particular attention due to their safety 
profile (very low chance of insertion-induced mutations) and efficiency in transducing a 
wide range of cell types (Ginn et al., 2013; Murlidharan et al., 2014; Ojala et al., 2015). 
Indeed, recent successful clinical trials with AAV vectors have been reported for 
haemophilia B and the retinal degenerative disorder Leber’s congenital amaurosis type 
2 (Bainbridge et al., 2008; Cideciyan et al., 2009; Nathwani et al., 2011; Testa et al., 
2013). In terms of neuropsychiatric disorders, clinical trials with Alzheimer’s disease 
(Mandel, 2010) and Parkinson’s disease (Bartus et al., 2013; LeWitt et al., 2011) are 
currently been held. A big challenge in the area is imposed by the blood brain barrier 
ability to block the access of the viral vectors to the central nervous system. For this 
reason clinical trials have so far been using intracranial or intracerebrospinal fluid 
injections of the vectors. Attempts with intravenous injection of AVV viral vectors have 
been made, but side effects in other tissues have been reported (Gray et al., 2011), 
making further studies necessary. More studies in the tropism of different types of AVV 
for specific cells are also required. AVV type 2, the one used in this thesis, has been 
shown to have a strong tropism for neuronal cells (Bartlett et al., 1998; Davidson et al., 
2000) and  is a good candidate for treatment of neuropsychiatric disorders. The 
relevance of CaMKII inhibitors in different neuropsychiatric disorders as well as the use 
of our viral vectors solutions in animal models of these diseases are discussed in detail 
at session “5.4 CaMKII endogenous inhibitors as therapeutic target for neuropsychiatric 




The study of the function of CaMKII endogenous inhibitors in other brain regions 
is also an interesting future experiment. The amygdala, for example, would be an area 
of much interest. The amygdala has been shown to play a key role in fear conditioning, 
with lesion of this region causing impairment in both cued and context fear conditioning 
(Phillips and LeDoux, 1992). Furthermore, injection of anisomycin in the amygdala has a 
retrieval-induced amnesic effect (Nader et al., 2000) and increase in c-fos expression has 
been shown to occur in the amygdala after memory retrieval (Do-Monte et al., 2015). 
The amygdala has also been shown to participate in memory destabilization, 
reconsolidation and extinction (Kim et al., 2014; Mamiya et al., 2009; Milton et al., 
2013). Considering this relevance of amygdala in different memory retrieval-induced 
processes and the fact that the endogenous inhibitors of CaMKII are expressed in this 
area of the brain (Chang et al., 2001; Chang et al., 1998; Radwanska et al., 2010), the 
amygdala becomes an interesting candidate for further experiments with our viral 
vector solutions.  
It would also be interesting to study the effects of changes in CaMK2N1 and 
CaMK2N2 expression on different neurotransmitters, besides the glutamatergic system. 
CaMKII has been show to regulate and/or been regulated by serotonin (Asaoka et al., 
2015; Ciccone et al., 2008; Moyano et al., 2004; Steinkellner et al., 2015) and GABA 
(Churn and DeLorenzo, 1998; Ghosh et al., 2015; Marsden et al., 2010; Saliba et al., 2012; 
Zhang et al., 2004), making these two neurotransmitters interesting candidates for more 
studies on the function of CaMKII endogenous inhibitors.  
Experiments with calcium channel and the inhibitors of CaMKII are also 
recommended. It is known that CaMK2N1 blocks binding of CaMKII to the calcium 




ability and if binding to other calcium channels area also affected by the endogenous 
inhibitors of CaMKII. Experiments with CaMK2N2 overexpression might help understand 
the answer to these questions. The calcium channel Cav1.2 is known to bind and be 
phosphorylated by CaMKII, which seems to increase Cav1.2 levels (Hudmon et al., 2005; 
Lee et al., 2006; Simms et al., 2015). Therefore is likely that the endogenous inhibitors 
of CaMKII regulate CaMKII interaction with Cav1.2, but this has not been tested 
experimentally. 
In this thesis we have not assessed any effects on neurogenesis by the two virus 
treatments. The DG is known to be one of the two brain areas where new neurons are 
born throughout adulthood, a process considered to be important for cognition (Lazarov 
et al., 2010; Shors, 2004). Ji et al. (2014) observed that forcing rats to run resulted in 
increase in DG neurogenesis and increase in T286 αCaMKII phosphorylation, and 
combining forced run with whole-brain irradiation reverse the decreased in 
neurogenesis caused by the irradiation as well as increases T286 αCaMKII 
phosphorylation. Furthermore, treatment of cultured DG cells with methamphetamine 
decreases cell proliferation and total CaMKII levels. Combining methamphetamine 
treatment with melatonin treatment attenuated the effects of methamphetamine in cell 
proliferation and CaMKII levels (Ekthuwapranee et al., 2015). Thakker-Varia et al. (2014) 
reported that treatment of cultured hippocampal neurons with the peptide TLQP-62 
increase neuronal proliferation and T286 αCaMKII phosphorylation, while blocking of 
CaMKII by KN-93 blocks the effects of TLQP-62 on neuronal proliferation. Therefore, is 
likely that CaMKII plays an important role in neurogenesis and study the effects of our 





5.4 CaMKII endogenous inhibitors as therapeutic target for 
neuropsychiatric diseases 
Although only ALS (Convertini et al., 2013) and FTLD (unpublished data from Dr. 
Shou-Chien Ling at National University of Singapore) have been directed linked with the 
inhibitors of CaMKII, the study of the functions of CaMK2N1 and CaMKN2 might increase 
knowledge in the field of other dieses that have been related to CaMKII. We have 
proposed in this thesis a role for CaMK2N1 in PTSD and addiction treatment. CaMKII has 
also been suggested to play an important role in depression (Li et al., 2013; Robison, 
2014). Li et al. (2013) observed that βCaMKII expression was increased in the lateral 
habenula of different animal models of depression, and that knockdown of βCaMKII 
expression in this region reduced depression-like behaviours. Therefore, an interest 
experiment would be to test if the injection of our CaMK2N2 virus solution in the lateral 
habenula of animal models of depression decrease depression-like behaviours. 
Additionally, the effect of this treatment could be compared to the effect of 
intraperitoneal injection of tatCN21.  
Another disease that has been related to CaMKII is Alzheimer’s disease (AD). First 
described by Dr. Alois Alzheimer in 1906, AD is the most common cause of dementia and 
is identified by accumulation of beta amyloid (Aβ) plaques, tangles of 
hyperphosphorylated tau protein, and decrease in brain volume. All of those hallmarks 
of AD seem to occur in specific areas of the brain with the hippocampus been one of the 
first to be affected. Furthermore, loss of spatial cognition is one of the first symptoms 
of AD (Agrawal and Biswas, 2015; Fellgiebel and Yakushev, 2011; Hardy and Selkoe, 
2002; Jucker and Walker, 2013; Lage, 2006; Rachakonda et al., 2004; Wang, 2014). Reese 




have an altered distribution of T286 phosphorylated αCaMKII from dendritic 
arborisations to neural perikarya in the hippocampus. This change in distribution of 
αCaMKII correlates with scores in cognitive tests. Additionally, Reese et al. (2011) also 
reported that intracerebroventricular injection of Aβ oligomers in mice resulted in the 
same alterations in T286 phosphorylated αCaMKII localization and treatment of primary 
hippocampal neurons with the same Aβ solution caused a reduction in synaptic spines 
immunostaining. Levels of T286 phosphorylated αCaMKII have also been shown to be 
reduced in the hippocampus of animal models of AD and vascular dementia (Min et al., 
2013). Same AD animal model also presents a decrease in Cav1.2 levels and decrease 
colocalization of CaMKII and Cav1.2 in the hippocampus (Min et al., 2013). Using a rat 
model with hyperhomocysteinemia, a risk factor of AD, Jiang et al. (2015) reported that 
training in MWM task improves animals’ performance in the CFC task and also increases 
hippocampal GluA1 levels and DG dendritic ramification and spine generation. 
Moreover, injection of KN93 into the DG blocked the training-induced cognitive 
improvement, spine generation and dendritic ramification, indicating that DG CaMKII is 
necessary for these MWM training-induced effects (Jiang et al., 2015). It is important to 
remember that loss synapses has the strongest correlation with the cognitive decline of 
AD patients ever observed (DeKosky and Scheff, 1990; Terry et al., 1991). The 
observations of Jiang et al. (2015), Min et al. (2013) and Reese et al. (2011) have 
stablished a direct link between AD and CaMKII, therefore it is possible that the 
endogenous inhibitors of CaMKII may also play a role in the progression of this dieses. 
Interestingly, Ohno (2009) has observed a retrieval-induced memory impairment in 
mutant animals with five AD-related mutations when animals were tested for the 





Changes in CaMKII autophosphorylation has been linked with -thalassemia X-
linked mental retardation (ATRX). ATRX is a syndrome characterized by alterations in 
craniofacial features, genitalia, hypotonia, mild-to-moderate anaemia, intellectual 
disability and developmental delay (Stevenson, 1993). In an ATRX animal model Shioda 
et al. (2011) observed an increase in T286 and T287 CaMKII autophosphorylation and 
elevated CaMKII autonomous activity in the medial prefrontal cortex. This increased 
autophosphorylation seems to be due to decreased levels of PP1, a known phosphatase 
of CaMKII (Blitzer et al., 1998; Brown et al., 2000; Strack et al., 1997), and the increase 
in kinase activity was specific to CaMKII as the activities of CaMKI, CaMKIV, ERK and 
PKC are not changed in the ATRX mouse model (Shioda et al., 2011). On the other hand, 
the hippocampus of the same mouse model has decreased αCaMKII T286 
autophosphorylation (Nogami et al., 2011). These observations suggest that the 
endogenous inhibitors of CaMKII are likely to have a role in ATRX. 
Juvenile male stroke-prone spontaneously hypertensive rats, an animal model of 
attention-deficit/hyperactivity disorder (ADHD), has also shown T286 and T287 CaMKII 
autophosphorylation increase in prefrontal cortex. In this ADHD model GluA1 
phosphorylation at the S831 was also elevated. Furthermore, those animals have 
impaired performance in in the Y-maze and novel object recognition tasks. Interestingly, 
acute treatment with methylphenidate reverts the behavioural phenotypes and 
restores T286/287 and GluA1 phosphorylation to normal levels (Yabuki et al., 2014). 
Experiments with this ADHD model and our virus might also increase knowledge of 
disease-causing mechanisms. ADHD is a disorder that is difficult to diagnose. As 
determined in DSM V (Association, 2013 ) children must have at least six symptoms from 




hyperactivity and impulsivity criteria. Adolescents and adults, on the other hand, must 
have at least five symptoms to reach criteria. Symptoms are various, including for 
example trouble holding attention, excessive talking, trouble waiting, difficulties in 
performing tasks that require prolonged mental effort, trouble organizing tasks and 
activities and many others (Association, 2013 ).  
CaMKII has also been suggested to play role in schizophrenia (Frankland et al., 
2008; Robison, 2014). To diagnose schizophrenia, as defined in the DSM V, the patient 
needs to present two or more of the following symptoms, been mandatory the 
presentation of one of the first 3 symptoms: Delusions; Hallucinations; Disorganized 
speech; Grossly disorganized or catatonic behaviour; Negative symptoms (for example 
diminished emotional expression). Frankland et al. (2008) and Robison (2014) 
suggestion of a possible role of CaMKII in schizophrenia is centred on the observations 
by  Yamasaki et al. (2008) that heterozygous mice for a null mutation in αCaMKII have 
behavioural abnormalities that are also found in patients with schizophrenia, like 
decrease sociability, infradian rhythm (daily cycle of more than 24 hours) and working 
memory deficits. Additionally, Yamasaki et al. (2008) also reported that gene expression 
alterations in the DG of these animals are clustered together with known genetic 
alterations of schizophrenic patients. A possible role for the endogenous inhibitors of 
CaMKII has never been addressed and could increase our knowledge of this complex 
disease.  
Another disease that has been related to CaMKII alterations is Angelman 
syndrome (AS). AS is a neurodevelopment disorder that occurs due to a maternally 
inherited dysfunction in the ubiquitin ligase E3A. AS symptoms include seizures, motor 




et al., 2013). Animals models of AS, with dysfunctional ubiquitin ligase E3A, have a 
reduction in BDNF-induced T286/287 CaMKII phosphorylation in the hippocampus and 
cortex, but increase basal levels of T286/287 phosphorylation in the same areas (Cao et 
al., 2013). Weeber et al. (2003) observed, in the same animal model of AS, an increase 
in hippocampal levels of T286 αCaMKII phosphorylation but also an increase in T305 
phosphorylation and a reduction in CaMKII kinase activity, autophosphorylation 
capability, and CaMKII levels at the PSD. Steinkellner et al. (2012) reported that animals 
with phosphorylation-mimicking mutation of the 305 site of αCaMKII (T305D) have a 
similar impairment in dopamine transport as the one observed in the AS animal model. 
Additionally, AS animal model have memory deficits in the MWM and CFC, but this 
deficits can be reversed by the introduction of a mutation on the T305/306 site of 
CaMKII, blocking its phosphorylation (van Woerden et al., 2007). Considering that the 
endogenous inhibitors of CaMKII are known to block T305 CaMKII phosphorylation (Vest 
et al., 2007) we suggested that changes in CaMK2N1 and CaMK2N2 expression might 
have a potential therapeutic effect on AS.       
Epilepsy is a neurologic disorder characterised by excessive neuronal firing due 
to an imbalance in glutamatergic versus GABAergic neurotransmission, resulting in 
seizures (DiNuzzo et al., 2014; During and Spencer, 1993). CaMKII has also been 
proposed to play a role in epilepsy (Liu and Murray, 2012; Robison, 2014). Different 
epileptic-inducing treatments have been reported to result in a decrease in T286 
phosphorylation. Such treatments include administration of GABA-receptor antagonists 
(Bronstein et al., 1988a; Perlin et al., 1992), pilocarpine-induced seizures (Churn et al., 
2000a; Kochan et al., 2000), kainic acid treatment (Yamagata et al., 2006), and in kindled 




Corroborating with a possible role of CaMKII in epilepsy, Butler et al. (1995) observed 
that αCaMKII knockout results in facilitation of epileptic seizure by electric stimulation 
due to hyperexcitability of limbic structures, including the hippocampus. Moreover, in 
cultured hippocampal neurons with inhibition of αCaMKII expression (Churn et al., 
2000b) or in cultured cortical neurons subjected to tatCN21 treatment (Ashpole et al., 
2012) epileptic-like activity was observed. Considering that decrease in CaMKII 
phosphorylation, expression and activity has been directly linked to epilepsy it is 
possible that inhibition of CaMK2N1 by shCaMK2N1 virus solution might have positive 
effects in the treatment of epilepsy. More experiments are necessary to confirm this 
hypothesis. 
The use of inhibitors of CaMKII in the treatment of cardiological diseases, cancer 
and rheumatoid arthritis has also been suggested (Pellicena and Schulman, 2014; Wang 
et al., 2015c). Table 5.4-1 summarize the neuropsychiatric disorders that have been 












Amyotrophic lateral sclerosis 
Convertini et al. (2013) 
Wang et al. (2008) 
Frontotemporal lobar degeneration 
Wang et al. (2008) 
Alquezar et al. (2014) 
Unpublished data from Dr. Shou-Chien 
Ling at National University of Singapore 
Addiction 
Robison et al. (2013) 
Loweth et al. (2010) 
Loweth et al. (2010) 
Pierce et al. (1998) 
Schopf et al. (2015) 
Easton et al. (2013b) 
Easton et al. (2013c) 
Easton et al. (2013a) 
Post-traumatic stress disorder 
Han et al. (2013) 
Liu et al. (2013) 
Wen et al. (2012) 
Xiao et al. (2009) 
Matsumoto et al. (2013) 
Alzheimer’s diseases 
Jiang et al. (2015) 
Min et al. (2013) 
Reese et al. (2011) 




-thalassemia X-linked mental 
retardation 
Nogami et al. (2011) 
Shioda et al. (2011) 
Attention-deficit/hyperactivity disorder Yabuki et al. (2014) 
Schizophrenia Yamasaki et al. (2008) 
Angelman syndrome 
Cao et al. (2013) 
Weeber et al. (2003) 
Steinkellner et al. (2012) 
van Woerden et al. (2007) 
Epilepsy 
Bronstein et al. (1988a) 
Perlin et al. (1992) 
Churn et al. (2000a) 
Kochan et al. (2000) 
Yamagata et al. (2006) 
Wasterlain and Farber (1984) 
Goldenring et al. (1986) 
Wu et al. (1990) 
Butler et al. (1995) 
Churn et al. (2000b) 
Ashpole et al. (2012) 
Table 5.4-1 Neuropsychiatric disorders related to CaMKII 
This table presents the psychiatric disorders that have been presented in this thesis due to their known association 
with CaMKII or with CaMKII endogenous inhibitors. The first column shows the name of the diseases and the second 
column show the reference that associates it with CaMKII. It is my believe that experiments manipulating CaMK2N1 
and/or CaMK2N2 expression in animal models of these diseases might help increase knowledge of the molecular 







Chapter 6 Conclusion  
In conclusion, we have shown for the first time that CaMK2N1 is necessary for 
memory maintenance after retrieval. We have also shown for the first time that T286 
phosphorylation of CaMKII is decreased 2h after retrieval of 1-shock-induced contextual 
fear memory. The data presented in this thesis seems to suggest that CaMK2N1 is 
expressed after memory retrieval and that this expression is necessary to block CaMKII 
activation, decrease AMPAR levels in the synapses and c-fos nuclear expression in order 
to keep the memory.  
 We have also confirmed that CaMKII activation is necessary for memory 
formation but not for memory maintenance in agreement with Buard et al. (2010) 
observations.  
Therefore this thesis has presented valid new data for the field of molecular bases 
of learning and memory. Our data, allied with different observations reported in the 
literature, suggests the endogenous inhibitors of CaMKII as potential therapeutic target 










Chapter 7 Appendix  
7.1 Sequence information of plasmids  





























































Table 7.1-1 Sequences inserted in the different plasmids 
The sequences presented in this table were inserted in our different plasmids with different proposes. In the column 
“name” is identified which insert is been address and in the column beside it is the sequence of this insert. Sequences 
are presented from 5’ to 3’ direction.  
  
 
7.2 RT-qPCR primers 
Gene Direction Sequence (5’ – 3’) Concentration 
HPRT 
Forward ATACAGGCCAGACTTTGTTGGATT 300nM 
Reverse TCACTAATGACACAAACGTGATTCAA 300nM 
CaMK2N1 
Forward GCTGAAAACCATGACCGACAA 300nM 
Reverse AAGAATAAGAAAGGGAGTTGTGTAAC 300nM 
CaMK2N2 
Forward CGCAGACCCCGAAGGTT 300nM 
Reverse TTGCCAGCGAAGAAGGAGTT 900nM 
Table 7.2-1 Primers' sequence 
Table shows the sequence of the primers used in this thesis for RT-qPCR. Both forward and reverse primers are 






7.3 Solutions & Buffers 
7.3.1 Paraformaldehyde solution 4% 
Reagent Volume or Weight 
Paraformaldehyde 40g 
NaOH (10M) 
(Sigma-Aldrich, St. Louis, MO, USA; 221465) 
≈ 50µL* 
10X PBS 
(Life Technologies, Paisley, UK; 70011-044) 
100mL 
Water Complete volume to 1L 
Table 7.3-1 Paraformaldehyde solution 4% 
This table shows the composition of perfusion solution of PFA 4%. Final pH should be adjusted to 7.5, solution should 
be filtered and stored in 4°C for no longer than a week. Ultrapure water was used for this solution. *More NaOH 
(10M) can be added to the solution to facilitate paraformaldehyde dilution.    
 
 
7.3.2 Reverse transcription solution 
Reagent Volume for 11.5μL of initial solution 
10 mM dNTP mix 1μL 
0.1M DTT 2μL 
RNasin® Inhibitor 0.5μL 
SuperScript® II Reverse 
Transcriptase 
1μL 
5x first strand buffer 4μL 
Table 7.3-2 Reverse transcription solution 
For synthesis of the first strand of cDNA the above solution was used. The table describes the volume of each reagent 
that was added to the initial solution. The initial solution should contain 1.3μg of sample RNA diluted to 10.5μL in 
nuclease free water and also 1μL of oligo(dT)12-18 primer solution. Initial solution has to be incubated at 70°C for 10 
minutes before mixture with the above reverse transcription solution. Reverse transcription solution must be 













7.3.3 RT-qPCR solution 
Reagent Volume for 5μL of cDNA solution 
2x qPCR MasterMix 10µL 
HPRT forward (5µM) 1.2µL 
HPRT reverse (5µM) 1.2µL 
CaMK2N1 forward (5µM) 1.2µL 
CaMK2N1 reverse (5µM) 1.2µL 
CaMK2N2 forward (15µM) 0.4µL 
CaMK2N2 reverse (15µM) 1.2µL 
Water Complete volume to 15µL 
Table 7.3-3 RT-qPCR solution 
Table above describes the volume of each reagent that should be used in RT-qPCR solution. The values presented are 
relative to one sample of 5µL of cDNA solution. Final reaction solution should contain a total of 20µL been 5µL from 
the cDNA sample and 15µL of the RT-qPCR solution. RT-qPCR solution must be prepared as close to moment of use 
as possible and kept on ice until used.  
 
 




(Calbiochem® - Merck Millipore, Darmstadt, Germany; 5737) 
0.32M 
NaHCO3 
(Sigma-Aldrich, St. Louis, MO, USA; S6014) 
1mM 
MgCl2 
(Sigma-Aldrich, St. Louis, MO, USA; M2670) 
1mM 
Hepes 






For 1mL of the above solution** 
Reagent Volume 
Protease inhibitor cocktail 
(Sigma-Aldrich, St. Louis, MO, USA; S8820) 
15µL 
Phosphatase inhibitor cocktail 2 
(Sigma-Aldrich, St. Louis, MO, USA; P5726) 
10µL 
Phosphatase inhibitor cocktail 3 
(Sigma-Aldrich, St. Louis, MO, USA; P0044) 
10µL 
Table 7.3-4 Homogenization buffer for protein extraction 
The composition of the homogenization buffer for protein extraction is described on the table above. All reagents 
should be diluted in ultrapure water. *Final pH of the solution should be 7.4 and stored at 4°C. **Adding of protease 
and phosphatase inhibitors should be done immediately prior to use.  
 
 
7.3.5 4X sample buffer for protein electrophoresis  
5X sample buffer (Stock solution)* 
Reagent Concentration 
Glycerol 
(Sigma-Aldrich, St. Louis, MO, USA; G5516) 
20% v/v 
Sodium dodecyl sulphate (SDS) 
(Sigma-Aldrich, St. Louis, MO, USA; 71727) 
10% w/v 
Trizma® base  
(Sigma-Aldrich, St. Louis, MO, USA; 93349) 
250mM 
Bromophenol blue 
(Sigma-Aldrich, St. Louis, MO, USA; B0126) 
Enough for the solution to get 
blue 
 
4X sample buffer ** 
Reagent Volume 





(Sigma-Aldrich, St. Louis, MO, USA; M6250) 
10µL 
Water 10µL 
Table 7.3-5 4X sample buffer for protein electrophoresis 
SDS based sample buffer was used for electrophoresis in this thesis. All solutions were diluted in ultrapure water. 
*The pH of this solution should be adjusted to 6.7  and it can be stored at RT. **Prior to use the 5X stock solution was 
diluted to 4X, as described in the table, and this solution was stored at -20°C.    
 
  
7.3.6 Running buffer  
10X running buffer 
Reagent Weight 
Glycine 144g 
Trizma® base  
(Sigma-Aldrich, St. Louis, MO, USA; 93349) 
30.2g 
SDS 




volume to 1L 
Table 7.3-6 10X running buffer 
The table above describes the composition of the 10X stock solution of running buffer. This solution can be stored at 



























7.3.7 Transfer buffer  
10X transfer buffer (Stock solution)* 
Reagent Weight 
Glycine 
(Sigma-Aldrich, St. Louis, MO, USA; G8898) 
144g 





1X transfer buffer ** 
Reagent Volume 
10X transfer buffer 150mL 
Methanol 
(Fisher Scientific International, Inc., Hampton, NH, USA;  A4124) 
300mL 
Water 1050mL 
Table 7.3-7 Transfer buffer 
This table describes the composition of the 10X stock solution and 1X transfer buffer solution. Only ultrapure water 
was used. *This stock solution can be stored at RT. **Prior to use the 10X stock solution was diluted to 1X, as described 
in the table. 
 
    
7.3.8 Tris-buffered saline  
10X TBS 
Reagent Weight 
Trizma® base  60g 
NaCl 87g 
Water Complete volume to 1L 
Table 7.3-8 10X TBS 
The table above describes the composition of the 10X stock solution of TBS. This solution can be stored at RT, 
ultrapure water should be used and pH of the solution should be adjusted to 7.5. Prior to use solution should be 














αCaMKII Chemicon (MAB8699) 1:100,000 1:30,000 
CREB** Cell Signaling (9104) 1:1000 1:2000 
GluA1 Millipore (05-855R) 1:1000 1:2000 
pc-Jun Santa Cruz (sc-16312-R) 1:200 1:2000 
NSE Millipore (AB951) 1:60,000 1:20,000 




pCREB** Cell Signaling (9191) 1:1000 1:2000 
pGluA1 Millipore (04-823) 1:1000 1:2000 
pRPT6** Custume design by ProSci 
Inc., Poway, CA, USA 
1:1000 1:20,000 
Rpt6** Enzo (BML-PW9265) 1:500 1:2000 
Shank Millipore (MABN24) 1:1000 1:2000 
Synaptotagmin Sigma (S2177) 1:30,000 1:2000 
Ubiquitin Millipore (05-1307) 1:1000 1:2000 
Zif268 Santa Cruz (sc-110) 1:200 1:2000 
c-fos Abcam (ab7963) 1:500 1:2000 
Lamin B1 Abcam (ab133741) 1:10,000 1:1000 
Table 7.4-1 Primary antibodies 
Table above shows the primary antibodies used in this thesis. Protein targeted by the antibody, manufacturer, dilution 
of the primary and secondary antibodies are presented on the table.  *For samples from fraction S2 a dilution of 
1:1000 was used. For samples from P2 fraction 1:10,000 dilution was used. **For good visualisation of these proteins 






7.5 Example images of western blot membranes 
Images bellow are example of photos taken by chemioluminescent detection of 
different antibodies. Only images for molecules that presented signficitant alterations, 
and their respective internal control, are presented in this section. 
 
 
Figure 7.5-1 Example membrane of Synaptotagmin 
The image above shows an example photo of a membrane tagged for Synaptotagmin. The unique band presented 
after antibody treatment was quantified. Synaptotagmin was used as internal control for samples from P2 fraction. 






Figure 7.5-2 Example membrane of αCaMKII 
This figure shows an example photo of a membrane tagged for αCaMKII. The unique band presented after antibody 
treatment was quantified. Although αCaMKII levels were not significant changed by treatment, αCaMKII levels were 
also used as internal control for the analyses of T286 αCaMKII phosphorylation. Standers of different molecular 
weights can be seen on the first and last lane of the membrane. 
 
Figure 7.5-3 Example membrane of pCaMKII (T286) 
This figure shows an example photo of a membrane tagged for T286 phosphorylation of αCaMKII. The unique band 
presented after antibody treatment was quantified. Standers of different molecular weights can be seen on the first 






Figure 7.5-4 Example membrane of GluA1 
This figure shows an example photo of a membrane tagged for GluA1. The band pointed by the red arrows was 
quantified. Standers of different molecular weights can be seen on the first and last lane of the membrane. 
 
Figure 7.5-5 Example membrane of Lamin B1 
This figure shows an example photo of a membrane tagged for Lamin B1. The band pointed by the red arrows was 
quantified. Lamin B1 was used as internal control for analysis of P1 samples.  Standers of different molecular weights 







Figure 7.5-6 Example membrane of pGluA1 (S831) 
This figure shows an example photo of a membrane tagged for S831 phosphorylation of GluA1. The unique band 
presented after antibody treatment was quantified. Standers of different molecular weights can be seen on the first 
and last lane of the membrane. 
 
 
Figure 7.5-7 Example membrane of Zif268 
This figure shows an example photo of a membrane tagged for Zif268. The band pointed by the red arrows was 






Figure 7.5-8 Example membrane of c-fos 
This figure shows an example photo of a membrane tagged for c-fos. The band pointed by the red arrows was 
quantified. Standers of different molecular weights can be seen on the first and last lane of the membrane. 
 
 
7.6 Failed experiment with CaMK2N2 knockdown  
 
Figure 7.6-1 CaMK2N2 mRNA levels from experiment with CaMK2N2 knockdown 
Quantitative analyses of the levels of CaMK2N2 mRNA, in dorsal hippocampus, 2 weeks after intra-hippocampal 
injection of viral vector solution. Groups are divided between control animals (shControl), animals that received 
injection of viral vector to knockdown CaMK2N2 (shCaMK2N2) and animals that receive injection of a combined 
solutions containing viral vectors to knockdown CaMK2N1 and N2 (shCaMK2N2 + shCaMK2N1). The result indicate 
that treatment with none of the viral vector solution had no effect in CaMK2N2 mRNA levels. CaMK2N2 mRNA levels 





7.7 Failed experiment with CaMK2N1 overexpression 
 
Figure 7.7-1 CaMK2N1 mRNA levels from experiment with CaMK2N1 overexpression 
Quantitative analyses of the levels of CaMK2N1 mRNA, in dorsal hippocampus, 2 weeks after intra-hippocampal 
injection of viral vector solution to overexpress CaMK2N1. The result indicate that treatment with viral vector solution 
had no effect. CaMK2N1 mRNA levels were normalized by HPRTL mRNA levels. All results were standardize to Control 
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